BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 012462
(463 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 250 bits (638), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 126/296 (42%), Positives = 193/296 (65%), Gaps = 3/296 (1%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA-EKE 183
LG F+LR+L++A++ FS +N+LG GG+G VY+G L +G+ VAVK++ Q E +
Sbjct: 22 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ 81
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
F+ EVE I H+NL+RL G+C+ R+LVY Y+ NG++ L L W R
Sbjct: 82 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
++ LG+A+ LAYLH+ +PK++HRD+K++NIL+D++F A V DFGLAKL+ HV
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH--EVNLVDWLK 361
V GT G++APEY +TG +EK+DV+ +GV+LLE ITG+ D R A+ +V L+DW+K
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
++ ++ E +VD +++ +++ + AL C +RPKMS+VVRMLE +
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 245 bits (625), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 124/296 (41%), Positives = 190/296 (64%), Gaps = 3/296 (1%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA-EKE 183
LG F+LR+L++A++ F +N+LG GG+G VY+G L +G VAVK++ Q E +
Sbjct: 14 LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ 73
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
F+ EVE I H+NL+RL G+C+ R+LVY Y+ NG++ L L W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
++ LG+A+ LAYLH+ +PK++HRD+K++NIL+D++F A V DFGLAKL+ HV
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH--EVNLVDWLK 361
V G G++APEY +TG +EK+DV+ +GV+LLE ITG+ D R A+ +V L+DW+K
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
++ ++ E +VD +++ +++ + AL C +RPKMS+VVRMLE +
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 202 bits (513), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 112/284 (39%), Positives = 173/284 (60%), Gaps = 4/284 (1%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
L DLE ATN F + ++G G +G VY+G L +G+ VA+K+ Q +EF E+E +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH +LV L+G+C E +L+Y+Y+ NGNL++ L+G+ ++WE R+++ +G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL-LGAGKSHVTTRVMGTFGY 311
L YLH ++HRD+KS NIL+D++F K++DFG++K G++H+ V GT GY
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
+ PEY G L EKSDVYSFGV+L E + R + P VNL +W + + E+
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+VDPN+ + +L++ TA++C+ SE RP M V+ LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 199 bits (506), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 111/284 (39%), Positives = 172/284 (60%), Gaps = 4/284 (1%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
L DLE ATN F + ++G G +G VY+G L +G+ VA+K+ Q +EF E+E +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH +LV L+G+C E +L+Y+Y+ NGNL++ L+G+ ++WE R+++ +G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL-LGAGKSHVTTRVMGTFGY 311
L YLH ++HRD+KS NIL+D++F K++DFG++K ++H+ V GT GY
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
+ PEY G L EKSDVYSFGV+L E + R + P VNL +W + + E+
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+VDPN+ + +L++ TA++C+ SE RP M V+ LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 161 bits (407), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 107/298 (35%), Positives = 169/298 (56%), Gaps = 19/298 (6%)
Query: 129 HWFTLRDLELATNRFSKE------NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG---- 178
H F+ +L+ TN F + N +GEGG+GVVY+G +N + VAVKK+ V
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 71
Query: 179 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ +++F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 130
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-G 297
+W R K+ G A + +LHE +HRDIKS+NIL+D+ F AK+SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
++ + +R++GT Y+APE A G + KSD+YSFGV+LLE ITG VD R ++ L
Sbjct: 188 QTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
++ + E+ +D + ST +++ A +C+ KRP + +V ++L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 160 bits (405), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 107/298 (35%), Positives = 168/298 (56%), Gaps = 19/298 (6%)
Query: 129 HWFTLRDLELATNRFSKE------NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG---- 178
H F+ +L+ TN F + N +GEGG+GVVY+G +N + VAVKK+ V
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 71
Query: 179 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ +++F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 130
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-G 297
+W R K+ G A + +LHE +HRDIKS+NIL+D+ F AK+SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
++ + R++GT Y+APE A G + KSD+YSFGV+LLE ITG VD R ++ L
Sbjct: 188 QTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
++ + E+ +D + ST +++ A +C+ KRP + +V ++L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 160 bits (404), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 108/298 (36%), Positives = 166/298 (55%), Gaps = 19/298 (6%)
Query: 129 HWFTLRDLELATNRFSKE------NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG---- 178
H F+ +L+ TN F + N +GEGG+GVVY+G +N + VAVKK+ V
Sbjct: 7 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 65
Query: 179 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ +++F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 66 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 124
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+W R K+ G A + +LHE +HRDIKS+NIL+D+ F AK+SDFGLA+
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 299 SHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
V R++GT Y+APE A G + KSD+YSFGV+LLE ITG VD R ++ L
Sbjct: 182 QXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 239
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
++ + E+ +D + ST +++ A +C+ KRP + +V ++L+
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 156 bits (395), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 108/298 (36%), Positives = 162/298 (54%), Gaps = 19/298 (6%)
Query: 129 HWFTLRDLELATNRFSKE------NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG---- 178
H F+ +L+ TN F + N GEGG+GVVY+G +N + VAVKK+ V
Sbjct: 4 HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 62
Query: 179 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ +++F E++ +H+NLV LLG+ +G LVY Y NG+L L + L
Sbjct: 63 ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPL 121
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+W R K+ G A + +LHE +HRDIKS+NIL+D+ F AK+SDFGLA+
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 299 SHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
V +R++GT Y APE A G + KSD+YSFGV+LLE ITG VD R ++ L
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 236
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
++ + E+ +D ST +++ A +C+ KRP + +V ++L+
Sbjct: 237 IKEEIEDEEKTIEDYIDKKXNDADST-SVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 119 bits (297), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 81/227 (35%), Positives = 120/227 (52%), Gaps = 10/227 (4%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK--EFRVEVEAIG 192
D+++ + + +G G +G V+R +GS VAVK ++ AE+ EF EV +
Sbjct: 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGT 250
+RH N+V +G + + +V EY++ G+L + LH GA L R+ +
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDV 146
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
AK + YLH P +VHRD+KS N+L+D + KV DFGL++ L A + GT
Sbjct: 147 AKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPE 204
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
++APE NEKSDVYSFGV+L E T + P + PA V V
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 117 bits (292), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 80/227 (35%), Positives = 120/227 (52%), Gaps = 10/227 (4%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK--EFRVEVEAIG 192
D+++ + + +G G +G V+R +GS VAVK ++ AE+ EF EV +
Sbjct: 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGT 250
+RH N+V +G + + +V EY++ G+L + LH GA L R+ +
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDV 146
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
AK + YLH P +VHR++KS N+L+D + KV DFGL++ L A + GT
Sbjct: 147 AKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPE 204
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
++APE NEKSDVYSFGV+L E T + P + PA V V
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 111 bits (278), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 89/271 (32%), Positives = 134/271 (49%), Gaps = 27/271 (9%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
E V+G G +GVV + VA+K+I + K F VE+ + V H N+V+L G
Sbjct: 14 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
C+ + LV EY G+L LHGA Y T M L ++ +AYLH +
Sbjct: 71 CLNPV--CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 266 VHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
+HRD+K N+L+ K+ DFG A + ++H+T G+ ++APE +E
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSE 183
Query: 325 KSDVYSFGVLLLEAITGRDPVDH-GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383
K DV+S+G++L E IT R P D G PA + W + G+R P I+ P
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---W-AVHNGTR------PPLIKNLPKP 233
Query: 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
SL+T RC D +RP M ++V+++
Sbjct: 234 ---IESLMT--RCWSKDPSQRPSMEEIVKIM 259
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 111 bits (278), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 88/271 (32%), Positives = 133/271 (49%), Gaps = 27/271 (9%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
E V+G G +GVV + VA+K+I + K F VE+ + V H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
C+ + LV EY G+L LHGA Y T M L ++ +AYLH +
Sbjct: 70 CLNPV--CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 266 VHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
+HRD+K N+L+ K+ DFG A + ++H+T G+ ++APE +E
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSE 182
Query: 325 KSDVYSFGVLLLEAITGRDPVDH-GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383
K DV+S+G++L E IT R P D G PA + + G+R P I+ P
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----VHNGTR------PPLIKNLPKP 232
Query: 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
SL+T RC D +RP M ++V+++
Sbjct: 233 ---IESLMT--RCWSKDPSQRPSMEEIVKIM 258
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 107 bits (268), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 88/298 (29%), Positives = 145/298 (48%), Gaps = 46/298 (15%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN----VGQAEKEFRVEVEAI 191
LE+ + E ++G GG+G VYR I G VAVK ++ + Q + R E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGT 250
++H N++ L G C++ + LV E+ G L + L G L W ++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ 114
Query: 251 AKALAYLH-EAIEPKVVHRDIKSSNILI-----DDDFN---AKVSDFGLAKLLGAGKSHV 301
A+ + YLH EAI P ++HRD+KSSNILI + D + K++DFGLA+ + H
Sbjct: 115 ARGMNYLHDEAIVP-IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHR 168
Query: 302 TTRV--MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359
TT++ G + ++APE + ++ SDV+S+GVLL E +TG P +D
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG---------IDG 219
Query: 360 LKMMVGSRRSEEVVD-PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
L + G ++ + P+ P + ++ C +PD RP + ++ L +
Sbjct: 220 LAVAYGVAMNKLALPIPSTCPEPFAKLME-------DCWNPDPHSRPSFTNILDQLTT 270
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 88/292 (30%), Positives = 149/292 (51%), Gaps = 38/292 (13%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKIL--NNVGQAE-----KEFRVEVE 189
LA N E +G+GG+G+V++G L+ + S VA+K ++ ++ G+ E +EF+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ ++ H N+V+L G + RM V E+V G+L H + + W +++++L
Sbjct: 76 IMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLD 130
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFN----AKVSDFGLAKLLGAGKSHVTTR 304
A + Y+ P +VHRD++S NI + D N AKV+DFGL++ H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSG 185
Query: 305 VMGTFGYVAPEY--ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
++G F ++APE A EK+D YSF ++L +TG P D + + ++ M
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE----YSYGKIKFINM 241
Query: 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ EE + P I R R+++ C D +KRP S +V+ L
Sbjct: 242 I-----REEGLRPTIPEDCPPRL--RNVIEL--CWSGDPKKRPHFSYIVKEL 284
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 87/292 (29%), Positives = 148/292 (50%), Gaps = 38/292 (13%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKIL--NNVGQAE-----KEFRVEVE 189
LA N E +G+GG+G+V++G L+ + S VA+K ++ ++ G+ E +EF+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ ++ H N+V+L G + RM V E+V G+L H + + W +++++L
Sbjct: 76 IMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLD 130
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFN----AKVSDFGLAKLLGAGKSHVTTR 304
A + Y+ P +VHRD++S NI + D N AKV+DFG ++ H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSG 185
Query: 305 VMGTFGYVAPEY--ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
++G F ++APE A EK+D YSF ++L +TG P D + + ++ M
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE----YSYGKIKFINM 241
Query: 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ EE + P I R R+++ C D +KRP S +V+ L
Sbjct: 242 I-----REEGLRPTIPEDCPPRL--RNVIEL--CWSGDPKKRPHFSYIVKEL 284
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 103 bits (258), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 87/292 (29%), Positives = 148/292 (50%), Gaps = 38/292 (13%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKIL--NNVGQAE-----KEFRVEVE 189
LA N E +G+GG+G+V++G L+ + S VA+K ++ ++ G+ E +EF+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ ++ H N+V+L G + RM V E+V G+L H + + W +++++L
Sbjct: 76 IMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLD 130
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFN----AKVSDFGLAKLLGAGKSHVTTR 304
A + Y+ P +VHRD++S NI + D N AKV+DF L++ H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSG 185
Query: 305 VMGTFGYVAPEY--ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
++G F ++APE A EK+D YSF ++L +TG P D + + ++ M
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE----YSYGKIKFINM 241
Query: 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ EE + P I R R+++ C D +KRP S +V+ L
Sbjct: 242 I-----REEGLRPTIPEDCPPRL--RNVIEL--CWSGDPKKRPHFSYIVKEL 284
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G +N VA+K I +E++F E E + + H LV+L G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV+E++ +G L +L G E + + L + +AYL EA V+HR
Sbjct: 72 QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 329 YSFGVLLLEAIT-GRDPVDH 347
+SFGVL+ E + G+ P ++
Sbjct: 186 WSFGVLMWEVFSEGKIPYEN 205
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G +N VA+K I +E++F E E + + H LV+L G C+E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV+E++ +G L +L G E + + L + +AYL EA V+HR
Sbjct: 74 QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 329 YSFGVLLLEAIT-GRDPVDH 347
+SFGVL+ E + G+ P ++
Sbjct: 188 WSFGVLMWEVFSEGKIPYEN 207
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G +N VA+K I +E++F E E + + H LV+L G C+E
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV+E++ +G L +L G E + + L + +AYL EA V+HR
Sbjct: 77 QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 329 YSFGVLLLEAIT-GRDPVDH 347
+SFGVL+ E + G+ P ++
Sbjct: 191 WSFGVLMWEVFSEGKIPYEN 210
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 102 bits (254), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G +N VA+K I +E++F E E + + H LV+L G C+E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV+E++ +G L +L G E + + L + +AYL EA V+HR
Sbjct: 74 QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIHR 127
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 329 YSFGVLLLEAIT-GRDPVDH 347
+SFGVL+ E + G+ P ++
Sbjct: 188 WSFGVLMWEVFSEGKIPYEN 207
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 101 bits (252), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G +N VA+K I +E +F E E + + H LV+L G C+E
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV+E++ +G L +L G E + + L + +AYL EA V+HR
Sbjct: 94 QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 329 YSFGVLLLEAIT-GRDPVDH 347
+SFGVL+ E + G+ P ++
Sbjct: 208 WSFGVLMWEVFSEGKIPYEN 227
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G +N VA+K I +E++F E E + + H LV+L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV E++ +G L +L G E + + L + +AYL EA V+HR
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 329 YSFGVLLLEAIT-GRDPVDH 347
+SFGVL+ E + G+ P ++
Sbjct: 189 WSFGVLMWEVFSEGKIPYEN 208
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 86/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGLA++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 30/288 (10%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGS---PVAVKKILNNVGQAEK-EFRVEVEAI 191
E+ +R E ++G G G V G L + G PVA+K + + ++ +F E +
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N++RL G G M+V EY+ NG+L+ +L H G T + +L G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVG 161
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG- 310
+ YL + VHRD+ + N+L+D + KVSDFGL+++L T G
Sbjct: 162 AGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPI 218
Query: 311 -YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM-VGSRR 368
+ APE + SDV+SFGV++ E + + RP + D + + G R
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE-----RPYWNMTNRDVISSVEEGYRL 273
Query: 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ P+ AL + +L C D +RP+ SQ+V +L++
Sbjct: 274 PAPMGCPH--------ALHQLMLD---CWHKDRAQRPRFSQIVSVLDA 310
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 30/288 (10%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGS---PVAVKKILNNVGQAEK-EFRVEVEAI 191
E+ +R E ++G G G V G L + G PVA+K + + ++ +F E +
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N++RL G G M+V EY+ NG+L+ +L H G T + +L G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVG 161
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL--GAGKSHVTTRVMGTF 309
+ YL + VHRD+ + N+L+D + KVSDFGL+++L ++ TT
Sbjct: 162 AGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM-VGSRR 368
+ APE + SDV+SFGV++ E + + RP + D + + G R
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE-----RPYWNMTNRDVISSVEEGYRL 273
Query: 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ P+ AL + +L C D +RP+ SQ+V +L++
Sbjct: 274 PAPMGCPH--------ALHQLMLD---CWHKDRAQRPRFSQIVSVLDA 310
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 29 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 86
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 87 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 143
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 144 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 249
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 250 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 293
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 39 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 96
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 97 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 153
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 154 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 259
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 260 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 303
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 69
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 70 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 126
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 127 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 232
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 233 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 99.0 bits (245), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 127/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL ++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G VY+G V + K+++ + + FR EV + RH N++ +GY +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------GTAKALAYLHEAIE 262
N + QW G+ + E + ++ TA+ + YLH
Sbjct: 104 D----------NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK-- 151
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPE---YAN 318
++HRD+KS+NI + + K+ DFGLA + S + G+ ++APE +
Sbjct: 152 -NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
+ +SDVYS+G++L E +TG P H +N D + MVG R D +
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSH------INNRDQIIFMVG--RGYASPDLSKL 262
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDR 426
+ +A+KR L A CV E+RP Q++ +E ++ + + +R
Sbjct: 263 YKNCPKAMKR--LVA-DCVKKVKEERPLFPQILSSIELLQHSLPKINR 307
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 83/265 (31%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
VLG+G YG+VY G +L N +A+K+I + + E+ H++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 207 IEGIHRMLVYEYVNNGNLEQWLH---GAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
E + E V G+L L G ++ + ++L G L YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLHDN--- 141
Query: 264 KVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL- 321
++VHRDIK N+LI+ K+SDFG +K L AG + T GT Y+APE + G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 322 -LNEKSDVYSFGVLLLEAITGRDPV-DHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
+ +D++S G ++E TG+ P + G P + V K V P E+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-----------VHP--EI 247
Query: 380 RPSTRALKRSLLTALRCVDPDSEKR 404
S A ++ + L+C +PD +KR
Sbjct: 248 PESMSAEAKAFI--LKCFEPDPDKR 270
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 137/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 29 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 88
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL------L 248
RH N++ +GY + ++ QW G+ +H E + +++
Sbjct: 89 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHIIETKFEMIKLIDIAR 138
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 139 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 195
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 249
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 250 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 295
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 84/288 (29%), Positives = 127/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V E + NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 83/265 (31%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
VLG+G YG+VY G +L N +A+K+I + + E+ H++HKN+V+ LG
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLH---GAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
E + E V G+L L G ++ + ++L G L YLH+
Sbjct: 75 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLHDN--- 127
Query: 264 KVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL- 321
++VHRDIK N+LI+ K+SDFG +K L AG + T GT Y+APE + G
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 322 -LNEKSDVYSFGVLLLEAITGRDPV-DHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
+ +D++S G ++E TG+ P + G P + V K V P E+
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-----------VHP--EI 233
Query: 380 RPSTRALKRSLLTALRCVDPDSEKR 404
S A ++ + L+C +PD +KR
Sbjct: 234 PESMSAEAKAFI--LKCFEPDPDKR 256
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 136/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 4 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------ 248
RH N++ +GY + + QW G+ +H E + +++
Sbjct: 64 RHVNILLFMGYSTKP----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 113
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 114 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 170
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 171 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 224
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 225 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 270
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 137/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 30 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL------L 248
RH N++ +GY + ++ QW G+ +H E + +++
Sbjct: 90 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHIIETKFEMIKLIDIAR 139
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 140 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 196
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 250
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 251 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 296
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 136/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 7 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------ 248
RH N++ +GY + + QW G+ +H E + +++
Sbjct: 67 RHVNILLFMGYSTKP----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 116
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 117 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 227
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 228 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 273
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 137/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 7 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------ 248
RH N++ +GY + ++ QW G+ +H E + +++
Sbjct: 67 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHIIETKFEMIKLIDIAR 116
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 117 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 227
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 228 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 273
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 136/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------ 248
RH N++ +GY + + QW G+ +H E + +++
Sbjct: 62 RHVNILLFMGYSTKP----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 112 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 222
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 223 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 84/288 (29%), Positives = 127/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 98
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V E + NG+L+ +L +H T + +L G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRG 155
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 261
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 262 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 87/312 (27%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L + VLG G +G VY+G + PVA+K + G +A EF E +
Sbjct: 35 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 94
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
+ H +LVRLLG C+ + LV + + +G L +++H H + + + + A
Sbjct: 95 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH---EHKDNIGSQLLLNWCVQIA 150
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-GAGKSHVTTRVMGTFG 310
K + YL E ++VHRD+ + N+L+ + K++DFGLA+LL G K +
Sbjct: 151 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 207
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G P E+ D L+ +
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLE------KG 258
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK + L +E + R+ +R+
Sbjct: 259 ERLPQPPI-------CTIDVYMVMVKCWMIDADSRPKFKE----LAAEFSRMARDPQRYL 307
Query: 430 RTQGGTSMEIES 441
QG M++ S
Sbjct: 308 VIQGDDRMKLPS 319
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 84/288 (29%), Positives = 127/288 (44%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVE 189
EL S + V+G G +G V G L S VA+K + VG EK+ F E
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEAS 69
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M+V E + NG+L+ +L +H T + +L G
Sbjct: 70 IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRG 126
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 127 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ +PE SDV+S+G++L E ++ + RP E++ D +K
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIK------ 232
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VD + P L C D RPK Q+V +L+
Sbjct: 233 ----AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 86/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 95 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 146
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS---HVTTRVMGTFGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + H T ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 258
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 259 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 287
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 78/294 (26%), Positives = 139/294 (47%), Gaps = 40/294 (13%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 30 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL------L 248
RH N++ +GY + ++ QW G+ +H E + +++
Sbjct: 90 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHIIETKFEMIKLIDIAR 139
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA--KLLGAGKSHVTTRVM 306
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA K +G SH ++
Sbjct: 140 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLS 195
Query: 307 GTFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
G+ ++APE N +SDVY+FG++L E +TG+ P + +N D + M
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFM 249
Query: 364 VGSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VG + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 250 VG----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 296
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 87/316 (27%), Positives = 148/316 (46%), Gaps = 35/316 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L + VLG G +G VY+G + PVA+K + G +A EF E +
Sbjct: 12 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
+ H +LVRLLG C+ + LV + + +G L +++H H + + + + A
Sbjct: 72 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH---EHKDNIGSQLLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-GAGKSHVTTRVMGTFG 310
K + YL E ++VHRD+ + N+L+ + K++DFGLA+LL G K +
Sbjct: 128 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G P E+ D L+ +
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLE------KG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK + L +E + R+ +R+
Sbjct: 236 ERLPQPPI-------CTIDVYMVMVKCWMIDADSRPKFKE----LAAEFSRMARDPQRYL 284
Query: 430 RTQGGTSMEIESQKEN 445
QG M++ S ++
Sbjct: 285 VIQGDDRMKLPSPNDS 300
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 95.9 bits (237), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 56 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 114
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 115 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 166
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 167 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 278
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 279 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 307
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 95.9 bits (237), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 78/294 (26%), Positives = 139/294 (47%), Gaps = 40/294 (13%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 22 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 81
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL------L 248
RH N++ +GY + ++ QW G+ +H E + +++
Sbjct: 82 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHIIETKFEMIKLIDIAR 131
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA--KLLGAGKSHVTTRVM 306
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA K +G SH ++
Sbjct: 132 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLS 187
Query: 307 GTFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
G+ ++APE N +SDVY+FG++L E +TG+ P + +N D + M
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFM 241
Query: 364 VGSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VG + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 242 VG----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 288
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 96 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 147
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 259
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 260 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 288
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE---KEFRVEVEAIG 192
++ R+ + LG GG VY + I VA+K I + E K F EV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+ H+N+V ++ E LV EY+ L +++ HG L+ + + T +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINF---TNQ 119
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
L + A + ++VHRDIK NILID + K+ DFG+AK L T V+GT Y
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+PE A +E +D+YS G++L E + G P
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 94 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 145
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 146 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 257
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 258 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 286
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 40/294 (13%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------ 248
RH N++ +GY + + QW G+ +H E + +++
Sbjct: 62 RHVNILLFMGYSTKP----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA--KLLGAGKSHVTTRVM 306
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA K +G SH ++
Sbjct: 112 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLS 167
Query: 307 GTFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
G+ ++APE N +SDVY+FG++L E +TG+ P + +N D + M
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFM 221
Query: 364 VGSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VG + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 222 VG----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 29 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 87
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 88 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 139
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 140 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 251
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 252 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 280
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 81/289 (28%), Positives = 139/289 (48%), Gaps = 33/289 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVGQAEKE---FRVEV 188
E+ + +++ V+G G +G VY+G L S PVA+K + G EK+ F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 97
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+G H N++RL G + M++ EY+ NG L+++L G + + +L
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLR 154
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
G A + YL VHRD+ + NIL++ + KVSDFGL+++L T G
Sbjct: 155 GIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 309 FG--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366
+ APE + SDV+SFG+++ E +T + RP E++ + +K +
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVMKAINDG 266
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
R +D PS A+ + + ++C + +RPK + +V +L+
Sbjct: 267 FRLPTPMDC-----PS--AIYQLM---MQCWQQERARRPKFADIVSILD 305
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 90
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 91 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 142
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 143 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 254
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 255 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 283
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 92
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 93 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 144
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 145 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 256
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 257 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 285
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 95 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 146
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 258
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 259 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 287
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 76/293 (25%), Positives = 135/293 (46%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL------ 248
RH N++ +GY + QW G+ +H E + +++
Sbjct: 62 RHVNILLFMGYSTAP----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 112 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 308 TFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE N +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMV 222
Query: 365 GSRRSEEVVDPNI-EVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G + P++ +VR + +A+KR + C+ ++RP Q++ +E
Sbjct: 223 G----RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 95.5 bits (236), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 96 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 147
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 259
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 260 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 288
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 55 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 113
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 114 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 165
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + + + G ++
Sbjct: 166 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 277
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E DP EV L+C P +E RP S++V
Sbjct: 278 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELV 306
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGS---PVAVKKILNNVGQAEKE---FRVEVE 189
E+ + + E V+G G +G V G L + G PVA+K + VG EK+ F E
Sbjct: 18 EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTL--KVGYTEKQRRDFLGEAS 75
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++ L G + M+V EY+ NG+L+ +L ++ G T + +L G
Sbjct: 76 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRG 132
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ + YL + VHRD+ + NILI+ + KVSDFGL+++L T G
Sbjct: 133 ISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ APE SDV+S+G+++ E ++ + RP E+ D +K +
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGE-----RPYWEMTNQDVIKAVEEGY 244
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
R +D AL + +L C + RPK ++V ML+
Sbjct: 245 RLPSPMD-------CPAALYQLMLD---CWQKERNSRPKFDEIVNMLD 282
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 71/230 (30%), Positives = 108/230 (46%), Gaps = 10/230 (4%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEA 190
+L E+ + ++ LG G YG VY G S VAVK + + + E EF E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ ++H NLV+LLG C ++ E++ GNL +L R E VLL
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ------EVSAVVLLYM 114
Query: 251 AKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A ++ E +E K +HRD+ + N L+ ++ KV+DFGL++L+
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358
+ APE + KSDV++FGVLL E T G P P+ L++
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE 224
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGS---PVAVKKILNNVGQAEKE---FRVEVE 189
EL + E V+G G +G V G L + G VA+K + VG EK+ F E
Sbjct: 39 ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL--KVGYTEKQRRDFLCEAS 96
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N+V L G G M+V E++ NG L+ +L +H G T + +L G
Sbjct: 97 IMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR---KHDGQFTVIQLVGMLRG 153
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NIL++ + KVSDFGL++++ V T G
Sbjct: 154 IAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI 210
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ APE SDV+S+G+++ E ++ + RP +++ D +K +
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVIKAIEEGY 265
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
R +D L + +L C + +RPK Q+V +L+
Sbjct: 266 RLPAPMD-------CPAGLHQLMLD---CWQKERAERPKFEQIVGILD 303
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 96 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 147
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 259
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 260 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 305
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 154
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 155 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 206
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 207 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 318
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 319 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGS----PVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 94 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 145
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 146 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 257
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 258 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 303
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 96 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 147
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 259
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 260 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 305
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 42 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 100
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 101 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 152
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 153 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 264
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 265 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 310
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 97 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 148
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 260
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 261 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 306
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G G +G VY G L++ AVK + + ++G+ +F E + H N++
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ T +K L+G AK +
Sbjct: 97 LLGICLRSEG-SPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMK 148
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYV 312
+L K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +VN D ++ RR
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP 260
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
E DP EV L+C P +E RP S++V + + + E H
Sbjct: 261 EYCPDPLYEV-------------MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 306
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 71/230 (30%), Positives = 108/230 (46%), Gaps = 10/230 (4%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEA 190
+L E+ + ++ LG G YG VY G S VAVK + + + E EF E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ ++H NLV+LLG C ++ E++ GNL +L R E VLL
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYM 114
Query: 251 AKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A ++ E +E K +HRD+ + N L+ ++ KV+DFGL++L+
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358
+ APE + KSDV++FGVLL E T G P P+ L++
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE 224
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 77/292 (26%), Positives = 139/292 (47%), Gaps = 36/292 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 6 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 65
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLG--- 249
RH N++ +GY + ++ QW G+ +H E + MK L+
Sbjct: 66 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHASETKFEMKKLIDIAR 115
Query: 250 -TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMG 307
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G
Sbjct: 116 QTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 308 TFGYVAPE---YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
+ ++APE ++ + +SDVY+FG++L E +TG+ P + +N D + MV
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIEMV 226
Query: 365 GSRRSEEVVDPNI-EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
G R S + P++ +VR + + L+ C+ ++RP +++ +E
Sbjct: 227 G-RGS---LSPDLSKVRSNCPKRMKRLMA--ECLKKKRDERPSFPRILAEIE 272
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 42 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 100
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
GY + L+ EY G + + L + T + A AL+Y H
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITELANALSYCHSK--- 153
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE + +
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHD 210
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
EK D++S GVL E + G+ P +
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 86 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 199 VWSFGILLTEIVTHGRIP 216
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLG--- 249
RH N++ +GY + ++ QW G+ +H E + MK L+
Sbjct: 78 RHVNILLFMGYSTKPQLAIVT----------QWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 250 -TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA--KLLGAGKSHVTTRVM 306
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA K +G SH ++
Sbjct: 128 QTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLS 183
Query: 307 GTFGYVAPE---YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
G+ ++APE ++ + +SDVY+FG++L E +TG+ P + +N D + M
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIEM 237
Query: 364 VGSRRSEEVVDPNI-EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VG R S + P++ +VR + + L+ C+ ++RP +++ +E
Sbjct: 238 VG-RGS---LSPDLSKVRSNCPKRMKRLMA--ECLKKKRDERPSFPRILAEIE 284
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 77/228 (33%), Positives = 116/228 (50%), Gaps = 27/228 (11%)
Query: 121 EFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA 180
EF + GW +++L+L +G+G +G V G+ G+ VAVK I N+
Sbjct: 182 EFYRSGWA--LNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--T 229
Query: 181 EKEFRVEVEAIGHVRHKNLVRLLGYCIE---GIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
+ F E + +RH NLV+LLG +E G++ +V EY+ G+L +L R
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYLRS--RGRSV 285
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
L + +K L +A+ YL VHRD+ + N+L+ +D AKVSDFGL K A
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EAS 340
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ T ++ + APE + KSDV+SFG+LL E + GR P
Sbjct: 341 STQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 10/230 (4%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEA 190
+L E+ + ++ LG G +G VY G S VAVK + + + E EF E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ ++H NLV+LLG C ++ E++ GNL +L R E VLL
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYM 114
Query: 251 AKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A ++ E +E K +HRD+ + N L+ ++ KV+DFGL++L+
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358
+ APE + KSDV++FGVLL E T G P P+ L++
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE 224
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 89 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 141
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 202 VWSFGILLTEIVTHGRIP 219
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 88 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 140
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 201 VWSFGILLTEIVTHGRIP 218
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 80 GYFHDATRVYLILEYAPRGEVYKELQKLSKFD-----EQRTATYITELANALSYCHSK-- 132
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 188
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 80/298 (26%), Positives = 136/298 (45%), Gaps = 32/298 (10%)
Query: 127 WGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEK 182
WG ++++++ + E V+G G +G V RG L S VA+K + + ++
Sbjct: 2 WGSMEFAKEIDVSYVKI--EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR 59
Query: 183 -EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE 241
EF E +G H N++RL G + M++ E++ NG L+ +L + G T
Sbjct: 60 REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVI 116
Query: 242 ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
+ +L G A + YL E VHRD+ + NIL++ + KVSDFGL++ L S
Sbjct: 117 QLVGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 173
Query: 302 T-TRVMG---TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
T T +G + APE SD +S+G+++ E ++ + RP +++
Sbjct: 174 TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE-----RPYWDMSNQ 228
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
D ++ + + + P + S L L C D RP+ QVV L+
Sbjct: 229 D----VINAIEQDYRLPPPPDCPTSLHQL------MLDCWQKDRNARPRFPQVVSALD 276
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 77/228 (33%), Positives = 116/228 (50%), Gaps = 27/228 (11%)
Query: 121 EFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA 180
EF + GW +++L+L +G+G +G V G+ G+ VAVK I N+
Sbjct: 10 EFYRSGWA--LNMKELKLL-------QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA--T 57
Query: 181 EKEFRVEVEAIGHVRHKNLVRLLGYCIE---GIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
+ F E + +RH NLV+LLG +E G++ +V EY+ G+L +L R
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYLRS--RGRSV 113
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
L + +K L +A+ YL VHRD+ + N+L+ +D AKVSDFGL K A
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EAS 168
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ T ++ + APE + KSDV+SFG+LL E + GR P
Sbjct: 169 STQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 33 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 91
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
GY + L+ EY G + + L + T + A AL+Y H
Sbjct: 92 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITELANALSYCHSK--- 144
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE + +
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHD 201
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
EK D++S GVL E + G+ P +
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFE 224
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 80 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 82 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 134
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 195 VWSFGILLTEIVTHGRIP 212
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 86 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 199 VWSFGILLTEIVTHGRIP 216
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 10 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 68
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 69 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 122
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 182
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 81 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 133
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 194 VWSFGILLTEIVTHGRIP 211
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 80 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 10 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 68
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 69 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 122
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 182
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 90 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 142
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 203 VWSFGILLTEIVTHGRIP 220
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 14 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 126
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 186
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 85 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 137
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 198 VWSFGILLTEIVTHGRIP 215
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 92.0 bits (227), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 82/303 (27%), Positives = 137/303 (45%), Gaps = 39/303 (12%)
Query: 131 FTLRDLELATNRFSKE---------NVLGEGGYGVVYRGNL-INGSP---VAVKKILNNV 177
FT D A F+KE V+G G +G V G+L + G VA+K + +
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 178 GQAEK-EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG 236
+ ++ +F E +G H N++ L G + M++ E++ NG+L+ +L ++ G
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 130
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
T + +L G A + YL + VHRD+ + NIL++ + KVSDFGL++ L
Sbjct: 131 QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 297 GKSHVT-TRVMG---TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
S T T +G + APE SDV+S+G+++ E ++ + RP
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYW 242
Query: 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ D + + R +D AL + +L C D RPK Q+V
Sbjct: 243 DMTNQDVINAIEQDYRLPPPMD-------CPSALHQLMLD---CWQKDRNHRPKFGQIVN 292
Query: 413 MLE 415
L+
Sbjct: 293 TLD 295
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 92.0 bits (227), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 126/279 (45%), Gaps = 30/279 (10%)
Query: 146 ENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLV 200
E V+G G +G V RG L S VA+K + + ++ EF E +G H N++
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
RL G + M++ E++ NG L+ +L + G T + +L G A + YL E
Sbjct: 81 RLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-TRVMG---TFGYVAPEY 316
VHRD+ + NIL++ + KVSDFGL++ L S T T +G + APE
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
SD +S+G+++ E ++ + RP +++ D + + R + P
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGE-----RPYWDMSNQDVINAIEQDYR----LPPP 245
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ S L L C D RP+ QVV L+
Sbjct: 246 PDCPTSLHQL------MLDCWQKDRNARPRFPQVVSALD 278
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 14 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 73 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 126
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 14 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 126
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 78 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 186
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 73/228 (32%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQ 179
LG +TL D ++ LG+G +G VY + I V K L G
Sbjct: 3 LGSKRQWTLEDFDIG-------RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG- 54
Query: 180 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
E + R EVE H+RH N++RL GY + L+ EY G + + L R
Sbjct: 55 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---- 110
Query: 240 WEARMKVLLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
E R + A AL+Y H +V+HRDIK N+L+ + K++DFG + + A
Sbjct: 111 -EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPS 164
Query: 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
S TT + GT Y+ PE + +EK D++S GVL E + G P +
Sbjct: 165 SRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 11 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 69
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 70 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 123
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 183
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 79/293 (26%), Positives = 140/293 (47%), Gaps = 38/293 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLG--- 249
RH N++ +GY ++ QW G+ +H E + MK L+
Sbjct: 78 RHVNILLFMGYSTAPQLAIVT----------QWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 250 -TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA--KLLGAGKSHVTTRVM 306
TA+ + YLH ++HRD+KS+NI + +D K+ DFGLA K +G SH ++
Sbjct: 128 QTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLS 183
Query: 307 GTFGYVAPE---YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
G+ ++APE ++ + +SDVY+FG++L E +TG+ P + +N D + M
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIEM 237
Query: 364 VGSRRSEEVVDPNI-EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
VG R S + P++ +VR + + L+ C+ ++RP +++ +E
Sbjct: 238 VG-RGS---LSPDLSKVRSNCPKRMKRLMA--ECLKKKRDERPSFPRILAEIE 284
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 14 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQIS 126
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 74
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 75 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 127
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 183
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 80 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 71
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 125
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 121
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 91.7 bits (226), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 14 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 126
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 68 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQIS 121
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 86/323 (26%), Positives = 144/323 (44%), Gaps = 43/323 (13%)
Query: 131 FTLRDLELATNRFSKE---------NVLGEGGYGVVYRGNL-INGS---PVAVKKI-LNN 176
FT D A F+KE V+G G +G V G L + G VA+K +
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 177 VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG 236
+ ++F E +G H N++ L G + M++ EY+ NG+L+ +L ++ G
Sbjct: 70 TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDG 126
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
T + +L G + YL + VHRD+ + NIL++ + KVSDFG++++L
Sbjct: 127 RFTVIQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 297 GKSHVTTRVMGTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHE 353
T G + APE SDV+S+G+++ E ++ +G RP +
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------YGERPYWD 237
Query: 354 VNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
++ D +K + R +D I AL + +L C + RPK Q+V M
Sbjct: 238 MSNQDVIKAIEEGYRLPPPMDCPI-------ALHQLMLD---CWQKERSDRPKFGQIVNM 287
Query: 414 LESEEYPIVREDRRHRRTQGGTS 436
L+ ++R +RT +S
Sbjct: 288 LDK----LIRNPNSLKRTGSESS 306
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 76/224 (33%), Positives = 114/224 (50%), Gaps = 25/224 (11%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF 184
LG G +++L+L +G+G +G V G+ G+ VAVK I N+ + F
Sbjct: 3 LGSGWALNMKELKLL-------QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA--TAQAF 52
Query: 185 RVEVEAIGHVRHKNLVRLLGYCIE---GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE 241
E + +RH NLV+LLG +E G++ +V EY+ G+L +L R L +
Sbjct: 53 LAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYLRS--RGRSVLGGD 108
Query: 242 ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
+K L +A+ YL VHRD+ + N+L+ +D AKVSDFGL K A +
Sbjct: 109 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD 163
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
T ++ + APE + KSDV+SFG+LL E + GR P
Sbjct: 164 TGKL--PVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 68 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQIS 121
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 80 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 132
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 188
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQIS 121
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 22 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 80
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 81 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 134
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 194
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQIS 121
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 15 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 73
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 74 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 126
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 127 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 182
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFE 206
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 121
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 85/281 (30%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI--NGSP--VAVKKI-LNNVGQAE-KEFRV 186
L D+ + N +LGEG +G V GNL +G+ VAVK + L+N Q E +EF
Sbjct: 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 187 EVEAIGHVRHKNLVRLLGYCIE----GIHR-MLVYEYVNNGNLEQWLHGAMRHHG--YLT 239
E + H N++RLLG CIE GI + M++ ++ G+L +L + G ++
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ +K ++ A + YL +HRD+ + N ++ DD V+DFGL+K + +G
Sbjct: 146 LQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 300 HVTTRVMGT-FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLV 357
+ R+ ++A E + KSDV++FGV + E T G P G HE +
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP-GVQNHE--MY 259
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPS---TRALKRSLLTALR 395
D+L ++ E+ +D E+ S T L R + LR
Sbjct: 260 DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 11 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 69
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 70 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 123
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 11 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 69
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 70 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 123
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 75 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 187
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 188 VWSFGILLTEIVTHGRIP 205
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 78 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 186
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 17 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 73
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 74 SEEPIY--IVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 187 SDVWSFGILLTELTTKGRVP 206
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 13 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 73 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVR---EHKDNIGSQYLLNWCVQIA 128
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 236
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 237 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 285
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 286 VIQGDERMHLPSPTDSN 302
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 74
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 75 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 127
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S T + GT Y+ PE +
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDYLPPEMIEGRMH 183
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 15 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 71
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 72 SEEPIY--IVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 185 SDVWSFGILLTELTTKGRVP 204
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 16 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 76 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 131
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 239
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 240 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 288
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 289 VIQGDERMHLPSPTDSN 305
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 13 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 73 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 128
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 236
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 237 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 285
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 286 VIQGDERMHLPSPTDSN 302
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 236 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 284
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 285 VIQGDERMHLPSPTDSN 301
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 75
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 128
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + A S TT + GT Y+ PE +
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT-LSGTLDYLPPEMIEGRMH 184
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 80 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ A F LG+G +G VY + I V K L G E + R EVE
Sbjct: 8 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQ 66
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-T 250
H+RH N++RL GY + L+ EY G + + L + E R +
Sbjct: 67 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITEL 121
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A AL+Y H +V+HRDIK N+L+ K++DFG + + A S TT + GT
Sbjct: 122 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLD 175
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
Y+ PE + +EK D++S GVL E + G+ P +
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 75 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 130
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 238
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 239 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 287
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 288 VIQGDERMHLPSPTDSN 304
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 74 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 237
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 238 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 286
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 287 VIQGDERMHLPSPTDSN 303
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVR---EHKDNIGSQYLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 236 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 284
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 285 VIQGDERMHLPSPTDSN 301
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 75 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 130
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 238
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 239 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 287
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 288 VIQGDERMHLPSPTDSN 304
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 236 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 284
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 285 VIQGDERMHLPSPTDSN 301
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 19 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 79 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 134
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 242
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 243 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 291
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 292 VIQGDERMHLPSPTDSN 308
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 121
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 229
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 230 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 278
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 279 VIQGDERMHLPSPTDSN 295
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 75 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 130
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 238
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 239 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 287
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 288 VIQGDERMHLPSPTDSN 304
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 74 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 237
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 238 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 286
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 287 VIQGDERMHLPSPTDSN 303
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 37 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 97 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 152
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 260
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 261 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 309
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 310 VIQGDERMHLPSPTDSN 326
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 18 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 78 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 133
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 241
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 242 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 290
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 291 VIQGDERMHLPSPTDSN 307
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 10/216 (4%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEA 190
++ E+ + ++ LG G YG VY G S VAVK + + + E EF E
Sbjct: 23 SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 81
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ ++H NLV+LLG C +V EY+ GNL +L R E VLL
Sbjct: 82 MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLYM 135
Query: 251 AKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A ++ E +E K +HRD+ + N L+ ++ KV+DFGL++L+
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI 195
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ APE + KSDV++FGVLL E T G P
Sbjct: 196 KWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 75
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 128
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S T + GT Y+ PE +
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 74
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 75 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 127
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S T + GT Y+ PE +
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 80 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 132
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S T + GT Y+ PE +
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 80 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 132
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEXIEGRXH 188
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ A F LG+G +G VY + I V K L G E + R EVE
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQ 62
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-T 250
H+RH N++RL GY + L+ EY G + + L + E R +
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITEL 117
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A AL+Y H +V+HRDIK N+L+ K++DFG + S T + GT
Sbjct: 118 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLD 171
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
Y+ PE + +EK D++S GVL E + G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVYRG-----NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY I V K L G E + R EVE H+RH N++RL
Sbjct: 13 LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 71
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 72 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 124
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S TT + GT Y+ PE +
Sbjct: 125 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 180
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFE 204
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 23 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY+N G+L +L G YL + + A +AY+
Sbjct: 80 SEEPIY--IVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 23 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY+N G+L +L G YL + + A +AY+
Sbjct: 80 SEEPIY--IVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 18 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 76
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 77 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 129
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K+++FG + + A S TT + GT Y+ PE +
Sbjct: 130 -RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 185
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFE 209
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 29/265 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+++ +N Q +KE + E+ + ++ N+
Sbjct: 24 RFEK---IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNI 79
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R +AL +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS 134
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S +T V GT ++APE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E I G P + P + L + + + E+ +P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 240
Query: 380 RPSTRALKRSLLTALRCVDPDSEKR 404
A+ R L RC+D D EKR
Sbjct: 241 --KLSAIFRDFLN--RCLDMDVEKR 261
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 74
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 75 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 127
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S T + GT Y+ PE +
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
+G+G +G V G+ G+ VAVK I N+ + F E + +RH NLV+LLG
Sbjct: 12 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 207 IE---GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
+E G++ +V EY+ G+L +L R L + +K L +A+ YL
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
VHRD+ + N+L+ +D AKVSDFGL K A + T ++ + APE +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFS 177
Query: 324 EKSDVYSFGVLLLEAIT-GRDP 344
KSDV+SFG+LL E + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQ 179
LG +TL D ++ LG+G +G VY + I V K L G
Sbjct: 3 LGSKRQWTLEDFDIG-------RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG- 54
Query: 180 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
E + R EVE H+RH N++RL GY + L+ EY G + + L R
Sbjct: 55 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---- 110
Query: 240 WEARMKVLLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
E R + A AL+Y H +V+HRDIK N+L+ + K++DFG + + A
Sbjct: 111 -EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPS 164
Query: 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
S T + GT Y+ PE + +EK D++S GVL E + G P +
Sbjct: 165 SRRDT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 78 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K+++FG + + A S TT + GT Y+ PE +
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMH 186
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 79
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
GY + L+ EY G + + L + T + A AL+Y H
Sbjct: 80 GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT----ATYITELANALSYCHSK--- 132
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
+V+HRDIK N+L+ K++DFG + S + GT Y+ PE + +
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTLDYLPPEMIEGRMHD 189
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
EK D++S GVL E + G+ P +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 26 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 83 SEEPIY--IVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD+ ++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 22 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 82 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 137
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 245
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I ++ +C D++ RPK +++ E + R+ +R+
Sbjct: 246 ERLPQPPICTIDVYMIMR-------KCWMIDADSRPKFRELI----IEFSKMARDPQRYL 294
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 295 VIQGDERMHLPSPTDSN 311
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 75
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 128
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + + A S T + GT Y+ PE +
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT-LCGTLDYLPPEMIEGRMH 184
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VAVK L + F E + ++H+ LVRL
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
E I+ ++ EY+ NG+L +L LT + + A+ +A++ E +H
Sbjct: 76 EPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
R+++++NIL+ D + K++DFGLA+L+ + + APE N G KSD
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E +T GR P
Sbjct: 189 VWSFGILLTEIVTHGRIP 206
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 42 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 100
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
GY + L+ EY G + + L + T + A AL+Y H
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITELANALSYCHSK--- 153
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
+V+HRDIK N+L+ K++DFG + S + GT Y+ PE + +
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
EK D++S GVL E + G+ P +
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 75 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 130
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 238
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I ++ +C D++ RPK +++ E + R+ +R+
Sbjct: 239 ERLPQPPICTIDVYMIMR-------KCWMIDADSRPKFRELI----IEFSKMARDPQRYL 287
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 288 VIQGDERMHLPSPTDSN 304
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L E
Sbjct: 16 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
+V EY++ G+L +L G YL + + A +AY+ VHR
Sbjct: 75 E-PIXIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 128
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D++++NIL+ ++ KV+DFGLA+L+ + + APE A G KSDV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 329 YSFGVLLLEAIT-GRDP 344
+SFG+LL E T GR P
Sbjct: 189 WSFGILLTELTTKGRVP 205
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 193 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 249
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G M YL + + A +AY+
Sbjct: 250 SEEPIY--IVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGL +L+ + + APE A G K
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 363 SDVWSFGILLTELTTKGRVP 382
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 274
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQIS 328
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HR++ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+ ++ +A KE E +
Sbjct: 46 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 161
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 162 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 269
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 270 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 318
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 319 VIQGDERMHLPSPTDSN 335
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 146/317 (46%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 9 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 69 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 124
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
+ + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 125 EGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 232
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 233 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 281
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 282 VIQGDERMHLPSPTDSN 298
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VL G +G VY+G I PVA+K++ +A KE E +
Sbjct: 19 LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 79 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 134
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 242
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 243 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 291
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 292 VIQGDERMHLPSPTDSN 308
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 18 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 76
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 77 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 129
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S + GT Y+ PE +
Sbjct: 130 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFE 209
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNV----GQAEKEFRVEVEAIGHVRHKNLVRLLG 204
LG+G +G VY N + K+L E + R EVE H+RH N++RL G
Sbjct: 16 LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEP 263
Y + L+ EY G + + L + E R + A AL+Y H
Sbjct: 76 YFHDSTRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK--- 127
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
KV+HRDIK N+L+ K++DFG + S + GT Y+ PE + +
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
EK D++S GVL E + G+ P +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 213 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 271
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 272 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 325
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HR++ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 326 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 385
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 386 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 416
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 19 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 75
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G YL + + A +AY+
Sbjct: 76 SEEPIY--IVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 189 SDVWSFGILLTELTTKGRVP 208
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 21/272 (7%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNV--GQAEKEFRVEVEAIGHVRHKN 198
F E +G G + VYR L++G PVA+KK+ + ++ +A + E++ + + H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+++ IE +V E + G+L + + + + K + AL ++H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+V+HRDIK +N+ I K+ D GL + + K+ ++GT Y++PE +
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIH 209
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
N KSD++S G LL E + P +G D + + ++ E+ P +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF-YG---------DKMNLYSLCKKIEQCDYPPLP 259
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ L R L+ C++PD EKRP ++ V
Sbjct: 260 SDHYSEEL-RQLVNM--CINPDPEKRPDVTYV 288
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 88.6 bits (218), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 148 VLGEGGYG----VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
VLG+G +G V +R G + +K+++ + ++ F EV+ + + H N+++ +
Sbjct: 17 VLGKGCFGQAIKVTHRET---GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G + + EY+ G L + + W R+ A +AYLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY---PWSQRVSFAKDIASGMAYLHSM--- 127
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-------------TRVMGTFG 310
++HRD+ S N L+ ++ N V+DFGLA+L+ K+ V+G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
++APE N +EK DV+SFG++L E I GR D P + +D+ + G +
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCE-IIGRVNAD---PDYLPRTMDFGLNVRGF--LD 241
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
PN PS + +RC D D EKRP ++ LE+
Sbjct: 242 RYCPPNCP--PSFFPI------TVRCCDLDPEKRPSFVKLEHWLET 279
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + + A K+F E E + +++H+++V+
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG-------------YLTWEARMKVLLG 249
G C+EG ++V+EY+ +G+L ++L R HG LT + +
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFL----RAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTRVMGT 308
A + YL VHRD+ + N L+ ++ K+ DFG+++ + V M
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++ PE +SDV+S GV+L E T G+ P
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK + + + E EF E + ++
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 313
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQIS 367
Query: 256 YLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
E +E K +HR++ + N L+ ++ KV+DFGL++L+ + AP
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 427
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
E + KSDV++FGVLL E T G P
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILN--NVGQAEKEFRV-EVEAIGHVRHKNLVRLLG 204
+G G YG + + + V K L+ ++ +AEK+ V EV + ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 205 YCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
I+ + L V EY G+L + + YL E ++V+ AL H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 263 P--KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
V+HRD+K +N+ +D N K+ DFGLA++L S T V GT Y++PE N
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
NEKSD++S G LL E P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VL G +G VY+G I PVA+K++ +A KE E +
Sbjct: 12 LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 236 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 284
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 285 VIQGDERMHLPSPTDSN 301
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VL G +G VY+G I PVA+K++ +A KE E +
Sbjct: 19 LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 79 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 134
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 242
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 243 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 291
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 292 VIQGDERMHLPSPTDSN 308
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 16 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 76 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 131
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFG AKLLGA K +
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 239
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 240 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 288
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 289 VIQGDERMHLPSPTDSN 305
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L E
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 209 -GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
I+ +V EY++ G+L +L G YL + + A +AY+ VH
Sbjct: 251 EPIY--IVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ ++ KV+DFGLA+L+ + + APE A G KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E T GR P
Sbjct: 364 VWSFGILLTELTTKGRVP 381
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 74 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFG AKLLGA K +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 237
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 238 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 286
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 287 VIQGDERMHLPSPTDSN 303
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+++ +N Q +KE + E+ + ++ N+
Sbjct: 24 RFEK---IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNI 79
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R +AL +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS 134
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S + ++GT ++APE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTR 190
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E I G P + P + L + + + E+ +P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 240
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC+D D EKR ++++
Sbjct: 241 --KLSAIFRDFLN--RCLDMDVEKRGSAKELLQ 269
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 78 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S + GT Y+ PE +
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ A F LG+G +G VY + I V K L G E + R EVE
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQ 62
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-T 250
H+RH N++RL GY + L+ EY G + + L + E R +
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITEL 117
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A AL+Y H +V+HRDIK N+L+ K++DFG + S + GT
Sbjct: 118 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLD 171
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
Y+ PE + +EK D++S GVL E + G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ A F LG+G +G VY + I V K L G E + R EVE
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQ 62
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-T 250
H+RH N++RL GY + L+ EY G + + L + E R +
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITEL 117
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A AL+Y H +V+HRDIK N+L+ K++DFG + S + GT
Sbjct: 118 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLD 171
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
Y+ PE + +EK D++S GVL E + G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 275 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 331
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G YL + + A +AY+
Sbjct: 332 SEEPIY--IVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G VY + I V K L G E + R EVE H+RH N++RL
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLY 77
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIE 262
GY + L+ EY G + + L + E R + A AL+Y H
Sbjct: 78 GYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANALSYCHSK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+V+HRDIK N+L+ K++DFG + S + GT Y+ PE +
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+EK D++S GVL E + G+ P +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L E
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 209 -GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
I+ +V EY++ G+L +L G YL + + A +AY+ VH
Sbjct: 251 EPIY--IVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RD++++NIL+ ++ KV+DFGLA+L+ + + APE A G KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 328 VYSFGVLLLEAIT-GRDP 344
V+SFG+LL E T GR P
Sbjct: 364 VWSFGILLTELTTKGRVP 381
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFG AKLLGA K +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 236 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 284
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 285 VIQGDERMHLPSPTDSN 301
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 10/213 (4%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
+EL + LG G +GVV G VAVK I +E EF E + + +
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLS 61
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY-LTWEARMKVLLGTAKAL 254
H LV+ G C + +V EY++NG L +L R HG L +++ + +
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGM 117
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
A+L + +HRD+ + N L+D D KVSDFG+ + + + + + AP
Sbjct: 118 AFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
E + + KSDV++FG+L+ E + G+ P D
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 19 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 79 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 134
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFG AKLLGA K +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 242
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK +++ E + R+ +R+
Sbjct: 243 ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELI----IEFSKMARDPQRYL 291
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 292 VIQGDERMHLPSPTDSN 308
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 70/228 (30%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQ 179
LG W L D E+ LG+G +G VY + I V K L G
Sbjct: 3 LGSRQW-ALEDFEIG-------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG- 53
Query: 180 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
E + R EVE H+RH N++RL GY + L+ EY G + + L +
Sbjct: 54 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---- 109
Query: 240 WEARMKVLLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
E R + A AL+Y H +V+HRDIK N+L+ K++DFG +
Sbjct: 110 -EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAP 162
Query: 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
S + GT Y+ PE + +EK D++S GVL E + G+ P +
Sbjct: 163 SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G NG+ K L + + F E + + +RH+ LV+L Y +
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V EY++ G+L +L G YL + + A +AY+
Sbjct: 249 SEEPIY--IVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE A G K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 81/308 (26%), Positives = 140/308 (45%), Gaps = 34/308 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGS---PVAVKKI-LNNVGQAEKEFRVEVEAI 191
E+ + E V+G G +G V G L + G VA+K + + ++F E +
Sbjct: 4 EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N++ L G + M++ EY+ NG+L+ +L ++ G T + +L G
Sbjct: 64 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIG 120
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG- 310
+ YL + VHRD+ + NIL++ + KVSDFG++++L T G
Sbjct: 121 SGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 311 -YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVGSRR 368
+ APE SDV+S+G+++ E ++ +G RP +++ D +K + R
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYR 231
Query: 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
+D I AL + +L C + RPK Q+V ML+ ++R
Sbjct: 232 LPPPMDCPI-------ALHQLMLD---CWQKERSDRPKFGQIVNMLDK----LIRNPNSL 277
Query: 429 RRTQGGTS 436
+RT +S
Sbjct: 278 KRTGSESS 285
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 81/308 (26%), Positives = 140/308 (45%), Gaps = 34/308 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGS---PVAVKKI-LNNVGQAEKEFRVEVEAI 191
E+ + E V+G G +G V G L + G VA+K + + ++F E +
Sbjct: 10 EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N++ L G + M++ EY+ NG+L+ +L ++ G T + +L G
Sbjct: 70 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIG 126
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG- 310
+ YL + VHRD+ + NIL++ + KVSDFG++++L T G
Sbjct: 127 SGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 311 -YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVGSRR 368
+ APE SDV+S+G+++ E ++ +G RP +++ D +K + R
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYR 237
Query: 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
+D I AL + +L C + RPK Q+V ML+ ++R
Sbjct: 238 LPPPMDCPI-------ALHQLMLD---CWQKERSDRPKFGQIVNMLDK----LIRNPNSL 283
Query: 429 RRTQGGTS 436
+RT +S
Sbjct: 284 KRTGSESS 291
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N SP VAVK + + A K+F+ E E + +++H+++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWL--HG--AM--------RHHGYLTWEARMKVLLGT 250
G C +G ++V+EY+ +G+L ++L HG AM + G L + +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTRVMGTF 309
A + YL VHRD+ + N L+ + K+ DFG+++ + V M
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++ PE +SDV+SFGV+L E T G+ P
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 74 ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFG AKLLGA K +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 237
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I ++ +C D++ RPK +++ E + R+ +R+
Sbjct: 238 ERLPQPPICTIDVYMIMR-------KCWMIDADSRPKFRELI----IEFSKMARDPQRYL 286
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 287 VIQGDERMHLPSPTDSN 303
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+++ +N Q +KE + E+ + ++ N+
Sbjct: 25 RFEK---IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNI 80
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R +AL +LH
Sbjct: 81 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS 135
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HR+IKS NIL+ D + K++DFG + +S +T V GT ++APE
Sbjct: 136 N---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 191
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E I G P + P + L + + + E+ +P
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 241
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC++ D EKR ++++
Sbjct: 242 --KLSAIFRDFLN--RCLEMDVEKRGSAKELIQ 270
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 29/273 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+++ +N Q +KE + E+ + ++ N+
Sbjct: 25 RFEK---IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNI 80
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R +AL +LH
Sbjct: 81 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS 135
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S + V GT ++APE
Sbjct: 136 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTR 191
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E I G P + P + L + + + E+ +P
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 241
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC++ D EKR ++++
Sbjct: 242 --KLSAIFRDFLN--RCLEMDVEKRGSAKELIQ 270
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 83/317 (26%), Positives = 145/317 (45%), Gaps = 35/317 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 74 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFG AKLLGA K +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 237
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I ++ +C D++ RPK +++ E + R+ +R+
Sbjct: 238 ERLPQPPICTIDVYMIMR-------KCWMIDADSRPKFRELI----IEFSKMARDPQRYL 286
Query: 430 RTQGGTSMEIESQKENS 446
QG M + S +++
Sbjct: 287 VIQGDERMHLPSPTDSN 303
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 82/304 (26%), Positives = 140/304 (46%), Gaps = 35/304 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I PVA+K++ +A KE E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + ++ RLLG C+ + L+ + + G L ++ H + + + + A
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIA 127
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA K +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G PA E++ + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKG 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I ++ +C D++ RPK +++ E + R+ +R+
Sbjct: 236 ERLPQPPICTIDVYMIMR-------KCWMIDADSRPKFRELI----IEFSKMARDPQRYL 284
Query: 430 RTQG 433
QG
Sbjct: 285 VIQG 288
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 8/204 (3%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILN--NVGQAEKEFRV-EVEAIGHVRHKNLVRLLG 204
+G G YG + + + V K L+ ++ +AEK+ V EV + ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 205 YCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
I+ + L V EY G+L + + YL E ++V+ AL H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 263 P--KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
V+HRD+K +N+ +D N K+ DFGLA++L S V GT Y++PE N
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRM 191
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
NEKSD++S G LL E P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 72/231 (31%), Positives = 113/231 (48%), Gaps = 20/231 (8%)
Query: 120 PEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ 179
P + LG+G W +++ F KE LG G +GVV G VA+K I
Sbjct: 9 PSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SM 61
Query: 180 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
+E EF E + + ++ H+ LV+L G C + ++ EY+ NG L +L MRH
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR---- 116
Query: 240 WEARMKVLLGTAKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ + LL K + E +E K +HRD+ + N L++D KVSDFGL++ +
Sbjct: 117 --FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LD 172
Query: 299 SHVTTRVMGTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
T+ V F + PE + KSD+++FGVL+ E + G+ P +
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 16/229 (6%)
Query: 120 PEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ 179
P + LG+G W +++ F KE LG G +GVV G VA+K I
Sbjct: 9 PSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SM 61
Query: 180 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
+E EF E + + ++ H+ LV+L G C + ++ EY+ NG L +L MRH
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR---- 116
Query: 240 WEARMKVLLGTAKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ + LL K + E +E K +HRD+ + N L++D KVSDFGL++ + +
Sbjct: 117 --FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
+ + PE + KSD+++FGVL+ E + G+ P +
Sbjct: 175 ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFR 185
FT+ D ++ LG+G +G VY + I V K L G E + R
Sbjct: 11 FTIDDFDIV-------RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLR 62
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
E+E H+RH N++R+ Y + L+ E+ G L + ++ HG +
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT 118
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ A AL Y HE KV+HRDIK N+L+ K++DFG + + R
Sbjct: 119 FMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRX 171
Query: 306 M-GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
M GT Y+ PE +EK D++ GVL E + G P D P+H
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSH 217
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFR 185
FT+ D ++ LG+G +G VY + I V K L G E + R
Sbjct: 11 FTIDDFDIG-------RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLR 62
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
E+E H+RH N++R+ Y + L+ E+ G L + ++ HG +
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT 118
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ A AL Y HE KV+HRDIK N+L+ K++DFG + + R
Sbjct: 119 FMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRX 171
Query: 306 M-GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
M GT Y+ PE +EK D++ GVL E + G P D P+H
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSH 217
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFR 185
FT+ D ++ LG+G +G VY + I V K L G E + R
Sbjct: 12 FTIDDFDIG-------RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLR 63
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
E+E H+RH N++R+ Y + L+ E+ G L + ++ HG +
Sbjct: 64 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT 119
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ A AL Y HE KV+HRDIK N+L+ K++DFG + + R
Sbjct: 120 FMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRX 172
Query: 306 M-GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
M GT Y+ PE +EK D++ GVL E + G P D P+H
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSH 218
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 29/265 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+++ +N Q +KE + E+ + ++ N+
Sbjct: 24 RFEK---IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNI 79
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R +AL +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS 134
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S + V GT ++APE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTR 190
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E I G P + P + L + + + E+ +P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 240
Query: 380 RPSTRALKRSLLTALRCVDPDSEKR 404
A+ R L RC++ D EKR
Sbjct: 241 --KLSAIFRDFLN--RCLEMDVEKR 261
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 73/279 (26%), Positives = 130/279 (46%), Gaps = 30/279 (10%)
Query: 146 ENVLGEGGYGVVYRGNL-INGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLV 200
E V+G G +G V G+L + G VA+K + + + ++ +F E +G H N++
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L G + M++ E++ NG+L+ +L ++ G T + +L G A + YL +
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-TRVMG---TFGYVAPEY 316
VHR + + NIL++ + KVSDFGL++ L S T T +G + APE
Sbjct: 129 ---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
SDV+S+G+++ E ++ + RP ++ D ++ + + + P
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMTNQD----VINAIEQDYRLPPP 236
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
++ + L L C D RPK Q+V L+
Sbjct: 237 MDCPSALHQL------MLDCWQKDRNHRPKFGQIVNTLD 269
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + A ++F+ E E + ++H+++VR
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL----------LGTAK 252
G C EG ++V+EY+ +G+L ++L R HG K+L LG +
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFL----RSHG-----PDAKLLAGGEDVAPGPLGLGQ 136
Query: 253 ALAYLHEAIEPKV-------VHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTR 304
LA + V VHRD+ + N L+ K+ DFG+++ + V R
Sbjct: 137 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
M ++ PE +SDV+SFGV+L E T G+ P
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + A ++F+ E E + ++H+++VR
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL----------LGTAK 252
G C EG ++V+EY+ +G+L ++L R HG K+L LG +
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFL----RSHG-----PDAKLLAGGEDVAPGPLGLGQ 130
Query: 253 ALAYLHEAIEPKV-------VHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTR 304
LA + V VHRD+ + N L+ K+ DFG+++ + V R
Sbjct: 131 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
M ++ PE +SDV+SFGV+L E T G+ P
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 8/204 (3%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILN--NVGQAEKEFRV-EVEAIGHVRHKNLVRLLG 204
+G G YG + + + V K L+ ++ +AEK+ V EV + ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 205 YCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
I+ + L V EY G+L + + YL E ++V+ AL H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 263 P--KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
V+HRD+K +N+ +D N K+ DFGLA++L + V GT Y++PE N
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRM 191
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
NEKSD++S G LL E P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + A ++F+ E E + ++H+++VR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL----------LGTAK 252
G C EG ++V+EY+ +G+L ++L R HG K+L LG +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFL----RSHG-----PDAKLLAGGEDVAPGPLGLGQ 159
Query: 253 ALAYLHEAIEPKV-------VHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTR 304
LA + V VHRD+ + N L+ K+ DFG+++ + V R
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
M ++ PE +SDV+SFGV+L E T G+ P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 20/226 (8%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF 184
LG+G W +++ F KE LG G +GVV G VA+K I +E EF
Sbjct: 5 LGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEF 57
Query: 185 RVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E + + ++ H+ LV+L G C + ++ EY+ NG L +L MRH +
Sbjct: 58 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR------FQT 110
Query: 245 KVLLGTAKALAYLHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
+ LL K + E +E K +HRD+ + N L++D KVSDFGL++ + T+
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTS 168
Query: 304 RVMGTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
V F + PE + KSD+++FGVL+ E + G+ P +
Sbjct: 169 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK---EFRVEVEAIGHVR 195
++R+ +LG GG V+ +L + VAVK + ++ + FR E + +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 196 HKNLVRLL----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 126
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTF 309
+AL + H+ ++HRD+K +NILI KV DFG+A+ + + V T V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y++PE A ++ +SDVYS G +L E +TG P P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK---EFRVEVEAIGHVR 195
++R+ +LG GG V+ +L + VAVK + ++ + FR E + +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 196 HKNLVRLL----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 126
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTF 309
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + VT V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y++PE A ++ +SDVYS G +L E +TG P P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK---EFRVEVEAIGHVR 195
++R+ +LG GG V+ +L + VAVK + ++ + FR E + +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 196 HKNLVRLL----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 126
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTF 309
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + VT V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y++PE A ++ +SDVYS G +L E +TG P P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L AM ++ L + K+
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 198 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 7/197 (3%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG G +G V+ G N + VAVK L + + F E + ++H LVRL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVK-TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
++ EY+ G+L +L G + + A+ +AY+ +HR
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 134
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D++++N+L+ + K++DFGLA+++ + + APE N G KSDV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 329 YSFGVLLLEAIT-GRDP 344
+SFG+LL E +T G+ P
Sbjct: 195 WSFGILLYEIVTYGKIP 211
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV G VA+K I +E EF E + + ++ H+ LV+L
Sbjct: 12 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 68
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + ++ EY+ NG L +L MRH + + LL K + E +E
Sbjct: 69 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR------FQTQQLLEMCKDVCEAMEYLE 121
Query: 263 PK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG--YVAPEYANT 319
K +HRD+ + N L++D KVSDFGL++ + T+ V F + PE
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
+ KSD+++FGVL+ E + G+ P +
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYE 207
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 11 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L AM ++ L + K+
Sbjct: 71 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 188 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG G +G V+ G + VA+K + E F E + + ++H LV+L Y +
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
E I+ +V EY+N G+L +L A++ + A++ A +AY+
Sbjct: 74 SEEPIY--IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQV------AAGMAYIERM- 124
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+HRD++S+NIL+ + K++DFGLA+L+ + + APE A G
Sbjct: 125 --NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 182
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
KSDV+SFG+LL E +T GR P
Sbjct: 183 FTIKSDVWSFGILLTELVTKGRVP 206
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 146 ENVLGEGGYGVVYRGNLINGSP----VAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNL 199
+ V+G+G +GVVY G I+ + A+K + + + Q E R + G + H N+
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG-LNHPNV 84
Query: 200 VRLLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
+ L+G + EG+ +L+ Y+ +G+L Q++ R+ T + + L A+ + YL
Sbjct: 85 LALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNP---TVKDLISFGLQVARGMEYL 140
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-----GAGKSHVTTRVMGTFGYV 312
E K VHRD+ + N ++D+ F KV+DFGLA+ + + + H R+ +
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWT 195
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
A E T KSDV+SFGVLL E +T P P ++ D + RR
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP-----PYRHIDPFDLTHFLAQGRRL--- 247
Query: 373 VDPNIEVRPSTRALKRSLLTAL-RCVDPDSEKRP-------KMSQVVRMLESEEY 419
P E P SL + +C + D RP ++ Q+V L + Y
Sbjct: 248 --PQPEYCPD------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHK 197
F N+LG+G + VYR I+ G VA+K I + G ++ + EV+ ++H
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHP 71
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
+++ L Y + + LV E +NG + ++L ++ + EAR + + YL
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEAR-HFMHQIITGMLYL 128
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEY 316
H ++HRD+ SN+L+ + N K++DFGLA +L + H T + GT Y++PE
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
A +SDV+S G + + GR P D
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV G VA+K I +E EF E + + ++ H+ LV+L
Sbjct: 13 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 69
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + ++ EY+ NG L +L MRH + + LL K + E +E
Sbjct: 70 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR------FQTQQLLEMCKDVCEAMEYLE 122
Query: 263 PK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG--YVAPEYANT 319
K +HRD+ + N L++D KVSDFGL++ + T+ V F + PE
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
+ KSD+++FGVL+ E + G+ P +
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYE 208
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV G VA+K I +E EF E + + ++ H+ LV+L
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + ++ EY+ NG L +L MRH + + LL K + E +E
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR------FQTQQLLEMCKDVCEAMEYLE 117
Query: 263 PK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG--YVAPEYANT 319
K +HRD+ + N L++D KVSDFGL++ + T+ V F + PE
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDPVD 346
+ KSD+++FGVL+ E + G+ P +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-E 183
F + E+A + + LG+G +G+VY G ++ P VA+K + E+ E
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTW 240
F E + ++VRLLG +G +++ E + G+L+ +L M ++ L
Sbjct: 66 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 241 EARMKVLLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL--- 294
+ K++ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182
Query: 295 ----GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 183 DYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 6 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 66 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG-------A 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 183 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 137
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 138 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 194
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 132
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 189
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 17/221 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK---EFRVEVEAIGHVR 195
++R+ +LG GG V+ +L VAVK + ++ + FR E + +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 196 HKNLVRLLGY----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 71 HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 126
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTF 309
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + VT V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y++PE A ++ +SDVYS G +L E +TG P P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 164
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 221
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG-------A 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 192 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 131
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 132 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 188
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 190
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 149 LGEGGYGVV--YRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G+ VAVK++ ++ +++F+ E++ + + +V+
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 204 GYCIEGIHRM---LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G G R LV EY+ +G L +L RH L + K + YL
Sbjct: 78 GVSY-GPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT--FGYVAPEYAN 318
+ VHRD+ + NIL++ + + K++DFGLAKLL K + R G + APE +
Sbjct: 134 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRD 343
+ + +SDV+SFGV+L E T D
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFTYCD 215
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 198 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLT 190
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 139
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 140 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 196
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 138
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 139 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 195
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 149 LGEGGYGVV--YRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G+ VAVK++ ++ +++F+ E++ + + +V+
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 204 GYCIEGIHRM---LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G G R LV EY+ +G L +L RH L + K + YL
Sbjct: 79 GVSY-GPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT--FGYVAPEYAN 318
+ VHRD+ + NIL++ + + K++DFGLAKLL K + R G + APE +
Sbjct: 135 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRD 343
+ + +SDV+SFGV+L E T D
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFTYCD 216
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 193
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 185 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 140
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 141 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 197
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 190
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 17/221 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK---EFRVEVEAIGHVR 195
++R+ +LG GG V+ +L VAVK + ++ + FR E + +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 196 HKNLVRLL----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 126
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTF 309
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + VT V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y++PE A ++ +SDVYS G +L E +TG P P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGA---MRHHGYLTWEARMKVLLGTAKALAYLH 258
G C R L+ EY+ G+L +L + H L + +++ K + YL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI------CKGMEYLG 134
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPE 315
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 135 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 190
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNV-GQAEKEFR 185
L+++ L+ RF +E LGE +G VY+G+L +P VA+K + + G +EFR
Sbjct: 20 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH----------- 234
E ++H N+V LLG + +++ Y ++G+L ++L H
Sbjct: 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 235 -HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK- 292
L + ++ A + YL VVH+D+ + N+L+ D N K+SD GL +
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ A + + ++APE G + SD++S+GV+L E +
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 149 LGEGGYGVV--YRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G+ VAVK++ ++ +++F+ E++ + + +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 204 GYCIEGIHRM---LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G G R LV EY+ +G L +L RH L + K + YL
Sbjct: 91 GVSY-GPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT--FGYVAPEYAN 318
+ VHRD+ + NIL++ + + K++DFGLAKLL K + R G + APE +
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRD 343
+ + +SDV+SFGV+L E T D
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCD 228
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV G VA+K I +E EF E + + ++ H+ LV+L
Sbjct: 13 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 69
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + ++ EY+ NG L +L MRH + + LL K + E +E
Sbjct: 70 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHR------FQTQQLLEMCKDVCEAMEYLE 122
Query: 263 PK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
K +HRD+ + N L++D KVSDFGL++ + + + + PE
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDPVD 346
+ KSD+++FGVL+ E + G+ P +
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYE 208
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L K VLG G +G VY+G I PVA+K + N +A KE E +
Sbjct: 14 LKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 73
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + RLLG C+ + LV + + G L L + G L + + + A
Sbjct: 74 AGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCL---LDHVRENRGRLGSQDLLNWCMQIA 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT---RVMGT 308
K ++YL + ++VHRD+ + N+L+ + K++DFGLA+LL ++ +V
Sbjct: 130 KGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--P 184
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR 367
++A E +SDV+S+GV + E +T G P D G PA E+ D L+
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIP--DLLE------ 235
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+ E + P I + ++C DSE RP+ ++V
Sbjct: 236 KGERLPQPPI-------CTIDVYMIMVKCWMIDSECRPRFRELV 272
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 149 LGEGGYGVV--YRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G+ VAVK++ ++ +++F+ E++ + + +V+
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 204 G--YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G Y LV EY+ +G L +L RH L + K + YL
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR- 130
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANT 319
+ VHRD+ + NIL++ + + K++DFGLAKLL K R G + APE +
Sbjct: 131 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 320 GLLNEKSDVYSFGVLLLEAITGRD 343
+ + +SDV+SFGV+L E T D
Sbjct: 189 NIFSRQSDVWSFGVVLYELFTYCD 212
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 191 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 191 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ E++ G+L ++L +H + ++ K + YL
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 193
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-E 183
F + E++ + + LG+G +G+VY GN +I G VAVK + + E+ E
Sbjct: 4 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL- 238
F E + ++VRLLG +G ++V E + +G+L+ +L A + G
Sbjct: 64 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 239 -TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG-- 295
T + +++ A +AYL+ K VHRD+ + N ++ DF K+ DFG+ + +
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 180
Query: 296 -----AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
GK + R ++APE G+ SD++SFGV+L E
Sbjct: 181 DXXRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWE 221
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-E 183
F + E++ + + LG+G +G+VY GN +I G VAVK + + E+ E
Sbjct: 7 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL- 238
F E + ++VRLLG +G ++V E + +G+L+ +L A + G
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 239 -TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG-- 295
T + +++ A +AYL+ K VHRD+ + N ++ DF K+ DFG+ + +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 296 -----AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
GK + R ++APE G+ SD++SFGV+L E
Sbjct: 184 DXXRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWE 224
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 191
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 192 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 151
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 208
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNV-GQAEKEFR 185
L+++ L+ RF +E LGE +G VY+G+L +P VA+K + + G +EFR
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH----------- 234
E ++H N+V LLG + +++ Y ++G+L ++L H
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 235 -HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK- 292
L + ++ A + YL VVH+D+ + N+L+ D N K+SD GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ A + + ++APE G + SD++S+GV+L E +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 80/285 (28%), Positives = 124/285 (43%), Gaps = 46/285 (16%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F + VLG+G +G V + N ++ A+KKI + + EV + + H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 202 LLGYCIE---------GIHR----MLVYEYVNNGNLEQWLHGA-MRHHGYLTWEARMKVL 247
+E + + + EY NG L +H + W ++L
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG------------ 295
+AL+Y+H ++HRD+K NI ID+ N K+ DFGLAK +
Sbjct: 127 ----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 296 -AGKSHVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAI----TGRDPVDHGR 349
G S T +GT YVA E + TG NEK D+YS G++ E I TG + V+ +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 350 PAHEVNL-----VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRS 389
V++ D KM V + ++D + RP R L S
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 151
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HRD+ + NIL++++ K+ DFGL K+L K + G F Y APE
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLT 208
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-E 183
F + E++ + + LG+G +G+VY GN +I G VAVK + + E+ E
Sbjct: 7 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL- 238
F E + ++VRLLG +G ++V E + +G+L+ +L A + G
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 239 -TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL--- 294
T + +++ A +AYL+ K VHRD+ + N ++ DF K+ DFG+ + +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 295 ----GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
GK + R ++APE G+ SD++SFGV+L E
Sbjct: 184 DYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWE 224
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-E 183
F + E++ + + LG+G +G+VY GN +I G VAVK + + E+ E
Sbjct: 7 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL- 238
F E + ++VRLLG +G ++V E + +G+L+ +L A + G
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 239 -TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL--- 294
T + +++ A +AYL+ K VHRD+ + N ++ DF K+ DFG+ + +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 295 ----GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
GK + R ++APE G+ SD++SFGV+L E
Sbjct: 184 AYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWE 224
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+G +G V R + + G VAVKK+ ++ + ++F E+E + ++H N+V+
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C R L+ EY+ G+L +L +H + ++ K + YL
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK- 134
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYAN 318
+ +HR++ + NIL++++ K+ DFGL K+L K + + G F Y APE
Sbjct: 135 --RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT 191
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
+ SDV+SFGV+L E T
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 15/226 (6%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAIGHV 194
K VLG G +G V++G I PV +K I + G Q+ + + AIG +
Sbjct: 31 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
H ++VRLLG C G LV +Y+ G+L L +H G L + + + AK +
Sbjct: 91 DHAHIVRLLGLC-PGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLLLNWGVQIAKGM 146
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVA 313
YL E +VHR++ + N+L+ +V+DFG+A LL K + + ++A
Sbjct: 147 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358
E + G +SDV+S+GV + E +T G +P R A +L++
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 249
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 149 LGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LG+G +G+VY GN +I G VAVK + + E+ EF E + ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL--TWEARMKVLLGTAKALA 255
LLG +G ++V E + +G+L+ +L A + G T + +++ A +A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG-------AGKSHVTTRVMGT 308
YL+ K VHRD+ + N ++ DF K+ DFG+ + + GK + R
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR---- 197
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
++APE G+ SD++SFGV+L E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWE 224
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 15/226 (6%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAIGHV 194
K VLG G +G V++G I PV +K I + G Q+ + + AIG +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
H ++VRLLG C G LV +Y+ G+L L +H G L + + + AK +
Sbjct: 73 DHAHIVRLLGLC-PGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVA 313
YL E +VHR++ + N+L+ +V+DFG+A LL K + + ++A
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358
E + G +SDV+S+GV + E +T G +P R A +L++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 17/221 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK---EFRVEVEAIGHVR 195
++R+ +LG GG V+ +L VAVK + ++ + FR E + +
Sbjct: 28 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 196 HKNLVRLL----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 88 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 143
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTF 309
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + VT V+GT
Sbjct: 144 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y++PE A ++ +SDVYS G +L E +TG P P
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N + +DF K+ DFG+ + +
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 185 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 43 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKV 246
+ ++VRLLG +G +++ E + G+L+ +L M ++ L + K+
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 247 LLGT---AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 219
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R +++PE G+ SDV+SFGV+L E T
Sbjct: 220 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 149 LGEGGYGVVYRGNL---INGSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLVRLLG 204
LG G +G V +G VA+K + +A+ +E E + + + + +VRL+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
C + MLV E G L ++L G + ++L + + YL E
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLL 322
VHRD+ + N+L+ + AK+SDFGL+K LGA S+ T R G + + APE N
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 323 NEKSDVYSFGVLLLEAIT-GRDP 344
+ +SDV+S+GV + EA++ G+ P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 149 LGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LG+G +G+VY GN +I G VAVK + + E+ EF E + ++VR
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL--TWEARMKVLLGTAKALA 255
LLG +G ++V E + +G+L+ +L A + G T + +++ A +A
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGT 308
YL+ K VHRD+ + N ++ DF K+ DFG+ + + GK + R
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 196
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
++APE G+ SD++SFGV+L E
Sbjct: 197 --WMAPESLKDGVFTTSSDMWSFGVVLWE 223
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 79.0 bits (193), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 84 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEFSFNPSHN 142
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ H+ T G ++APE + +SDV+SFGVLL E T
Sbjct: 200 I----HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 78.6 bits (192), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 7/197 (3%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG G +G V+ G N + VAVK L + + F E + ++H LVRL +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKT-LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
++ E++ G+L +L G + + A+ +AY+ +HR
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 133
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D++++N+L+ + K++DFGLA+++ + + APE N G KS+V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 329 YSFGVLLLEAIT-GRDP 344
+SFG+LL E +T G+ P
Sbjct: 194 WSFGILLYEIVTYGKIP 210
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 78.6 bits (192), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 149 LGEGGYGVVYRG------NLINGSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLVR 201
LG G +G V +G I+ VA+K + +A+ +E E + + + + +VR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L+G C + MLV E G L ++L G + ++L + + YL E
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 455
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANT 319
VHR++ + N+L+ + AK+SDFGL+K LGA S+ T R G + + APE N
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ +SDV+S+GV + EA++ G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 78.6 bits (192), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 42/229 (18%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFRV 186
++L+D ++ LG G +G R +LI NG A+K + +KE V
Sbjct: 3 YSLQDFQIL-------RTLGTGSFG---RVHLIRSRHNGRYYAMKVL-------KKEIVV 45
Query: 187 EVEAIGH----------VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG 236
++ + H V H ++R+ G + ++ +Y+ G L L + R
Sbjct: 46 RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN 105
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
+ +V L AL YLH +++RD+K NIL+D + + K++DFG AK +
Sbjct: 106 PVAKFYAAEVCL----ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-- 156
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
VT + GT Y+APE +T N+ D +SFG+L+ E + G P
Sbjct: 157 --PDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 78.2 bits (191), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYC 206
LG GG+G V R + G VA+K+ + +E + +E++ + + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA-REV 80
Query: 207 IEGIHRM-------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLH 258
+G+ ++ L EY G+L ++L+ G E ++ LL + AL YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK--EGPIRTLLSDISSALRYLH 138
Query: 259 EAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
E +++HRD+K NI++ K+ D G AK L G+ + T +GT Y+APE
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPE 193
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
D +SFG L E ITG P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 78.2 bits (191), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYC 206
LG GG+G V R + G VA+K+ + +E + +E++ + + H N+V
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA-REV 81
Query: 207 IEGIHRM-------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLH 258
+G+ ++ L EY G+L ++L+ G E ++ LL + AL YLH
Sbjct: 82 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK--EGPIRTLLSDISSALRYLH 139
Query: 259 EAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
E +++HRD+K NI++ K+ D G AK L G+ + T +GT Y+APE
Sbjct: 140 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPE 194
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
D +SFG L E ITG P
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITGFRP 223
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 78.2 bits (191), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 10/210 (4%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
LGEG YG VY+ + G VA+K++ V +E E+ + ++V+ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
+ +V EY G++ + +R+ LT + +L T K L YLH + +H
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIR--LRNKT-LTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSD 327
RDIK+ NIL++ + +AK++DFG+A L + V+GT ++APE N +D
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 328 VYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
++S G+ +E G+ P P + ++
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEV 188
+ DL + R K +G+G + V +++ G VAVK K N +K FR EV
Sbjct: 1 MADLHIGNYRLLK--TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EV 57
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKV 246
+ + H N+V+L LV EY + G + +L HG M+ EAR K
Sbjct: 58 RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-----EARAK- 111
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
A+ Y H+ +VHRD+K+ N+L+D D N K++DFG + G T
Sbjct: 112 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 166
Query: 307 GTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
G+ Y APE + + DV+S GV+L ++G P D
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYCYNPSHN 127
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ H+ T G ++APE + +SDV+SFGVLL E T
Sbjct: 185 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 13 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 72
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 73 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYSYNPSHN 131
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ H+ T G ++APE + +SDV+SFGVLL E T
Sbjct: 189 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 79 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + AG M ++ PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 77/282 (27%), Positives = 136/282 (48%), Gaps = 30/282 (10%)
Query: 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVR 195
+ ++ ++GEG YG+V + N G VA+KK L ++ +K E++ + +R
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNN---GNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
H+NLV LL C + LV+E+V++ +LE + +G L ++ K L
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-------LDYQVVQKYLFQIIN 135
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
+ + H ++HRDIK NIL+ K+ DFG A+ L A V + T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYR 191
Query: 313 APEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR--RS 369
APE + K+ DV++ G L+ E G +P+ G +++ + + M +G+ R
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDS--DIDQLYHIMMCLGNLIPRH 248
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+E+ + N P ++ L ++ +P + PK+S+VV
Sbjct: 249 QELFNKN----PVFAGVR---LPEIKEREPLERRYPKLSEVV 283
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 56 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + AG M ++ PE
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 234 AFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 17 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 76
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 77 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYSYNPSHN 135
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ H+ T G ++APE + +SDV+SFGVLL E T
Sbjct: 193 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 38/247 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 84 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYCYNPSHN 142
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347
+ H+ T G ++APE + +SDV+SFGVLL E T G P
Sbjct: 200 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP- 254
Query: 348 GRPAHEV 354
G P E+
Sbjct: 255 GVPVEEL 261
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 38/247 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 84 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYSYNPSHN 142
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347
+ H+ T G ++APE + +SDV+SFGVLL E T G P
Sbjct: 200 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP- 254
Query: 348 GRPAHEV 354
G P E+
Sbjct: 255 GVPVEEL 261
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 10/216 (4%)
Query: 134 RDLELATNRFSKENVLGEGGYGVV-YRGNLINGSPVAVKKI-LNNVGQAEKEFRVEVEAI 191
+D + + +G GG+ V +++ G VA+K + N +G + E+EA+
Sbjct: 3 KDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEAL 62
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
++RH+++ +L +V EY G L ++ R L+ E V
Sbjct: 63 KNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDR----LSEEETRVVFRQIV 118
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
A+AY+H HRD+K N+L D+ K+ DFGL K + G+ Y
Sbjct: 119 SAVAYVHSQ---GYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAY 175
Query: 312 VAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDPVD 346
APE L ++DV+S G+LL + G P D
Sbjct: 176 AAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFD 211
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 38/247 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 16 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 75
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 76 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYSYNPSHN 134
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347
+ H+ T G ++APE + +SDV+SFGVLL E T G P
Sbjct: 192 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP- 246
Query: 348 GRPAHEV 354
G P E+
Sbjct: 247 GVPVEEL 253
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 80 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 134
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVY-----RGNLINGSPVAVKKILNNVGQAEKEFR 185
FT+ D E+ LG+G +G VY + + I V K + G E + R
Sbjct: 20 FTIDDFEIG-------RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG-VEHQLR 71
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
E+E H+ H N++RL Y + L+ EY G L + L + +
Sbjct: 72 REIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT----FDEQRTAT 127
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
++ A AL Y H KV+HRDIK N+L+ K++DFG + S +
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTM 181
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
GT Y+ PE + NEK D++ GVL E + G P +
Sbjct: 182 CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 72/249 (28%), Positives = 126/249 (50%), Gaps = 33/249 (13%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVR 201
++ V+G G +GVV++ L+ VA+KK+L +K F+ E++ + V+H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVD 96
Query: 202 LLGYCI------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV----LLGTA 251
L + + + LV EYV + ++ A RH+ L M + +
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFG 310
++LAY+H + HRDIK N+L+D K+ DFG AK+L AG+ +V+ + +
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRY 206
Query: 311 YVAPEYANTGLLNEKS--DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM-VGSR 367
Y APE G N + D++S G ++ E + G+ P+ G + LV+ +K++ SR
Sbjct: 207 YRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGID-QLVEIIKVLGTPSR 263
Query: 368 RSEEVVDPN 376
+ ++PN
Sbjct: 264 EQIKTMNPN 272
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F + ++G GG+G V++ + I+G +K++ N +AE+E V+A+ + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 202 LLGYCIEGIHR-----------------MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
G C +G + E+ + G LEQW+ R L +
Sbjct: 69 YNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLAL 125
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL-AKLLGAGKSHVTT 303
++ K + Y+H K+++RD+K SNI + D K+ DFGL L GK
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---X 179
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339
R GT Y++PE ++ ++ D+Y+ G++L E +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
V G +G V++ L+N VAVK + + + E+ EV ++ ++H+N+++ +G
Sbjct: 31 VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAE 87
Query: 207 IEG----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI- 261
G + L+ + G+L +L + ++W + A+ LAYLHE I
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIP 142
Query: 262 ------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR-VMGTFGYVAP 314
+P + HRDIKS N+L+ ++ A ++DFGLA AGKS T +GT Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 315 EYANTGLLNEKS-----DVYSFGVLLLEA---ITGRD-PVD 346
E + ++ D+Y+ G++L E T D PVD
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 149 LGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LG+G +G+VY GN +I G VAVK + + E+ EF E + ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL--TWEARMKVLLGTAKALA 255
LLG +G ++V E + +G+L+ +L A + G T + +++ A +A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGT 308
YL+ K VHR++ + N ++ DF K+ DFG+ + + GK + R
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 197
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
++APE G+ SD++SFGV+L E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWE 224
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 66/255 (25%), Positives = 118/255 (46%), Gaps = 35/255 (13%)
Query: 111 TAPSPLI-GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLI------ 163
TA +P++ G+ E+ W E ++ + LGEG +G V +
Sbjct: 56 TADTPMLAGVSEYELPEDPKW------EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 164 --NGSPVAVKKILNNVGQAE-KEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYV 219
VAVK + ++ + + + E+E + + +HKN++ LLG C + ++ EY
Sbjct: 110 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 220 NNGNLEQWLHGAMRHHGY-------------LTWEARMKVLLGTAKALAYLHEAIEPKVV 266
+ GNL ++L A R G +T++ + A+ + YL K +
Sbjct: 170 SKGNLREYLR-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCI 225
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEK 325
HRD+ + N+L+ ++ K++DFGLA+ + + TT ++APE + +
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285
Query: 326 SDVYSFGVLLLEAIT 340
SDV+SFGVL+ E T
Sbjct: 286 SDVWSFGVLMWEIFT 300
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 38/247 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYSYNPSHN 183
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347
+ H+ T G ++APE + +SDV+SFGVLL E T G P
Sbjct: 241 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP- 295
Query: 348 GRPAHEV 354
G P E+
Sbjct: 296 GVPVEEL 302
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT--FGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVR 201
LG+G +GVV RG S VAVK + +V +A +F EV A+ + H+NL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + +M V E G+L L +H G+ + + A+ + YL
Sbjct: 80 LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 134
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT--FGYVAPEYANT 319
+ +HRD+ + N+L+ K+ DFGL + L H + F + APE T
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ SD + FGV L E T G++P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 46/285 (16%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F + VLG+G +G V + N ++ A+KKI + + EV + + H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 202 LLGYCIE---------GIHR----MLVYEYVNNGNLEQWLHGA-MRHHGYLTWEARMKVL 247
+E + + + EY N L +H + W ++L
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG------------ 295
+AL+Y+H ++HRD+K NI ID+ N K+ DFGLAK +
Sbjct: 127 ----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 296 -AGKSHVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAI----TGRDPVDHGR 349
G S T +GT YVA E + TG NEK D+YS G++ E I TG + V+ +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 350 PAHEVNL-----VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRS 389
V++ D KM V + ++D + RP R L S
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 149 LGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LG+G +G+VY GN +I G VAVK + + E+ EF E + ++VR
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL--TWEARMKVLLGTAKALA 255
LLG +G ++V E + +G+L+ +L A + G T + +++ A +A
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGT 308
YL+ K VHR++ + N ++ DF K+ DFG+ + + GK + R
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 198
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
++APE G+ SD++SFGV+L E
Sbjct: 199 --WMAPESLKDGVFTTSSDMWSFGVVLWE 225
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VAVK K N +K FR EV + + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
LV EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 81 VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAK-FRQIVSAVQYCHQKF- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
+VHRD+K+ N+L+D D N K++DFG + G T G+ Y APE +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKY 189
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEXSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 L-GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 45/229 (19%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F + ++G GG+G V++ + I+G ++++ N +AE+E V+A+ + H N+V
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVH 69
Query: 202 LLGYCIEGIHR------------------------------MLVYEYVNNGNLEQWLHGA 231
G C +G + E+ + G LEQW+
Sbjct: 70 YNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-- 126
Query: 232 MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL- 290
R L +++ K + Y+H K++HRD+K SNI + D K+ DFGL
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339
L GK TR GT Y++PE ++ ++ D+Y+ G++L E +
Sbjct: 184 TSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VAVK K N +K FR EV + + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
LV EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 81 VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAK-FRQIVSAVQYCHQKF- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
+VHRD+K+ N+L+D D N K++DFG + G T G+ Y APE +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKY 189
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 L-GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 36/246 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG------------AMRH 234
+E + + +HKN++ LLG C + ++ EY + GNL ++L +
Sbjct: 84 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+ +
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 295 GAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHG 348
H+ T G ++APE + +SDV+SFGVLL E T G P G
Sbjct: 201 ----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-G 255
Query: 349 RPAHEV 354
P E+
Sbjct: 256 VPVEEL 261
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 152 GGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-- 209
G +G V++ L+N VAVK Q+ + R E+ + ++H+NL++ + G
Sbjct: 26 GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSER-EIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 210 --IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI------ 261
+ L+ + + G+L +L G + +TW V ++ L+YLHE +
Sbjct: 84 LEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 262 --EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR-VMGTFGYVAPEYAN 318
+P + HRD KS N+L+ D A ++DFGLA GK T +GT Y+APE
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 319 TGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
+ ++ D+Y+ G++L E ++ D P E L + +G S E +
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD--GPVDEYMLP--FEEEIGQHPSLEEL 254
Query: 374 DPNI---EVRPSTR-------ALKRSLLTALRCVDPDSEKR 404
+ ++RP+ + L + +T C D D+E R
Sbjct: 255 QEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 66/284 (23%), Positives = 128/284 (45%), Gaps = 23/284 (8%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + + V+G G VV VA+K+I L + E E++A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGN----LEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V + LV + ++ G+ ++ + G L +L + L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG----KSHVTTRVMGTFG 310
YLH+ + +HRD+K+ NIL+ +D + +++DFG++ L G ++ V +GT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++APE + K+D++SFG+ +E TG P H P +V +M+ +
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYPPMKV-------LMLTLQND 243
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALR-CVDPDSEKRPKMSQVVR 412
++ ++ + + +S + C+ D EKRP ++++R
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I + H+N+V
Sbjct: 39 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 98 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 146 ENVLGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
+ +G+G + V +++ G VAVK K N +K FR EV + + H N+V+
Sbjct: 20 QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVK 78
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
L LV EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 79 LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAK-FRQIVSAVQYCHQ 132
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YAN 318
+VHRD+K+ N+L+D D N K++DFG + G T G+ Y APE +
Sbjct: 133 KY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQG 187
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 488
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKP 572
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 66/284 (23%), Positives = 128/284 (45%), Gaps = 23/284 (8%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + + V+G G VV VA+K+I L + E E++A+ H N
Sbjct: 10 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGN----LEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V + LV + ++ G+ ++ + G L +L + L
Sbjct: 70 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG----KSHVTTRVMGTFG 310
YLH+ + +HRD+K+ NIL+ +D + +++DFG++ L G ++ V +GT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++APE + K+D++SFG+ +E TG P H P +V +M+ +
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYPPMKV-------LMLTLQND 238
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALR-CVDPDSEKRPKMSQVVR 412
++ ++ + + +S + C+ D EKRP ++++R
Sbjct: 239 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYC 206
+G G +G V+ G L + + VAVK + K +F E + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV- 265
+ +V E V G+ +L R G R+K LL A E +E K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGA---RLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-FGYVAPEYANTGLLNE 324
+HRD+ + N L+ + K+SDFG+++ G + + + APE N G +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 325 KSDVYSFGVLLLEAIT 340
+SDV+SFG+LL E +
Sbjct: 295 ESDVWSFGILLWETFS 310
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 147 NVLGEGGYGVVYRG-NLINGSPVAVKKI-------LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ LG G +G V G + + G VAVK + L+ VG+ ++E ++ + RH +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPH 72
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+++L +V EYV+ G L ++ +H EAR ++ A+ Y H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEAR-RLFQQILSAVDYCH 128
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ VVHRD+K N+L+D NAK++DFGL+ ++ G+ T+ G+ Y APE +
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 183
Query: 319 TGLL-NEKSDVYSFGVLLLEAITGRDPVD 346
L + D++S GV+L + G P D
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFD 212
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F LG GG+GVV+ N ++ A+K+I L N A ++ EV+A+ + H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 201 RLLGYCIEG------------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR----- 243
R +E ++ + + NL+ W++G T E R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR------CTIEERERSVC 120
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT- 302
+ + L A+A+ +LH ++HRD+K SNI D KV DFGL + + T
Sbjct: 121 LHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 303 ----------TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339
T +GT Y++PE + + K D++S G++L E +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 489
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 550 FSSKSDVWSFGVLMWEAFSYGQKP 573
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 55 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 232
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 233 AFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VAV+ K N +K FR EV + + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
LV EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 81 VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAK-FRQIVSAVQYCHQKF- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
+VHRD+K+ N+L+D D N K++DFG + G T G+ Y APE +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKY 189
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 39 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 98 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 65 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 242
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 243 AFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 95 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 146
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 95 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 146
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 45 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 222
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 223 AFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I + H+N+V
Sbjct: 53 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 231 AFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 LGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 39 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 98 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 33 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 93 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 144
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKP 228
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYC 206
+G G +G V+ G L + + VAVK + K +F E + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV- 265
+ +V E V G+ +L R G R+K LL A E +E K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGA---RLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-FGYVAPEYANTGLLNE 324
+HRD+ + N L+ + K+SDFG+++ G + + + APE N G +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 325 KSDVYSFGVLLLEAIT 340
+SDV+SFG+LL E +
Sbjct: 295 ESDVWSFGILLWETFS 310
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 28/228 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ + TT ++APE + +SDV+SFGVL+ E T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 38 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 97 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 120/241 (49%), Gaps = 22/241 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R+++ +GEG YG+V + + + VA+KKI + ++ R E++ + RH+N
Sbjct: 44 RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHEN 102
Query: 199 LVR----LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
++ L +E + + + + + +L + L + ++ + L + L
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGL 157
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGYV 312
Y+H A V+HRD+K SN+LI+ + K+ DFGLA++ H T + T Y
Sbjct: 158 KYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 313 APEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E+
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQED 271
Query: 372 V 372
+
Sbjct: 272 L 272
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 38 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 75.5 bits (184), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VAV+ K N +K FR EV + + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
LV EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 81 VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAK-FRQIVSAVQYCHQKF- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
+VHRD+K+ N+L+D D N K++DFG + G G+ Y APE +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPELFQGKKY 189
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 75.5 bits (184), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 30 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 89 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 207
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 208 AFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 18 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 78 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 136
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 194 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 252
Query: 352 HEV 354
E+
Sbjct: 253 EEL 255
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAE-KEFRVEVEAI-- 191
L N ++V+GEG +G V + + A+K++ + + ++F E+E +
Sbjct: 12 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 71
Query: 192 -GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG------------AMRHHGYL 238
GH H N++ LLG C + L EY +GNL +L A L
Sbjct: 72 LGH--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ + + A+ + YL + + +HRD+ + NIL+ +++ AK++DFGL++ G+
Sbjct: 130 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQ 182
Query: 299 SHVTTRVMGTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356
+ MG ++A E N + SDV+S+GVLL E ++ G P +
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----GGTPYCGMTC 237
Query: 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV----R 412
+ + + R E+ ++ + EV R +C +RP +Q++ R
Sbjct: 238 AELYEKLPQGYRLEKPLNCDDEVYDLMR----------QCWREKPYERPSFAQILVSLNR 287
Query: 413 MLE 415
MLE
Sbjct: 288 MLE 290
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VAVK K N +K FR EV + + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
LV EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 81 VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-----EARAK-FRQIVSAVQYCHQKF- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
+VHRD+K+ N+L+D D N K++DFG + G G Y APE +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGKKY 189
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG+G +G VY+ S +A K+++ + E E + VE++ + H N+V+LL
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVV 266
+ ++ E+ G ++ + R LT E++++V+ T AL YLH+ K++
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERP---LT-ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEYANTGL-- 321
HRD+K+ NIL D + K++DFG++ A + R +GT ++APE
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 322 ---LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ K+DV+S G+ L+E + +P P HE+N
Sbjct: 214 DRPYDYKADVWSLGITLIE-MAEIEP-----PHHELN 244
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG G +G V+ + VAVK + E F E + ++H
Sbjct: 11 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 69
Query: 197 KNLVRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
LV+L E I+ ++ E++ G+L +L L + A+ +A
Sbjct: 70 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 125
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
++ + +HRD++++NIL+ K++DFGLA+++ + + APE
Sbjct: 126 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 182
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
N G KSDV+SFG+LL+E +T GR P
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 212
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 136
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 32/295 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
DV+S G++L + G P D + + DW + + ++P ++ +
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------KEKKTYLNPWKKIDSAPL 238
Query: 385 ALKRSLLT---ALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTS 436
AL +L + R PD +K ++ P+ + +R R T GG S
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK----------PLKKGAKRPRVTSGGVS 283
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVR 195
++++F + LG G Y VY+G N G VA+K K+ + G R E+ + ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELK 61
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG----------AMRHHGYLTWEARMK 245
H+N+VRL LV+E+++N +L++++ + Y W+
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL--- 117
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ LA+ HE K++HRD+K N+LI+ K+ DFGLA+ G + ++ V
Sbjct: 118 -----LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 306 MGTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGR 342
+ T Y AP+ + + D++S G +L E ITG+
Sbjct: 170 V-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VA+K K N +K FR EV + + H N+V+L
Sbjct: 20 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 78
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
L+ EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 79 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSK-FRQIVSAVQYCHQK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
++VHRD+K+ N+L+D D N K++DFG + G T G+ Y APE +
Sbjct: 131 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQGKKY 187
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFD 212
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 53 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 231 AFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 27/227 (11%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRH 196
++ F +++LGEG YGVV + G VA+KKI + A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 197 KNLVRLLGY----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+N++ + E + + + + + +L + + M ++ + + T +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLR 123
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG---------AGKSHVTT 303
A+ LH + V+HRD+K SN+LI+ + + KV DFGLA+++ G+ T
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGR 349
+ T Y APE T ++ DV+S G +L E R P+ GR
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGR 226
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 23 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 83 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 141
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 199 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 257
Query: 352 HEV 354
E+
Sbjct: 258 EEL 260
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 32/295 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
DV+S G++L + G P D + + DW + + ++P ++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------KEKKTYLNPWKKIDSAPL 239
Query: 385 ALKRSLLT---ALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTS 436
AL +L + R PD +K ++ P+ + +R R T GG S
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK----------PLKKGAKRPRVTSGGVS 284
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 20 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 80 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 138
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 196 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 254
Query: 352 HEV 354
E+
Sbjct: 255 EEL 257
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAE-KEFRVEVEAI-- 191
L N ++V+GEG +G V + + A+K++ + + ++F E+E +
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 192 -GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG------------AMRHHGYL 238
GH H N++ LLG C + L EY +GNL +L A L
Sbjct: 82 LGH--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ + + A+ + YL + + +HRD+ + NIL+ +++ AK++DFGL++ G+
Sbjct: 140 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQ 192
Query: 299 SHVTTRVMGTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356
+ MG ++A E N + SDV+S+GVLL E ++ G P +
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----GGTPYCGMTC 247
Query: 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV----R 412
+ + + R E+ ++ + EV R +C +RP +Q++ R
Sbjct: 248 AELYEKLPQGYRLEKPLNCDDEVYDLMR----------QCWREKPYERPSFAQILVSLNR 297
Query: 413 MLE 415
MLE
Sbjct: 298 MLE 300
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 67
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 68 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 124
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 180
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 27/227 (11%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRH 196
++ F +++LGEG YGVV + G VA+KKI + A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 197 KNLVRLLGY----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+N++ + E + + + + + +L + + M ++ + + T +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLR 123
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG---------AGKSHVTT 303
A+ LH + V+HRD+K SN+LI+ + + KV DFGLA+++ G+ T
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGR 349
+ T Y APE T ++ DV+S G +L E R P+ GR
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGR 226
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG+G +G VY+ S +A K+++ + E E + VE++ + H N+V+LL
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVV 266
+ ++ E+ G ++ + R LT E++++V+ T AL YLH+ K++
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERP---LT-ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEYANTGL-- 321
HRD+K+ NIL D + K++DFG++ A + R +GT ++APE
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 322 ---LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ K+DV+S G+ L+E + +P P HE+N
Sbjct: 214 DRPYDYKADVWSLGITLIE-MAEIEP-----PHHELN 244
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG+G +G VY+ S +A K+++ + E E + VE++ + H N+V+LL
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVV 266
+ ++ E+ G ++ + R LT E++++V+ T AL YLH+ K++
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERP---LT-ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEYANTGL-- 321
HRD+K+ NIL D + K++DFG++ A + R +GT ++APE
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 322 ---LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ K+DV+S G+ L+E + +P P HE+N
Sbjct: 214 DRPYDYKADVWSLGITLIE-MAEIEP-----PHHELN 244
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 79 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 130
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 13 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 73 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 124
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKP 208
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE N
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP 210
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 32/295 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
DV+S G++L + G P D + + DW + + ++P ++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------KEKKTYLNPWKKIDSAPL 239
Query: 385 ALKRSLLT---ALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTS 436
AL +L + R PD +K ++ P+ + +R R T GG S
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK----------PLKKGAKRPRVTSGGVS 284
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 32/295 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
DV+S G++L + G P D + + DW + + ++P ++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------KEKKTYLNPWKKIDSAPL 239
Query: 385 ALKRSLLT---ALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTS 436
AL +L + R PD +K ++ P+ + +R R T GG S
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK----------PLKKGAKRPRVTSGGVS 284
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 32/295 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
DV+S G++L + G P D + + DW + + ++P ++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------KEKKTYLNPWKKIDSAPL 239
Query: 385 ALKRSLLT---ALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTS 436
AL +L + R PD +K ++ P+ + +R R T GG S
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK----------PLKKGAKRPRVTSGGVS 284
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 70
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 71 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 127
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 149 LGEGGYG-VVYRGNLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGY 205
+GEG +G + + +G +K+I ++ + E+E R EV + +++H N+V+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR-MKVLLGTAKALAYLHEAIEPK 264
E +V +Y G+L + ++ G L E + + + AL ++H+ K
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
++HRDIKS NI + D ++ DFG+A++L + + +GT Y++PE N
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYYLSPEICENKPYNN 204
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366
KSD+++ G +L E T + + G NLV LK++ GS
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMK---NLV--LKIISGS 241
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE--- 315
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 316 ---YANTGLLNEKSDVYSFGVLLLEAITGR 342
Y +T + D++S G + E +T R
Sbjct: 177 GXKYYSTAV-----DIWSLGCIFAEMVTRR 201
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 70
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 71 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 127
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE--- 315
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 316 ---YANTGLLNEKSDVYSFGVLLLEAITGR 342
Y +T + D++S G + E +T R
Sbjct: 184 GXKYYSTAV-----DIWSLGCIFAEMVTRR 208
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPV-AVKKILNNVGQAEKEFR---VEVEAI 191
++L F +LG+G +G V+ + A+K + +V + + VE +
Sbjct: 13 IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 192 GHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
H L + + V EY+N G+L + + +++LG
Sbjct: 73 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG- 131
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK--LLGAGKSHVTTRVMGT 308
L +LH +V+RD+K NIL+D D + K++DFG+ K +LG K T GT
Sbjct: 132 ---LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGT 182
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
Y+APE N D +SFGVLL E + G+ P HG+ E+
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 227
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ +++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 125
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQ 208
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+ LH V+H
Sbjct: 219 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 270
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
D++S G++++E + G P + P + ++
Sbjct: 328 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 177
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKN 198
++ K +GEG YGVVY+ G VA+K+I + G R E+ + + H N
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPN 80
Query: 199 LVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKA 253
+V L I+ IH LV+E+ +E+ L + + ++++K+ L +
Sbjct: 81 IVSL----IDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
+A+ H+ +++HRD+K N+LI+ D K++DFGLA+ G T V+ T Y A
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 314 PE-YANTGLLNEKSDVYSFGVLLLEAITGR 342
P+ + + D++S G + E ITG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKN 198
++ K +GEG YGVVY+ G VA+K+I + G R E+ + + H N
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPN 80
Query: 199 LVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKA 253
+V L I+ IH LV+E+ +E+ L + + ++++K+ L +
Sbjct: 81 IVSL----IDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
+A+ H+ +++HRD+K N+LI+ D K++DFGLA+ G T V+ T Y A
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 314 PE-YANTGLLNEKSDVYSFGVLLLEAITGR 342
P+ + + D++S G + E ITG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG G +G V+ + VAVK + E F E + ++H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 242
Query: 197 KNLVRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
LV+L E I+ ++ E++ G+L +L L + A+ +A
Sbjct: 243 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 298
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
++ + +HRD++++NIL+ K++DFGLA+++ + + APE
Sbjct: 299 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
N G KSDV+SFG+LL+E +T GR P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 147 NVLGEGGYGVVYRG-NLINGSPVAVKKI-------LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ LG G +G V G + + G VAVK + L+ VG+ ++E ++ + RH +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPH 72
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+++L +V EYV+ G L ++ +H EAR ++ A+ Y H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEAR-RLFQQILSAVDYCH 128
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ VVHRD+K N+L+D NAK++DFGL+ ++ G+ G+ Y APE +
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRDSCGSPNYAAPEVIS 183
Query: 319 TGLL-NEKSDVYSFGVLLLEAITGRDPVD 346
L + D++S GV+L + G P D
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFD 212
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 31/241 (12%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G YGVV + G VA+KKI N V A++ R E++ + H +H N++
Sbjct: 63 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNII---- 117
Query: 205 YCIEGIHRMLVYE------YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
I+ I R V YV +E LH + LT E L + L Y+H
Sbjct: 118 -AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG---AGKSHVTTRVMGTFGYVAPE 315
A +V+HRD+K SN+L++++ K+ DFG+A+ L A + T + T Y APE
Sbjct: 177 SA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 316 YANTGLLNEKS---DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
+ L+E + D++S G + E + R H++ L+ MMV S V
Sbjct: 234 LMLS--LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI----MMVLGTPSPAV 287
Query: 373 V 373
+
Sbjct: 288 I 288
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 149 LGEGGYGVVYRGNLINGSP-------VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLV 200
LG G +G VY G ++G P VAVK + Q E +F +E I H+N+V
Sbjct: 53 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R +G ++ + R ++ E + G+L+ +L R M LL A+ +A +
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 261 IEPK-VVHRDIKSSNILIDDDFN---AKVSDFGLAK-LLGAGKSHVTTRVMGTFGYVAPE 315
+E +HRDI + N L+ AK+ DFG+A+ + A M ++ PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT 340
G+ K+D +SFGVLL E +
Sbjct: 231 AFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 149 LGEGGYGVV----YRGNLIN-GSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y N G VAVK + G + + E+E + ++ H+N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 203 LGYCIE--GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G C E G L+ E++ +G+L+++L ++ + + ++K + K + YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT---RVMGTFGYVAPEYA 317
+ VHRD+ + N+L++ + K+ DFGL K + K T R F Y APE
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRD 343
SDV+SFGV L E +T D
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCD 227
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+V+ +L+ ++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 31/241 (12%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G YGVV + G VA+KKI N V A++ R E++ + H +H N++
Sbjct: 62 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNII---- 116
Query: 205 YCIEGIHRMLV------YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
I+ I R V YV +E LH + LT E L + L Y+H
Sbjct: 117 -AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG---AGKSHVTTRVMGTFGYVAPE 315
A +V+HRD+K SN+L++++ K+ DFG+A+ L A + T + T Y APE
Sbjct: 176 SA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 316 YANTGLLNEKS---DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
+ L+E + D++S G + E + R H++ L+ MMV S V
Sbjct: 233 LMLS--LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI----MMVLGTPSPAV 286
Query: 373 V 373
+
Sbjct: 287 I 287
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 80/314 (25%), Positives = 131/314 (41%), Gaps = 44/314 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVE 189
E N LG G +G V VAVK + + EKE E++
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ H+ +H+N+V LLG C G +++ EY G+L +L R L + +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR---RKSRVLETDPAFAIAN 158
Query: 249 GTAKALAYLHEAIE----------PKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAG 297
TA LH + + +HRD+ + N+L+ + AK+ DFGLA+ ++
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNL 356
V ++APE + +SDV+S+G+LL E + G +P P VN
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNS 274
Query: 357 VDWLKMMVGSRRSEEVVDP-NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ + G + ++ P NI S++ A ++P RP Q+ L+
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNI----------YSIMQACWALEP--THRPTFQQICSFLQ 322
Query: 416 SEEYPIVREDRRHR 429
+ +EDRR R
Sbjct: 323 EQ----AQEDRRER 332
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 149 LGEGGYGVV----YRGNLIN-GSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y N G VAVK + G + + E+E + ++ H+N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 203 LGYCIE--GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G C E G L+ E++ +G+L+++L ++ + + ++K + K + YL
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT---RVMGTFGYVAPEYA 317
+ VHRD+ + N+L++ + K+ DFGL K + K T R F Y APE
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRD 343
SDV+SFGV L E +T D
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCD 215
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN----VGQAEKEFRVEVEA 190
++ L N FS ++G GG+G VY + + K L+ + Q E E
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 241
Query: 191 IGHVRHKN--LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-- 245
+ V + + + Y ++ + + +N G+L H + HG + EA M+
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFS-EADMRFY 296
Query: 246 ---VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
++LG L ++H VV+RD+K +NIL+D+ + ++SD GLA K H +
Sbjct: 297 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 349
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH--GRPAHEVN 355
+GT GY+APE G+ + S D +S G +L + + G P + HE++
Sbjct: 350 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 402
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 127
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG--NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + KIL N + E E + + + +VR++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++ + ++++ + + YL E+
Sbjct: 79 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 130
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K L A ++ + G + + APE N
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN----VGQAEKEFRVEVEA 190
++ L N FS ++G GG+G VY + + K L+ + Q E E
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 191 IGHVRHKN--LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-- 245
+ V + + + Y ++ + + +N G+L H + HG + EA M+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFS-EADMRFY 297
Query: 246 ---VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
++LG L ++H VV+RD+K +NIL+D+ + ++SD GLA K H +
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH--GRPAHEVN 355
+GT GY+APE G+ + S D +S G +L + + G P + HE++
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VA+K K N +K FR EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
L+ EY + G + +L HG M+ EAR K A+ Y H+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSK-FRQIVSAVQYCHQK-- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
++VHRD+K+ N+L+D D N K++DFG + G G Y APE +
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQGKKY 190
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 31 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 89 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILY 144
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 145 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 201
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 202 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 255
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 256 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 302
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 36/295 (12%)
Query: 129 HW-FTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFR 185
HW FT DL+ +G G YG V + + +G +AVK+I + V + E K+
Sbjct: 16 HWDFTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 186 VEVEAIGHVRHKN---LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
++++ + +R + +V+ G + E ++ + + + + E
Sbjct: 69 MDLDVV--MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
K+ L T KAL +L E + K++HRDIK SNIL+D N K+ DFG++ L S
Sbjct: 127 LGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAK 182
Query: 303 TRVMGTFGYVAPEYANTGL----LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVD 358
TR G Y+APE + + +SDV+S G+ L E TGR P ++ D
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN-----SVFD 237
Query: 359 WLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALR-CVDPDSEKRPKMSQVVR 412
L +V DP R S + + C+ D KRPK ++++
Sbjct: 238 QLTQVVKG-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVE--VEAIGHVRHKNLVRLLG 204
LGEG +G V + VA+K I + +++ RVE + + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
++V EY G L ++ R +T + + A+ Y H K
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-N 323
+VHRD+K N+L+DD+ N K++DFGL+ ++ G T+ G+ Y APE N L
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVINGKLYAG 186
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S G++L + GR P D
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD 209
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN----VGQAEKEFRVEVEA 190
++ L N FS ++G GG+G VY + + K L+ + Q E E
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 191 IGHVRHKN--LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-- 245
+ V + + + Y ++ + + +N G+L H + HG + EA M+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFS-EADMRFY 297
Query: 246 ---VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
++LG L ++H VV+RD+K +NIL+D+ + ++SD GLA K H +
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH--GRPAHEVN 355
+GT GY+APE G+ + S D +S G +L + + G P + HE++
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN----VGQAEKEFRVEVEA 190
++ L N FS ++G GG+G VY + + K L+ + Q E E
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 191 IGHVRHKN--LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-- 245
+ V + + + Y ++ + + +N G+L H + HG + EA M+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFS-EADMRFY 297
Query: 246 ---VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
++LG L ++H VV+RD+K +NIL+D+ + ++SD GLA K H +
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH--GRPAHEVN 355
+GT GY+APE G+ + S D +S G +L + + G P + HE++
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/241 (27%), Positives = 119/241 (49%), Gaps = 22/241 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 44 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 102
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKAL 254
++ I I R E + + L L GA + +L+ + L + L
Sbjct: 103 IIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGYV 312
Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 158 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 313 APEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E+
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQED 271
Query: 372 V 372
+
Sbjct: 272 L 272
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y + N G VAVK + G Q ++ E+E + + H+++V+
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 203 LGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL---GTAKALAYL 257
G C + + LV EYV G+L +L RH L ++LL + +AYL
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLA-----QLLLFAQQICEGMAYL 128
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAP 314
H +HR + + N+L+D+D K+ DFGLAK + G + R G F Y AP
Sbjct: 129 HAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AP 184
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRD 343
E SDV+SFGV L E +T D
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLTYCD 213
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 3 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 61 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILY 116
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 227
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 228 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 274
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y + N G VAVK + + G Q ++ E++ + + H+++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 203 LGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G C + + LV EYV G+L +L RH + + + +AYLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHS--IGLAQLLLFAQQICEGMAYLHSQ 136
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYA 317
+HR++ + N+L+D+D K+ DFGLAK + G + R G F Y APE
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECL 192
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRD 343
SDV+SFGV L E +T D
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCD 218
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 6 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 64 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILY 119
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 120 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 176
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 177 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 230
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 231 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 277
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPV-AVKKILNNVGQAEKEFR---VEVEAI 191
++L F +LG+G +G V+ + A+K + +V + + VE +
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 192 GHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
H L + + V EY+N G+L + + +++LG
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG- 130
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK--LLGAGKSHVTTRVMGT 308
L +LH +V+RD+K NIL+D D + K++DFG+ K +LG K T GT
Sbjct: 131 ---LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGT 181
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
Y+APE N D +SFGVLL E + G+ P HG+ E+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 226
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 27/227 (11%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRH 196
++ F +++LGEG YGVV + G VA+KKI + A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 197 KNLVRLLGY----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+N++ + E + + + + + +L + + M ++ + + T +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLR 123
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG---------AGKSHVTT 303
A+ LH + V+HRD+K SN+LI+ + + KV DFGLA+++ G+
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGR 349
+ T Y APE T ++ DV+S G +L E R P+ GR
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGR 226
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y + N G VAVK + G Q ++ E+E + + H+++V+
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 203 LGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL---GTAKALAYL 257
G C + + LV EYV G+L +L RH L ++LL + +AYL
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLA-----QLLLFAQQICEGMAYL 127
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAP 314
H +HR + + N+L+D+D K+ DFGLAK + G + R G F Y AP
Sbjct: 128 HAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AP 183
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRD 343
E SDV+SFGV L E +T D
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLTYCD 212
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG YG V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 5 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 63 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILY 118
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 175
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 176 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 229
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 230 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 276
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ Y + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 147 NVLGEGGYGVVYRG-NLINGSPVAVKKI-------LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ LG G +G V G + + G VAVK + L+ VG+ R E++ + RH +
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK----IRREIQNLKLFRHPH 77
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+++L +V EYV+ G L ++ +G L + ++ + Y H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCH 133
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ VVHRD+K N+L+D NAK++DFGL+ ++ G+ G+ Y APE +
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAAPEVIS 188
Query: 319 TGLL-NEKSDVYSFGVLLLEAITGRDPVD 346
L + D++S GV+L + G P D
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFD 217
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y + N G VAVK + + G Q ++ E++ + + H+++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 203 LGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL---GTAKALAYL 257
G C + + LV EYV G+L +L RH L ++LL + +AYL
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLA-----QLLLFAQQICEGMAYL 133
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAP 314
H +HR++ + N+L+D+D K+ DFGLAK + G + R G F Y AP
Sbjct: 134 HAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AP 189
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRD 343
E SDV+SFGV L E +T D
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCD 218
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + L++ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLSFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 3 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 61 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILY 116
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 227
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 228 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 274
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 79/314 (25%), Positives = 132/314 (42%), Gaps = 44/314 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVE 189
E N LG G +G V VAVK + + EKE E++
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR----------HHGYL 238
+ H+ +H+N+V LLG C G +++ EY G+L +L R + L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAG 297
+ + A+ +A+L +HRD+ + N+L+ + AK+ DFGLA+ ++
Sbjct: 162 STRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNL 356
V ++APE + +SDV+S+G+LL E + G +P P VN
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNS 274
Query: 357 VDWLKMMVGSRRSEEVVDP-NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ + G + ++ P NI S++ A ++P RP Q+ L+
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNI----------YSIMQACWALEP--THRPTFQQICSFLQ 322
Query: 416 SEEYPIVREDRRHR 429
+ +EDRR R
Sbjct: 323 EQ----AQEDRRER 332
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 74/303 (24%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAE-KEFRVEVEAI-- 191
L N ++V+GEG +G V + + A+K++ + + ++F E+E +
Sbjct: 19 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 78
Query: 192 -GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG------------AMRHHGYL 238
GH H N++ LLG C + L EY +GNL +L A L
Sbjct: 79 LGH--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ + + A+ + YL + + +HR++ + NIL+ +++ AK++DFGL++ G+
Sbjct: 137 SSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR----GQ 189
Query: 299 SHVTTRVMGTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356
+ MG ++A E N + SDV+S+GVLL E ++ G P +
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----GGTPYCGMTC 244
Query: 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV----R 412
+ + + R E+ ++ + EV R +C +RP +Q++ R
Sbjct: 245 AELYEKLPQGYRLEKPLNCDDEVYDLMR----------QCWREKPYERPSFAQILVSLNR 294
Query: 413 MLE 415
MLE
Sbjct: 295 MLE 297
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 8 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 66 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILY 121
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 122 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 232
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 233 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 279
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILN-NVGQ-AEKEFRV- 186
F + ++R+ + VLG+G +G V+ + I G AVK I V Q +KE +
Sbjct: 22 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 81
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
EV+ + + H N+++L + + + LV E G L + R +V
Sbjct: 82 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 141
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTT 303
L G + Y+H+ K+VHRD+K N+L++ D N ++ DFGL+ A K
Sbjct: 142 LSG----ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 192
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
+GT Y+APE + G +EK DV+S GV+L ++G P + N D LK +
Sbjct: 193 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA------NEYDILKKV 245
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLT 392
+ + E+ +V S + L R +LT
Sbjct: 246 EKGKYTFELPQWK-KVSESAKDLIRKMLT 273
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 149 LGEGGYGVV--YRGNLIN---GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V Y + N G VAVK + + G Q ++ E++ + + H+++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 203 LGYCIEG--IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G C + LV EYV G+L +L RH + + + +AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS--IGLAQLLLFAQQICEGMAYLHAQ 153
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYA 317
+HRD+ + N+L+D+D K+ DFGLAK + G R G F Y APE
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECL 209
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRD 343
SDV+SFGV L E +T D
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCD 235
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+V+ +L++++ + + L + LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+ LH V+H
Sbjct: 97 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 148
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
D++S G++++E + G P + P + ++
Sbjct: 206 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 118/255 (46%), Gaps = 15/255 (5%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F+K +G+G +G V++G + VA+K I L ++ + E+ + +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G ++G ++ EY+ G+ L + +K +L K L YLH
Sbjct: 85 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLHSE 139
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
K +HRDIK++N+L+ + + K++DFG+A L + T V GT ++APE
Sbjct: 140 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV--DWLKMMVG--SRRSEEVVDPN 376
+ K+D++S G+ +E G P P + L+ + +VG ++ +E +D
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDAC 255
Query: 377 IEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 256 LNKDPSFRPTAKELL 270
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRV---EVEAIGH 193
L + F VLG+G +G V + G AVK + +V + + E +
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 194 VRHKNLVRLLGYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TA 251
R+ + L C + R+ V E+VN G+L + + R EAR +
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEII 134
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
AL +LH+ +++RD+K N+L+D + + K++DFG+ K G T GT Y
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDY 190
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+APE L D ++ GVLL E + G P +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F + VLG+G +G V + N ++ A+KKI + + EV + + H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 202 LLGYCIE---------GIHR----MLVYEYVNNGNLEQWLHGA-MRHHGYLTWEARMKVL 247
+E + + + EY N L +H + W ++L
Sbjct: 67 YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG------------ 295
+AL+Y+H ++HR++K NI ID+ N K+ DFGLAK +
Sbjct: 127 ----EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 296 -AGKSHVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAI----TGRDPVDHGR 349
G S T +GT YVA E + TG NEK D YS G++ E I TG + V+ +
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILK 239
Query: 350 PAHEVNL-----VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRS 389
V++ D K V + ++D + RP R L S
Sbjct: 240 KLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNS 284
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+ LH V+H
Sbjct: 99 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 150
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
D++S G++++E + G P + P + ++
Sbjct: 208 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 83 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 250
Query: 371 EV 372
++
Sbjct: 251 DL 252
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 26 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 84
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 85 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 138
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 252
Query: 371 EV 372
++
Sbjct: 253 DL 254
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+ LH V+H
Sbjct: 142 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 193
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
D++S G++++E + G P + P + ++
Sbjct: 251 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLL 203
K+ LGEG + + + + KI++ + E + E+ A+ H N+V+L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
+ +H LV E +N G L + ++ + + ++ A++++H+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLVSAVSHMHDV--- 125
Query: 264 KVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
VVHRD+K N+L +D+ K+ DFG A+L + T T Y APE N
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQN 184
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVD-HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
+E D++S GV+L ++G+ P H R + V+ +K + S E E
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG-----EA 239
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMS 408
+ + L+ L VDP+ KR KMS
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPN--KRLKMS 266
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 87 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQ-HLSNDHICYFLYQILRG 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 254
Query: 371 EV 372
++
Sbjct: 255 DL 256
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 83 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 250
Query: 371 EV 372
++
Sbjct: 251 DL 252
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 127 WGHWFTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQA-EKEF 184
W +RD+ + +VLG G + V+ + VA+K I + E
Sbjct: 10 WKQAEDIRDI------YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 185 RVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E+ + ++H N+V L G H L+ + V+ G L + G+ T
Sbjct: 64 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL---IDDDFNAKVSDFGLAKLLGAGKSHV 301
+++ A+ YLH+ +VHRD+K N+L +D+D +SDFGL+K+ G V
Sbjct: 120 RLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--V 174
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ GT GYVAPE ++ D +S GV+ + G P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 22 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 80
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 81 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 134
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 135 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPEQE 248
Query: 371 EV 372
++
Sbjct: 249 DL 250
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 127 WGHWFTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQA-EKEF 184
W +RD+ + +VLG G + V+ + VA+K I + E
Sbjct: 10 WKQAEDIRDI------YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 185 RVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E+ + ++H N+V L G H L+ + V+ G L + G+ T
Sbjct: 64 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL---IDDDFNAKVSDFGLAKLLGAGKSHV 301
+++ A+ YLH+ +VHRD+K N+L +D+D +SDFGL+K+ G V
Sbjct: 120 RLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--V 174
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ GT GYVAPE ++ D +S GV+ + G P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 32 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 90
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 91 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 144
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 145 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 201
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 202 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 258
Query: 371 EV 372
++
Sbjct: 259 DL 260
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 83 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 250
Query: 371 EV 372
++
Sbjct: 251 DL 252
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 127 WGHWFTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQA-EKEF 184
W +RD+ + +VLG G + V+ + VA+K I + E
Sbjct: 10 WKQAEDIRDI------YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSM 63
Query: 185 RVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E+ + ++H N+V L G H L+ + V+ G L + G+ T
Sbjct: 64 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL---IDDDFNAKVSDFGLAKLLGAGKSHV 301
+++ A+ YLH+ +VHRD+K N+L +D+D +SDFGL+K+ G V
Sbjct: 120 RLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--V 174
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ GT GYVAPE ++ D +S GV+ + G P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAE-KEFRVE 187
E ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ Y + GNL ++L A R G
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLR-ARRPPGMEYSYDINRV 149
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPV 265
Query: 352 HEV 354
E+
Sbjct: 266 EEL 268
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 44 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 102
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 103 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 156
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 270
Query: 371 EV 372
++
Sbjct: 271 DL 272
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 12/227 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGHV 194
EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 21 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q L A G + + KV + K L
Sbjct: 81 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGL 136
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++P
Sbjct: 137 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 191
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-NLVDWL 360
E + +SD++S G+ L+E GR P+ G + + L+D++
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI 238
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFR-- 185
W L + + F VLG GG+G V+ + G A KK+ + K ++
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 186 -VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE--- 241
VE + + V H + L Y E + + + NG G +R+H Y E
Sbjct: 233 MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG-------GDIRYHIYNVDEDNP 284
Query: 242 --ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ + TA+ ++ L + +++RD+K N+L+DDD N ++SD GLA L AG++
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
T GT G++APE + D ++ GV L E I R P
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 83 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 250
Query: 371 EV 372
++
Sbjct: 251 DL 252
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 29 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 87
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 88 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 141
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 142 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 198
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 255
Query: 371 EV 372
++
Sbjct: 256 DL 257
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 30 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 88
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 89 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 143 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 199
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 200 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 256
Query: 371 EV 372
++
Sbjct: 257 DL 258
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 21 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 79
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 80 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 134 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 190
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 191 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 247
Query: 371 EV 372
++
Sbjct: 248 DL 249
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 87 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 254
Query: 371 EV 372
++
Sbjct: 255 DL 256
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFR-- 185
W L + + F VLG GG+G V+ + G A KK+ + K ++
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 186 -VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE--- 241
VE + + V H + L Y E + + + NG G +R+H Y E
Sbjct: 233 MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG-------GDIRYHIYNVDEDNP 284
Query: 242 --ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ + TA+ ++ L + +++RD+K N+L+DDD N ++SD GLA L AG++
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
T GT G++APE + D ++ GV L E I R P
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 22 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 80
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 81 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 134
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 135 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 248
Query: 371 EV 372
++
Sbjct: 249 DL 250
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+ KI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+ KI + G R E+ + + H N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 26 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHEN 84
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 85 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 138
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 252
Query: 371 EV 372
++
Sbjct: 253 DL 254
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 67
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 68 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 124
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 180
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 123 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFR-- 185
W L + + F VLG GG+G V+ + G A KK+ + K ++
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 186 -VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE--- 241
VE + + V H + L Y E + + + NG G +R+H Y E
Sbjct: 233 MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG-------GDIRYHIYNVDEDNP 284
Query: 242 --ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ + TA+ ++ L + +++RD+K N+L+DDD N ++SD GLA L AG++
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
T GT G++APE + D ++ GV L E I R P
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFR-- 185
W L + + F VLG GG+G V+ + G A KK+ + K ++
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 186 -VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE--- 241
VE + + V H + L Y E + + + NG G +R+H Y E
Sbjct: 233 MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG-------GDIRYHIYNVDEDNP 284
Query: 242 --ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ + TA+ ++ L + +++RD+K N+L+DDD N ++SD GLA L AG++
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
T GT G++APE + D ++ GV L E I R P
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILN-NVGQ-AEKEFRV- 186
F + ++R+ + VLG+G +G V+ + I G AVK I V Q +KE +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
EV+ + + H N+++L + + + LV E G L + R +V
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTT 303
L G + Y+H+ K+VHRD+K N+L++ D N ++ DFGL+ A K
Sbjct: 136 LSG----ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 186
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP------------VDHGRPA 351
+GT Y+APE + G +EK DV+S GV+L ++G P V+ G+
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLL 391
E L W K+ S +++++ + PS R R L
Sbjct: 246 FE--LPQWKKV---SESAKDLIRKMLTYVPSMRISARDAL 280
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/243 (25%), Positives = 112/243 (46%), Gaps = 23/243 (9%)
Query: 132 TLRDLELATNR-----FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV 186
+L +++L+ R F ++G G YG VY+G + +A K+++ G E+E +
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ 69
Query: 187 EVEAIG-HVRHKNLVRLLGYCIE----GIHRML--VYEYVNNGNLEQWLHGAMRHHGYLT 239
E+ + + H+N+ G I+ G+ L V E+ G++ + +
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
W A + + L++LH+ KV+HRDIK N+L+ ++ K+ DFG++ L
Sbjct: 130 WIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 300 HVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
T +GT ++APE + KSD++S G+ +E G P+ P +
Sbjct: 185 RRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 355 NLV 357
L+
Sbjct: 244 FLI 246
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 149 LGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + G VAVKK+ Q + EV + H N+V + +
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+YLH V+H
Sbjct: 113 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 164
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVS---KEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 326 SDVYSFGVLLLEAITGRDP 344
D++S G++++E I G P
Sbjct: 222 VDIWSLGIMVIEMIDGEPP 240
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 127 WGHWFTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQA-EKEF 184
W +RD+ + +VLG G + V+ + VA+K I + E
Sbjct: 10 WKQAEDIRDI------YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 185 RVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E+ + ++H N+V L G H L+ + V+ G L + G+ T
Sbjct: 64 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL---IDDDFNAKVSDFGLAKLLGAGKSHV 301
+++ A+ YLH+ +VHRD+K N+L +D+D +SDFGL+K+ G V
Sbjct: 120 RLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--V 174
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ GT GYVAPE ++ D +S GV+ + G P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 143 FSKENVLGEGGYGVVYRGNLING---SPVAVKKILNNVGQAEK-----EFRVEVEAIGHV 194
F VLG G YG V+ I+G + K+L +K R E + + H+
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 195 RHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAK 252
R + L Y + ++ L+ +Y+N G L + H + R E +++ +G
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRER---FTEHEVQIYVGEIVL 170
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL +LH+ +++RDIK NIL+D + + ++DFGL+K A ++ GT Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 313 APEYANTGLL--NEKSDVYSFGVLLLEAITGRDP 344
AP+ G ++ D +S GVL+ E +TG P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 139
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEYANTGLLNE 324
RDIKS +IL+ D K+SDFG A S R ++GT ++APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
+ D++S G++++E + G P + P + ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGH 193
+EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V G + E+++ G+L+Q L A G + + KV + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPV-------DHGRPAHEVNLVDWL 360
PE + +SD++S G+ L+E GR P+ D P L+D++
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYI 225
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 82/316 (25%), Positives = 137/316 (43%), Gaps = 49/316 (15%)
Query: 132 TLRDLELATNRFSKENV-----LGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQA 180
+ LE F ++N+ LGEG +G V + + + VAVK + N +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 181 E-KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR-HHGYL 238
E ++ E + V H ++++L G C + +L+ EY G+L +L + + GYL
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 239 TWEARMK-----------VLLGTAKALAY-----LHEAIEPKVVHRDIKSSNILIDDDFN 282
+ +G + A+ + E K+VHRD+ + NIL+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 283 AKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
K+SDFGL++ + S+V R G ++A E + +SDV+SFGVLL E +T
Sbjct: 189 MKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 341 -GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDP 399
G +P P NL+ G R RP + + L L+C
Sbjct: 248 LGGNPYPGIPPERLFNLLK-----TGHRME----------RPDNCSEEMYRLM-LQCWKQ 291
Query: 400 DSEKRPKMSQVVRMLE 415
+ +KRP + + + LE
Sbjct: 292 EPDKRPVFADISKDLE 307
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 87 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 254
Query: 371 EV 372
++
Sbjct: 255 DL 256
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILN-NVGQ-AEKEFRV- 186
F + ++R+ + VLG+G +G V+ + I G AVK I V Q +KE +
Sbjct: 40 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 99
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
EV+ + + H N+++L + + + LV E G L + R +V
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 159
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTT 303
L G + Y+H+ K+VHRD+K N+L++ D N ++ DFGL+ A K
Sbjct: 160 LSG----ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 210
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP------------VDHGRPA 351
+GT Y+APE + G +EK DV+S GV+L ++G P V+ G+
Sbjct: 211 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 269
Query: 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLL 391
E L W K+ S +++++ + PS R R L
Sbjct: 270 FE--LPQWKKV---SESAKDLIRKMLTYVPSMRISARDAL 304
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G G+V + + G VAVKK+ N A++ +R E+ + V HK
Sbjct: 23 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 81
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
N++ LL +E + + + + NL Q +H + H RM LL
Sbjct: 82 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE-------RMSYLLYQML 134
Query: 253 A-LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ A + + T + T Y
Sbjct: 135 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYY 189
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
APE E D++S G ++ E + G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R L + +
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFS-LDLASLILY 496
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 497 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 607
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 608 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 654
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILN-NVGQ-AEKEFRV- 186
F + ++R+ + VLG+G +G V+ + I G AVK I V Q +KE +
Sbjct: 39 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 98
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
EV+ + + H N+++L + + + LV E G L + R +V
Sbjct: 99 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 158
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTT 303
L G + Y+H+ K+VHRD+K N+L++ D N ++ DFGL+ A K
Sbjct: 159 LSG----ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 209
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP------------VDHGRPA 351
+GT Y+APE + G +EK DV+S GV+L ++G P V+ G+
Sbjct: 210 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 268
Query: 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLL 391
E L W K+ S +++++ + PS R R L
Sbjct: 269 FE--LPQWKKV---SESAKDLIRKMLTYVPSMRISARDAL 303
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+ LH V+H
Sbjct: 92 VGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIH 143
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
D++S G++++E + G P + P + ++
Sbjct: 201 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L+G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S GV++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 83 II-----GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 250
Query: 371 EV 372
++
Sbjct: 251 DL 252
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 21/216 (9%)
Query: 148 VLGE-GGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGY 205
++GE G +G VY+ S +A K+++ + E E + VE++ + H N+V+LL
Sbjct: 16 IIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 75
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPK 264
+ ++ E+ G ++ + R LT E++++V+ T AL YLH+ K
Sbjct: 76 FYYENNLWILIEFCAGGAVDAVMLELERP---LT-ESQIQVVCKQTLDALNYLHDN---K 128
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL--- 321
++HRD+K+ NIL D + K++DFG++ +GT ++APE
Sbjct: 129 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPYWMAPEVVMCETSKD 188
Query: 322 --LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ K+DV+S G+ L+E + +P P HE+N
Sbjct: 189 RPYDYKADVWSLGITLIE-MAEIEP-----PHHELN 218
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L+G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S GV++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L+ ++ + + L + LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 121 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 124 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 3 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R L + +
Sbjct: 61 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFS-LDLASLILY 116
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + ++
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGK 173
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 227
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 228 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 274
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L+ ++ + + L + LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQA-EKEFRVEVEAIGHV 194
EL + F K + LG G GVV++ + V +K+++ + A + E++ +
Sbjct: 64 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q L A G + + KV + K L
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGL 179
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++P
Sbjct: 180 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 234
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
E + +SD++S G+ L+E GR P+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGH 193
+EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V G + E+++ G+L+Q L A G + + KV + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
PE + +SD++S G+ L+E GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L++++ + + L + LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGH 193
+EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V G + E+++ G+L+Q L A G + + KV + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
PE + +SD++S G+ L+E GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 38/309 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVE 189
E N LG G +G V VAVK + + EKE E++
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL----HGAMRHHGYLTWEARM 244
+ H+ +H+N+V LLG C G +++ EY G+L +L + E R
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 245 KVLLGT--AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHV 301
+ + A+ +A+L +HRD+ + N+L+ + AK+ DFGLA+ ++ V
Sbjct: 162 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361
++APE + +SDV+S+G+LL E + + L +
Sbjct: 219 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPYPG 265
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALK-RSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
++V S+ + V D +P+ S++ A ++P RP Q+ L+ +
Sbjct: 266 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP--THRPTFQQICSFLQEQ--- 320
Query: 421 IVREDRRHR 429
+EDRR R
Sbjct: 321 -AQEDRRER 328
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA++KI + ++ R E++ + RH+N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 87 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 254
Query: 371 EV 372
++
Sbjct: 255 DL 256
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 43/300 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R + LG G +G V + VAVK + +E + E++
Sbjct: 23 EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR--------HHGYLT 239
+ H+ H N+V LLG C + G M++ E+ GNL +L + +LT
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 143 LEHLICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 300 HV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVN 355
+V R+ ++APE + +SDV+SFGVLL E + G P P +++
Sbjct: 200 YVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKID 253
Query: 356 LVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ G+R R+ + P + T L C + +RP S++V L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 301
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 149 LGEGGYGVVYRG---NLINGSP---VAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVR 201
+GEG +G V++ L+ P VAVK + + +F+ E + + N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH------HGYLTWEAR------------ 243
LLG C G L++EY+ G+L ++L H H L+ AR
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 244 --MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSH 300
+ + A +AYL E K VHRD+ + N L+ ++ K++DFGL++ + A
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
++ PE +SDV+++GV+L E +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 43/300 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R + LG G +G V + VAVK + +E + E++
Sbjct: 23 EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR--------HHGYLT 239
+ H+ H N+V LLG C + G M++ E+ GNL +L + +LT
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 143 LEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD 199
Query: 300 HV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVN 355
+V R+ ++APE + +SDV+SFGVLL E + G P P +++
Sbjct: 200 YVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKID 253
Query: 356 LVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ G+R R+ + P + T L C + +RP S++V L
Sbjct: 254 EEFXRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 301
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 26 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHEN 84
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 85 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 138
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 252
Query: 371 EV 372
++
Sbjct: 253 DL 254
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L+ ++ + + L + LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 120/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHEN 86
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 87 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 254
Query: 371 EV 372
++
Sbjct: 255 DL 256
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVE 187
D E+ R +GEG +G V++G I SP VA+K N + +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPALAVAIKTCKNCTSDSVREKFLQE 58
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
+ H ++V+L+G E ++ E G L +L +R + L + +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYS-LDLASLILYA 114
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG 307
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 115 YQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 308 TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVGS 366
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIENG 225
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 226 ER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 271
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGH 193
+EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V G + E+++ G+L+Q L A G + + KV + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
PE + +SD++S G+ L+E GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGH 193
+EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V G + E+++ G+L+Q L A G + + KV + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMS 171
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
PE + +SD++S G+ L+E GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + G R E+ + + H N
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ +L+ ++ + + L + LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
+V+HRD+K N+LI+ + K++DFGLA+ G V+ T Y APE
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGR 342
+ D++S G + E +T R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTA 251
N++ LL +E + + + + NL Q + + H RM LL
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHE-------RMSYLLYQML 136
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 137 XGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
APE E D++S G ++ E + GRD +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGHV 194
EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 5 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q L A G + + KV + K L
Sbjct: 65 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGL 120
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++P
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDEMANEFVGTRSYMSP 175
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-NLVDW--------LKMMVG 365
E + +SD++S G+ L+E GR P RP + L+D+ L V
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP----RPPMAIFELLDYIVNEPPPKLPSAVF 231
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLT 392
S ++ V+ + P+ RA + L+
Sbjct: 232 SLEFQDFVNKCLIKNPAERADLKQLMV 258
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G+G + V +++ G VAVK K N +K FR EV + H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
LV EY + G + +L HG + EAR K A+ Y H+
Sbjct: 81 VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-----EARAK-FRQIVSAVQYCHQKF- 133
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGL 321
+VHRD+K+ N+L+D D N K++DFG + G G Y APE +
Sbjct: 134 --IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGKKY 189
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L ++G P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 11/211 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQAEKEFRV-EVEAIGHV 194
EL + F K + LG G GVV++ + V +K+++ + A + + E++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q L A G + + KV + K L
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGL 144
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++P
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 199
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
E + +SD++S G+ L+E GR P+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 47/316 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 74 ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 191 KDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 244
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 292
Query: 411 VRMLESEEYPIVREDR 426
V L + ++DR
Sbjct: 293 VEHLGNLLQANAQQDR 308
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 47/316 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 74 ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 191 KDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 244
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 292
Query: 411 VRMLESEEYPIVREDR 426
V L + ++DR
Sbjct: 293 VEHLGNLLQANAQQDR 308
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG G +G V+ + VAVK + E F E + ++H
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 236
Query: 197 KNLVRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
LV+L E I+ ++ E++ G+L +L L + A+ +A
Sbjct: 237 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 292
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVA 313
++ + +HRD++++NIL+ K++DFGLA RV F + A
Sbjct: 293 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLA------------RVGAKFPIKWTA 337
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
PE N G KSDV+SFG+LL+E +T GR P
Sbjct: 338 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEG G V N + VAVK + + + + E+ + H+N+V+ G+
Sbjct: 14 LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
EG + L EY + G L + + G +A+ + + YLH +
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQ-RFFHQLMAGVVYLHGI---GIT 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE + E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 325 KSDVYSFGVLLLEAITGRDPVDH 347
DV+S G++L + G P D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 80/279 (28%), Positives = 122/279 (43%), Gaps = 30/279 (10%)
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVY------RGNLINGSPVAVKKILNNVGQAEK 182
W L + N F + VLG+GG+G V G + + K+I G+A
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA-- 229
Query: 183 EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTW- 240
+ + I + V L Y E + LV +N G+L+ ++ H G +
Sbjct: 230 -MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----HMGQAGFP 284
Query: 241 EARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300
EAR + A+ L + ++V+RD+K NIL+DD + ++SD GLA + G++
Sbjct: 285 EAR--AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ RV GT GY+APE D ++ G LL E I G+ P + + V+ L
Sbjct: 342 IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDP 399
V SE R S +A RSL + L C DP
Sbjct: 401 VKEVPEEYSE---------RFSPQA--RSLCSQLLCKDP 428
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 34/280 (12%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILN-NVGQ-AEKEFRV- 186
F + ++R+ + VLG+G +G V+ + I G AVK I V Q +KE +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
EV+ + + H N+ +L + + + LV E G L + R +V
Sbjct: 76 EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTT 303
L G + Y H+ K+VHRD+K N+L++ D N ++ DFGL+ A K
Sbjct: 136 LSG----ITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--XK 186
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP------------VDHGRPA 351
+GT Y+APE + G +EK DV+S GV+L ++G P V+ G+
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLL 391
E L W K+ S +++++ + PS R R L
Sbjct: 246 FE--LPQWKKV---SESAKDLIRKXLTYVPSXRISARDAL 280
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 80/279 (28%), Positives = 122/279 (43%), Gaps = 30/279 (10%)
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVY------RGNLINGSPVAVKKILNNVGQAEK 182
W L + N F + VLG+GG+G V G + + K+I G+A
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA-- 229
Query: 183 EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTW- 240
+ + I + V L Y E + LV +N G+L+ ++ H G +
Sbjct: 230 -MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----HMGQAGFP 284
Query: 241 EARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300
EAR + A+ L + ++V+RD+K NIL+DD + ++SD GLA + G++
Sbjct: 285 EAR--AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ RV GT GY+APE D ++ G LL E I G+ P + + V+ L
Sbjct: 342 IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDP 399
V SE R S +A RSL + L C DP
Sbjct: 401 VKEVPEEYSE---------RFSPQA--RSLCSQLLCKDP 428
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 77/303 (25%), Positives = 127/303 (41%), Gaps = 46/303 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R + LG G +G V + VAVK + +E + E++
Sbjct: 24 EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 83
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR-----------HHG 236
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 84 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD 143
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 297 GKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352
V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 201 DPDXVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGV 254
Query: 353 EVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+++ ++ G+R R+ + P + T L C + +RP S++V
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELV 302
Query: 412 RML 414
L
Sbjct: 303 EHL 305
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 11/217 (5%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILN--NVGQAEKEFRVEVEAIGHVRHKNLV 200
F+K + +G+G +G VY+G + V KI++ ++ + E+ + +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
R G ++ ++ EY+ G+ L Y+ +L K L YLH
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 135
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
+ +HRDIK++N+L+ + + K++DFG+A L + V GT ++APE
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 191
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
+ K+D++S G+ +E G P P + L+
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 47/304 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 25 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 84
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 85 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK 144
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 145 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 202 KDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 255
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 256 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 303
Query: 411 VRML 414
V L
Sbjct: 304 VEHL 307
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 44/315 (13%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVE 189
E N LG G +G V VAVK + + EKE E++
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL------------HGAMRHHG 236
+ H+ +H+N+V LLG C G +++ EY G+L +L + +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLG 295
L+ + A+ +A+L +HRD+ + N+L+ + AK+ DFGLA+ ++
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
V ++APE + +SDV+S+G+LL E + +
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LG 265
Query: 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALK-RSLLTALRCVDPDSEKRPKMSQVVRML 414
L + ++V S+ + V D +P+ S++ A ++P RP Q+ L
Sbjct: 266 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP--THRPTFQQICSFL 323
Query: 415 ESEEYPIVREDRRHR 429
+ + +EDRR R
Sbjct: 324 QEQ----AQEDRRER 334
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 82/316 (25%), Positives = 136/316 (43%), Gaps = 49/316 (15%)
Query: 132 TLRDLELATNRFSKENV-----LGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQA 180
+ LE F ++N+ LGEG +G V + + + VAVK + N +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 181 E-KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR-HHGYL 238
E ++ E + V H ++++L G C + +L+ EY G+L +L + + GYL
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 239 TWEARMK-----------VLLGTAKALAY-----LHEAIEPKVVHRDIKSSNILIDDDFN 282
+ +G + A+ + E K+VHRD+ + NIL+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 283 AKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
K+SDFGL++ + S V R G ++A E + +SDV+SFGVLL E +T
Sbjct: 189 MKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 341 -GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDP 399
G +P P NL+ G R RP + + L L+C
Sbjct: 248 LGGNPYPGIPPERLFNLLK-----TGHRME----------RPDNCSEEMYRLM-LQCWKQ 291
Query: 400 DSEKRPKMSQVVRMLE 415
+ +KRP + + + LE
Sbjct: 292 EPDKRPVFADISKDLE 307
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTA 251
N++ LL +E + + + + NL Q + + H RM LL
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHE-------RMSYLLYQML 136
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 137 XGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
APE E D++S G ++ E + GRD +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 25 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 84
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR----------HHGY 237
+ H+ H N+V LLG C + G M++ E+ GNL +L + +
Sbjct: 85 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF 144
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 298 KSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHE 353
V R+ ++APE + +SDV+SFGVLL E + G P P +
Sbjct: 202 PDXVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVK 255
Query: 354 VNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ ++ G+R R+ + P + T L C + +RP S++V
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVE 303
Query: 413 ML 414
L
Sbjct: 304 HL 305
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 3 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R L + +
Sbjct: 61 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFS-LDLASLILY 116
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ K+ DFGL++ + + ++
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 227
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 228 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 274
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 47/304 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 200 KDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 253
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 301
Query: 411 VRML 414
V L
Sbjct: 302 VEHL 305
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 76
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTA 251
N++ LL +E + + + + NL Q + + H RM LL
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHE-------RMSYLLYQML 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 130 XGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
APE E D++S G ++ E + GRD +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR------VEVEAIGHV 194
++F VLG+G +G V+ I+GS + + +A + R +E + + V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 195 RHKNLVRL-LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
H +V+L + EG L+ +++ G+L L + T E L A A
Sbjct: 84 NHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALA 138
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L +LH +++RD+K NIL+D++ + K++DFGL+K GT Y+A
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
PE N + +D +SFGVL+ E +TG P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 37/297 (12%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRV 186
RD E+ R +GEG +G V++G I SP VA+K N + +E F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQG--IYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + H ++V+L+G E ++ E G L +L +R L + +
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFS-LDLASLILY 496
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ ALAYL + VHRDI + N+L+ K+ DFGL++ + + ++
Sbjct: 497 AYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG-RPAHEVNLVDWLKMMVG 365
++APE N SDV+ FGV + E + HG +P V D + +
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIEN 607
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS----QVVRMLESEE 418
R + + P+ SL+T +C D +RP+ + Q+ +LE E+
Sbjct: 608 GER--------LPMPPNCPPTLYSLMT--KCWAYDPSRRPRFTELKAQLSTILEEEK 654
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 47/304 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 119
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 237 KDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 290
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 291 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 338
Query: 411 VRML 414
V L
Sbjct: 339 VEHL 342
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L+G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 119/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 87 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H + T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 197
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 254
Query: 371 EV 372
++
Sbjct: 255 DL 256
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 119/242 (49%), Gaps = 24/242 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH+N
Sbjct: 29 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHEN 87
Query: 199 LVRLLGYCIEGIHRMLVYE-----YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++ I I R E Y+ +E L+ ++ +L+ + L +
Sbjct: 88 IIG-----INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRG 141
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTFGY 311
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H + T Y
Sbjct: 142 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 198
Query: 312 VAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
APE N+ + D++S G +L E ++ R P+ G+ H ++ ++ + ++GS E
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK--HYLDQLNHILGILGSPSQE 255
Query: 371 EV 372
++
Sbjct: 256 DL 257
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 79/316 (25%), Positives = 131/316 (41%), Gaps = 47/316 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 74 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 191 KDPDXVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 244
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 292
Query: 411 VRMLESEEYPIVREDR 426
V L + ++DR
Sbjct: 293 VEHLGNLLQANAQQDR 308
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 47/304 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 200 KDPDXVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 253
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 301
Query: 411 VRML 414
V L
Sbjct: 302 VEHL 305
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 24 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 82
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 83 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 137
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 138 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 189
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 84
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 85 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 139
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 140 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQA--EKEFRVEVEAIGHVRHKN 198
++ K +GEG YGVV++ N G VA+KK L + +K E+ + ++H N
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNG---NLEQWLHGAMRHH-GYLTWEARMKVLLGTAKAL 254
LV LL LV+EY ++ L+++ G H +TW+ T +A+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAV 115
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
+ H+ +HRD+K NILI K+ DFG A+LL G S + T Y +P
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSP 171
Query: 315 E-YANTGLLNEKSDVYSFGVLLLEAITG 341
E DV++ G + E ++G
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG 199
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G+G YG V+ G G VAVK + +A E+ +RH+N++ + I+
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 209 GI----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI--- 261
G L+ +Y NG+L +L L ++ +K+ + L +LH I
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 262 --EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV----TTRVMGTFGYVAPE 315
+P + HRD+KS NIL+ + ++D GLA + + V TRV GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPE 216
Query: 316 YANTGLLNEK------SDVYSFGVLLLE----AITGRDPVDHGRPAHEV 354
+ L +D+YSFG++L E ++G ++ P H++
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 79/316 (25%), Positives = 131/316 (41%), Gaps = 47/316 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 74 ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 191 KDPDXVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 244
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 292
Query: 411 VRMLESEEYPIVREDR 426
V L + ++DR
Sbjct: 293 VEHLGNLLQANAQQDR 308
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+GEG YGVVY+ G A+KKI + G R E+ + ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+LV+E+++ +L++ L G L LL +AY H+ +V
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNE 324
+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y AP+ + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 325 KSDVYSFGVLLLEAITG 341
D++S G + E + G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 84
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 85 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 139
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 140 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 84
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 139
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 140 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 191
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 76
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 131
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 132 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 183
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+GEG YGVVY+ G A+KKI + G R E+ + ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+LV+E+++ +L++ L G L LL +AY H+ +V
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNE 324
+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y AP+ + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 325 KSDVYSFGVLLLEAITG 341
D++S G + E + G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 121
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 176
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 177 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 228
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 19 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 77
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 78 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 132
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 133 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR------VEVEAIGHV 194
++F VLG+G +G V+ I+GS + + +A + R +E + + V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 195 RHKNLVRL-LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
H +V+L + EG L+ +++ G+L L + T E L A A
Sbjct: 84 NHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALA 138
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L +LH +++RD+K NIL+D++ + K++DFGL+K GT Y+A
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE N + +D +SFGVL+ E +TG P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 30 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 88
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 89 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 143
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 144 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 195
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT------GRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGS--------PVAVKKILNNVGQAEKEFRVEVEAIGHV 194
F VLG+GGYG V++ + G+ V K ++ + + E + V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+H +V L+ G L+ EY++ G L L G + L + AL
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMAL 134
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
+LH+ +++RD+K NI+++ + K++DFGL K VT GT Y+AP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAP 190
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E N D +S G L+ + +TG P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 19 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 77
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 78 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 132
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 133 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 159
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 216
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 217 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 272
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 306
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+GEG YGVVY+ G A+KKI + G R E+ + ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+LV+E+++ +L++ L G L LL +AY H+ +V
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNE 324
+HRD+K N+LI+ + K++DFGLA+ G T ++ T Y AP+ + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 325 KSDVYSFGVLLLEAITG 341
D++S G + E + G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR------VEVEAIGHV 194
++F VLG+G +G V+ I+GS + + +A + R +E + + V
Sbjct: 25 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 195 RHKNLVRL-LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
H +V+L + EG L+ +++ G+L L + T E L A A
Sbjct: 85 NHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALA 139
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L +LH +++RD+K NIL+D++ + K++DFGL+K GT Y+A
Sbjct: 140 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 195
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE N + +D +SFGVL+ E +TG P
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGS--------PVAVKKILNNVGQAEKEFRVEVEAIGHV 194
F VLG+GGYG V++ + G+ V K ++ + + E + V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+H +V L+ G L+ EY++ G L L G + L + AL
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMAL 134
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
+LH+ +++RD+K NI+++ + K++DFGL K VT GT Y+AP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAP 190
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E N D +S G L+ + +TG P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 47/304 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V + VAVK + +E + E++
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 190 AIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMR------------HH 235
+ H+ H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 296 AGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 200 KDPDXVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 253
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 301
Query: 411 VRML 414
V L
Sbjct: 302 VEHL 305
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 121
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 176
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 177 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 228
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 50 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 104
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 153
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 154 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 209
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 210 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 266
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 267 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 300
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 50/273 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
++ V+G G +GVVY+ L + G VA+KK+L G+A K E++ + + H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKN--RELQIMRKLDHCNIVR 77
Query: 202 LLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA---- 251
L + ++ LV +YV + ++ RH+ +R K L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVKL 126
Query: 252 ------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTR 304
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 305 VMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K++
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKVL 239
Query: 364 VGSRRSE---------EVVDPNIEVRPSTRALK 387
R + E P I+ P T+ +
Sbjct: 240 GTPTREQIREMNPNYTEFAFPQIKAHPWTKVFR 272
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 201 RL-LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-------- 251
RL + G + +VY + + + ++ RH+ +R K L
Sbjct: 77 RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHY------SRAKQTLPVIYVKLYMYQ 130
Query: 252 --KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGT 308
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+ + +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICS 185
Query: 309 FGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
Y APE S DV+S G +L E + G+ P+ G + LV+ +K++
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKVLGTPT 243
Query: 368 RSE---------EVVDPNIEVRPSTRALK 387
R + E P I+ P T+ +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFR 272
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 78 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 134 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 30/263 (11%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
++ V+G G +GVVY+ L + G VA+KK+L G+A K E++ + + H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKN--RELQIMRKLDHCNIVR 77
Query: 202 LLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
L + ++ LV +YV H + ++ + ++LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
Y+H + HRDIK N+L+D D K+ DFG AK L G+ +V+ + + Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 191
Query: 315 EYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE--- 370
E S DV+S G +L E + G+ P+ G + LV+ +K++ R +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249
Query: 371 ------EVVDPNIEVRPSTRALK 387
E P I+ P T+ +
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFR 272
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 19 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 77
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
N++ LL +E + + + + NL Q + + H RM LL
Sbjct: 78 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-------RMSYLLYQML 130
Query: 253 A-LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 131 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT------GRDPVDH 347
APE E D++S G ++ E + GRD +D
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 159
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 215
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 216 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 272
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 306
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G G+V + + G VAVKK+ N A++ +R E+ + V HK
Sbjct: 25 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
N++ LL +E + + + + NL Q +H + H RM LL
Sbjct: 84 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE-------RMSYLLYQML 136
Query: 253 A-LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ A + + T + T Y
Sbjct: 137 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYY 191
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
APE D++S G ++ E + G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 37/282 (13%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG+G +G VY+ +A K++ + E E + VE+E + H +V+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
++ E+ G ++ + R LT V +AL +LH +++H
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 268 RDIKSSNILIDDDFNAKVSDFGL-AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE-- 324
RD+K+ N+L+ + + +++DFG+ AK L + +GT ++APE + +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMKDTP 198
Query: 325 ---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
K+D++S G+ L+E + +P P HE+N + L + S DP + P
Sbjct: 199 YDYKADIWSLGITLIE-MAQIEP-----PHHELNPMRVLLKIAKS-------DPPTLLTP 245
Query: 382 STRALK-RSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422
S +++ R L +D + E RP +Q++ E+P V
Sbjct: 246 SKWSVEFRDFLKI--ALDKNPETRPSAAQLL------EHPFV 279
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 58 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 112
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 161
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 162 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 217
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 218 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 274
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 275 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 308
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 41 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 95
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 96 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 144
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 145 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 201
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 202 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 257
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 258 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 291
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 30 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 84
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 85 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 133
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 134 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 190
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 191 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 246
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 247 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 280
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 46/222 (20%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKIL----NNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
++G G YG VY+G+L + PVAVK N + +RV + + H N+ R +
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPL-----MEHDNIARFI 73
Query: 204 ----GYCIEG-IHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAY 256
+G + +LV EY NG+L ++L H + W + ++ + LAY
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVTRGLAY 126
Query: 257 LHEAI------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-------SHVTT 303
LH + +P + HRD+ S N+L+ +D +SDFGL+ L + +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 304 RVMGTFGYVAPEYANTGLLN--------EKSDVYSFGVLLLE 337
+GT Y+APE G +N ++ D+Y+ G++ E
Sbjct: 187 SEVGTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWE 227
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 89 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ + T + T Y A
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 60 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 114
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 163
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 164 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 219
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 220 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 276
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 277 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 310
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 81/316 (25%), Positives = 135/316 (42%), Gaps = 49/316 (15%)
Query: 132 TLRDLELATNRFSKENV-----LGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQA 180
+ LE F ++N+ LGEG +G V + + + VAVK + N +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 181 E-KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR-HHGYL 238
E ++ E + V H ++++L G C + +L+ EY G+L +L + + GYL
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 239 TWEARMK-----------VLLGTAKALAY-----LHEAIEPKVVHRDIKSSNILIDDDFN 282
+ +G + A+ + E +VHRD+ + NIL+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRK 188
Query: 283 AKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
K+SDFGL++ + S V R G ++A E + +SDV+SFGVLL E +T
Sbjct: 189 MKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 341 -GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDP 399
G +P P NL+ G R RP + + L L+C
Sbjct: 248 LGGNPYPGIPPERLFNLLK-----TGHRME----------RPDNCSEEMYRLM-LQCWKQ 291
Query: 400 DSEKRPKMSQVVRMLE 415
+ +KRP + + + LE
Sbjct: 292 EPDKRPVFADISKDLE 307
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 35 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 89
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 90 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 138
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 139 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 194
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 195 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 251
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 252 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 285
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 23 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 77
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 78 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 126
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 127 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 183
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 184 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 239
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 240 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 273
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 125
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 183 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 238
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 89 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ + T + T Y A
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 125
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 183 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 238
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 88
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 89 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 137
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 138 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 194
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 195 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 250
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 251 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 284
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 15/229 (6%)
Query: 120 PEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVG 178
P + L +W + + ++ F E+ LG G +VYR P A+K + V
Sbjct: 32 PGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD 91
Query: 179 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ K R E+ + + H N+++L LV E V G L + GY
Sbjct: 92 K--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYY 145
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLG 295
+ + +A+AYLHE +VHRD+K N+L D K++DFGL+K++
Sbjct: 146 SERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ V GT GY APE + D++S G++ + G +P
Sbjct: 203 --HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 88
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 89 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 137
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 138 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 194
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 195 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 250
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 251 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 284
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 89 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ + T + T Y A
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 143 FSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLV 200
F ++VLG G G +VYRG + + VAVK+IL A++E ++ E+ H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFADREVQLLRES---DEHPNVI 81
Query: 201 RLLGYCIEGIHRMLVYEYV----NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
R +C E + ++Y+ L++++ + +L E + +L T LA+
Sbjct: 82 RY--FCTEKDRQ---FQYIAIELCAATLQEYV--EQKDFAHLGLEP-ITLLQQTTSGLAH 133
Query: 257 LHEAIEPKVVHRDIKSSNILID-----DDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTF 309
LH +VHRD+K NILI A +SDFGL K L G+ + R V GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 310 GYVAPEYANTGLLNEKS---DVYSFGVLLLEAIT 340
G++APE + + D++S G + I+
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 155
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 204
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 205 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 260
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 261 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 317
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 318 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 351
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 28 RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 87 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 27 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 81
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 82 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 130
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 131 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 186
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 187 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 243
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 244 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 277
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 42 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 100
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 101 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 157 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 209
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 43 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 102 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 158 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 210
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 27 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 85
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 86 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 140
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + + T
Sbjct: 141 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTRY 192
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E I G
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 125
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 181
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 182 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 238
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAE-----KEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V+ L+ +++++ + + ++ E+E + + H N++++
Sbjct: 30 LGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
E H M +V E G L + + A L+ +++ ALAY H
Sbjct: 87 E-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 263 PKVVHRDIKSSNILIDDD---FNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
VVH+D+K NIL D K+ DFGLA+L + + +T GT Y+APE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFKR 200
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN--I 377
+ K D++S GV++ +TG P G EV ++ +PN +
Sbjct: 201 D-VTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEV------------QQKATYKEPNYAV 246
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
E RP T LL + DP E+RP +QV+
Sbjct: 247 ECRPLTPQ-AVDLLKQMLTKDP--ERRPSAAQVL 277
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 78 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 134 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 50/273 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
++ V+G G +GVVY+ L + G VA+KK+L G+A K E++ + + H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKN--RELQIMRKLDHCNIVR 77
Query: 202 LLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA---- 251
L + ++ LV +YV + ++ RH+ +R K L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVKL 126
Query: 252 ------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTR 304
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 305 VMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K++
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKVL 239
Query: 364 VGSRRSE---------EVVDPNIEVRPSTRALK 387
R + E P I+ P T+ +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 28 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 87 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 22 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 80
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 81 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 137 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 189
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ L + G VA+KK+L +K F+ E++ + + H N+V
Sbjct: 26 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 80
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA--- 251
RL + ++ LV +YV + ++ RH+ +R K L
Sbjct: 81 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHY------SRAKQTLPVIYVK 129
Query: 252 -------KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+
Sbjct: 130 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 186
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ + Y APE S DV+S G +L E + G+ P+ G + LV+ +K+
Sbjct: 187 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD-QLVEIIKV 242
Query: 363 MVGSRRSE---------EVVDPNIEVRPSTRALK 387
+ R + E P I+ P T+ +
Sbjct: 243 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 276
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 148 VLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRL 202
+LGEG +G VY G N VAVK + KE F E + ++ H ++V+L
Sbjct: 31 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
+G IE ++ E G L +L R+ L + L KA+AYL E+I
Sbjct: 91 IGI-IEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYL-ESI- 144
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
VHRDI NIL+ K+ DFGL++ + + + +++PE N
Sbjct: 145 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 323 NEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL--KMMVGS-RRSEEVVDPNIE 378
SDV+ F V + E ++ G+ P WL K ++G + + + P++
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGVLEKGDRLPKPDL- 250
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ +L+T RC D D RP+ +++V L
Sbjct: 251 ----CPPVLYTLMT--RCWDYDPSDRPRFTELVCSL 280
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFG 310
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ H + G T
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRW 187
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 84 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 37/282 (13%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG+G +G VY+ +A K++ + E E + VE+E + H +V+LLG
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
++ E+ G ++ + R LT V +AL +LH +++H
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 268 RDIKSSNILIDDDFNAKVSDFGL-AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE-- 324
RD+K+ N+L+ + + +++DFG+ AK L + +GT ++APE + +
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMKDTP 190
Query: 325 ---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
K+D++S G+ L+E + +P P HE+N + L + S DP + P
Sbjct: 191 YDYKADIWSLGITLIE-MAQIEP-----PHHELNPMRVLLKIAKS-------DPPTLLTP 237
Query: 382 STRALK-RSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422
S +++ R L +D + E RP +Q++ E+P V
Sbjct: 238 SKWSVEFRDFLKI--ALDKNPETRPSAAQLL------EHPFV 271
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 43 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 102 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG--- 310
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ H + G
Sbjct: 158 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRW 207
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TGR
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 148 VLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRL 202
+LGEG +G VY G N VAVK + KE F E + ++ H ++V+L
Sbjct: 15 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
+G IE ++ E G L +L R+ L + L KA+AYL E+I
Sbjct: 75 IGI-IEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYL-ESI- 128
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
VHRDI NIL+ K+ DFGL++ + + + +++PE N
Sbjct: 129 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 323 NEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL--KMMVGS-RRSEEVVDPNIE 378
SDV+ F V + E ++ G+ P WL K ++G + + + P++
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGVLEKGDRLPKPDL- 234
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ +L+T RC D D RP+ +++V L
Sbjct: 235 ----CPPVLYTLMT--RCWDYDPSDRPRFTELVCSL 264
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 88 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 196
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 28 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 87 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 84 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 143 FSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQA-EKEFRVEVEAIGHVRHKNLV 200
F + LG G + VV G AVK I + E E+ + ++H+N+V
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L H LV + V+ G L + G+ T + ++ A+ YLH
Sbjct: 84 ALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 261 IEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+VHRD+K N+L D++ +SDFGL+K+ GK V + GT GYVAPE
Sbjct: 140 ---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVL 194
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDP 344
++ D +S GV+ + G P
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCGYPP 221
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 89 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 197
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 46 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 104
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 105 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 161 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 213
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFG 310
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ H + G T
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRW 187
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TGR
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V ++ +G +AVKK+ ++ A++ +R E+ + H++H+
Sbjct: 52 RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 110
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL E N+ L L GA + LT + ++ +
Sbjct: 111 NVIGLLDVFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 167 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 219
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N D++S G ++ E +TGR
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQA-EKEFRVEVEAIGHV 194
EL + F + + LG G GVV + + +K+++ + A + E++ +
Sbjct: 12 ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q L A R + E KV + + L
Sbjct: 72 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 127
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
AYL E + +++HRD+K SNIL++ K+ DFG++ G + +GT Y+AP
Sbjct: 128 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMAP 182
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
E + +SD++S G+ L+E GR P+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 88 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 196
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 42 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 100
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 101 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 157 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 209
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 84 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 20 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 78
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 79 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 135 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 187
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 28 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 87 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 35 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 94 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 150 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 202
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 35 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 94 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 150 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 202
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 33 RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 91
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 92 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 148 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 200
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 20 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 78
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 79 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 135 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 187
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 78 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 134 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 34 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 93 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 149 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 201
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 43 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 102 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 158 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 210
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 35 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 94 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 150 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 202
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 21 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 79
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 80 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 136 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 188
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 79/322 (24%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 123 SQLGWGH-WFTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILN 175
+QL + H W E NR S LG G +G V LI VAVK +
Sbjct: 26 TQLPYDHKW------EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 79
Query: 176 NVGQAEKE-FRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR 233
+ E+E E++ + ++ H N+V LLG C G +++ EY G+L +L +
Sbjct: 80 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RK 137
Query: 234 HHGYLTWEARMKVLLG----------------TAKALAYLHEAIEPKVVHRDIKSSNILI 277
++ + ++ AK +A+L +HRD+ + NIL+
Sbjct: 138 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 194
Query: 278 DDDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLL 336
K+ DFGLA+ + ++V ++APE + +SDV+S+G+ L
Sbjct: 195 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 254
Query: 337 EAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALR 395
E + G P G P + KM+ + ++ P +K
Sbjct: 255 ELFSLGSSPYP-GMPVDS----KFYKMI---KEGFRMLSPEHAPAEMYDIMK-------T 299
Query: 396 CVDPDSEKRPKMSQVVRMLESE 417
C D D KRP Q+V+++E +
Sbjct: 300 CWDADPLKRPTFKQIVQLIEKQ 321
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 88 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 196
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
L E G +++G G+ + VK K+ + + ++F E + H N++ +LG C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 207 --IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
H L+ ++ G+L LH + +K L A+ +A+LH +EP
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFLH-TLEPL 133
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL--L 322
+ + S +++ID+D A++S + S + M +VAPE
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 323 NEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE--V 379
N +S D++SF VLL E +T EV D M +G + + E + P I +
Sbjct: 188 NRRSADMWSFAVLLWELVT-----------REVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
P L + C++ D KRPK +V +LE
Sbjct: 237 SPHVSKLMKI------CMNEDPAKRPKFDMIVPILE 266
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 34 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 93 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 149 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 201
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 148 VLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRL 202
+LGEG +G VY G N VAVK + KE F E + ++ H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
+G IE ++ E G L +L R+ L + L KA+AYL E+I
Sbjct: 79 IGI-IEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYL-ESI- 132
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
VHRDI NIL+ K+ DFGL++ + + + +++PE N
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 323 NEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL--KMMVGS-RRSEEVVDPNIE 378
SDV+ F V + E ++ G+ P WL K ++G + + + P++
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGVLEKGDRLPKPDL- 238
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ +L+T RC D D RP+ +++V L
Sbjct: 239 ----CPPVLYTLMT--RCWDYDPSDRPRFTELVCSL 268
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V +G VAVK + Q + EV + +H N+V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G ++ E++ G L + L E V +ALAYLH V+H
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIH 164
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + L +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAH 352
D++S G++++E + G P P
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQ 248
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 78 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFG 310
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ H + G T
Sbjct: 134 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRW 183
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 51/321 (15%)
Query: 123 SQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNN 176
+QL + H E NR S LG G +G V LI VAVK + +
Sbjct: 33 TQLPYDH-----KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 177 VGQAEKE-FRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH 234
E+E E++ + ++ H N+V LLG C G +++ EY G+L +L +
Sbjct: 88 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKR 145
Query: 235 HGYLTWEARMKVL----------------LGTAKALAYLHEAIEPKVVHRDIKSSNILID 278
++ + ++ AK +A+L +HRD+ + NIL+
Sbjct: 146 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 202
Query: 279 DDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
K+ DFGLA+ + ++V ++APE + +SDV+S+G+ L E
Sbjct: 203 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 262
Query: 338 AIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRC 396
+ G P G P + KM+ + ++ P +K C
Sbjct: 263 LFSLGSSPYP-GMPVDS----KFYKMI---KEGFRMLSPEHAPAEMYDIMK-------TC 307
Query: 397 VDPDSEKRPKMSQVVRMLESE 417
D D KRP Q+V+++E +
Sbjct: 308 WDADPLKRPTFKQIVQLIEKQ 328
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 51/321 (15%)
Query: 123 SQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNN 176
+QL + H E NR S LG G +G V LI VAVK + +
Sbjct: 33 TQLPYDH-----KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 177 VGQAEKE-FRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH 234
E+E E++ + ++ H N+V LLG C G +++ EY G+L +L +
Sbjct: 88 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKR 145
Query: 235 HGYLTWEARMKVL----------------LGTAKALAYLHEAIEPKVVHRDIKSSNILID 278
++ + ++ AK +A+L +HRD+ + NIL+
Sbjct: 146 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 202
Query: 279 DDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
K+ DFGLA+ + ++V ++APE + +SDV+S+G+ L E
Sbjct: 203 HGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 262
Query: 338 AIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRC 396
+ G P G P + KM+ + ++ P +K C
Sbjct: 263 LFSLGSSPYP-GMPVDS----KFYKMI---KEGFRMLSPEHAPAEMYDIMK-------TC 307
Query: 397 VDPDSEKRPKMSQVVRMLESE 417
D D KRP Q+V+++E +
Sbjct: 308 WDADPLKRPTFKQIVQLIEKQ 328
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 88 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRA 196
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVE--VEAIGHVRHKNLVRLLG 204
LGEG +G V + G VA+K I V +++ + R+E + + +RH ++++L
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
++V EY N + ++ EAR + A+ Y H K
Sbjct: 72 VIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---K 123
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-N 323
+VHRD+K N+L+D+ N K++DFGL+ ++ G T+ G+ Y APE + L
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISGKLYAG 181
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L + R P D
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFD 204
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 79/322 (24%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 123 SQLGWGH-WFTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILN 175
+QL + H W E NR S LG G +G V LI VAVK +
Sbjct: 10 TQLPYDHKW------EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 176 NVGQAEKE-FRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR 233
+ E+E E++ + ++ H N+V LLG C G +++ EY G+L +L +
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RK 121
Query: 234 HHGYLTWEARMKVLLG----------------TAKALAYLHEAIEPKVVHRDIKSSNILI 277
++ + ++ AK +A+L +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178
Query: 278 DDDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLL 336
K+ DFGLA+ + ++V ++APE + +SDV+S+G+ L
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 337 EAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALR 395
E + G P G P + KM+ + ++ P +K
Sbjct: 239 ELFSLGSSPYP-GMPVDS----KFYKMI---KEGFRMLSPEHAPAEMYDIMK-------T 283
Query: 396 CVDPDSEKRPKMSQVVRMLESE 417
C D D KRP Q+V+++E +
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQ 305
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 84 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ T + T Y A
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 46 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 104
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 105 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFG 310
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ H + G T
Sbjct: 161 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRW 210
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TGR
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT------GRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQ 233
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVE--VEAIGHVRHKNLVRLLG 204
LGEG +G V + G VA+K I V +++ + R+E + + +RH ++++L
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
++V EY N + ++ EAR + A+ Y H K
Sbjct: 82 VIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---K 133
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-N 323
+VHRD+K N+L+D+ N K++DFGL+ ++ G T+ G+ Y APE + L
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISGKLYAG 191
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L + R P D
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFD 214
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 51/321 (15%)
Query: 123 SQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNN 176
+QL + H E NR S LG G +G V LI VAVK + +
Sbjct: 28 TQLPYDH-----KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 82
Query: 177 VGQAEKE-FRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH 234
E+E E++ + ++ H N+V LLG C G +++ EY G+L +L +
Sbjct: 83 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKR 140
Query: 235 HGYLTWEARMKVL----------------LGTAKALAYLHEAIEPKVVHRDIKSSNILID 278
++ + ++ AK +A+L +HRD+ + NIL+
Sbjct: 141 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 197
Query: 279 DDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
K+ DFGLA+ + ++V ++APE + +SDV+S+G+ L E
Sbjct: 198 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 257
Query: 338 AIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRC 396
+ G P G P + KM+ + ++ P +K C
Sbjct: 258 LFSLGSSPYP-GMPVDS----KFYKMI---KEGFRMLSPEHAPAEMYDIMK-------TC 302
Query: 397 VDPDSEKRPKMSQVVRMLESE 417
D D KRP Q+V+++E +
Sbjct: 303 WDADPLKRPTFKQIVQLIEKQ 323
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVE--VEAIGHVRHKNLVRLLG 204
LGEG +G V + G VA+K I V +++ + R+E + + +RH ++++L
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
++V EY N + ++ EAR + A+ Y H K
Sbjct: 81 VIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---K 132
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-N 323
+VHRD+K N+L+D+ N K++DFGL+ ++ G T+ G+ Y APE + L
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISGKLYAG 190
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L + R P D
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFD 213
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVE--VEAIGHVRHKNLVRLLG 204
LGEG +G V + G VA+K I V +++ + R+E + + +RH ++++L
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
++V EY N + ++ EAR + A+ Y H K
Sbjct: 76 VIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRH---K 127
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-N 323
+VHRD+K N+L+D+ N K++DFGL+ ++ G T+ G+ Y APE + L
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISGKLYAG 185
Query: 324 EKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S GV+L + R P D
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFD 208
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 40/307 (13%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVE 189
E N LG G +G V VAVK + + EKE E++
Sbjct: 34 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL----HGAMRHHGYLTWEARM 244
+ H+ +H+N+V LLG C G +++ EY G+L +L + E R
Sbjct: 94 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 245 KVLLGT--AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHV 301
+ + A+ +A+L +HRD+ + N+L+ + AK+ DFGLA+ ++ V
Sbjct: 154 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL 360
++APE + +SDV+S+G+LL E + G +P +
Sbjct: 211 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--------------YP 256
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALK-RSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419
++V S+ + V D +P+ S++ A ++P RP Q+ L+ +
Sbjct: 257 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP--THRPTFQQICSFLQEQ-- 312
Query: 420 PIVREDR 426
+EDR
Sbjct: 313 --AQEDR 317
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 148 VLGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
VLG G + V+ + G A+K I + + E+ + ++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
H LV + V+ G L + G T + V+ A+ YLHE +V
Sbjct: 76 ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 267 HRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
HRD+K N+L +++ ++DFGL+K+ G + + GT GYVAPE +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYS 185
Query: 324 EKSDVYSFGVLLLEAITGRDP 344
+ D +S GV+ + G P
Sbjct: 186 KAVDCWSIGVITYILLCGYPP 206
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 15/255 (5%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F+K +G+G +G V++G + VA+K I L ++ + E+ + +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G ++ ++ EY+ G+ L G L +L K L YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 123
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
K +HRDIK++N+L+ + K++DFG+A L + T V GT ++APE
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV--DWLKMMVG--SRRSEEVVDPN 376
+ K+D++S G+ +E G P P + L+ + + G S+ +E V+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 239
Query: 377 IEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 240 LNKEPSFRPTAKELL 254
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ D+GLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 135 DLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEA 190
D ++ N F +LG+G +G V+ G A+K + V A+ E E
Sbjct: 4 DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 63
Query: 191 IGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ + RH L L Y + R+ V EY N G L + H + R + AR
Sbjct: 64 LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERARFYGA-E 118
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 119 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 174
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 217
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DFGL + T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 149 LGEGGYGVVYRGNLING-SPVAVKKILN-------------NVGQAEKEFRVEVEAIGHV 194
LG G YG V NG S A+K I N+ + +E E+ + +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLGTAK 252
H N+++L + + LV E+ G L + + + H + +A MK +L
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILS--- 157
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ YLH+ +VHRDIK NIL+++ N K+ DFGL+ K + +GT
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTA 212
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
Y+APE NEK DV+S GV++ + G P
Sbjct: 213 YYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPF 247
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q + + H YL ++ +L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG- 138
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + + T
Sbjct: 139 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRY 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT------GRDPVDH 347
Y APE E D++S G ++ E + GRD +D
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 233
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKEF-RVEVEAIGHVRHKNLVRLL 203
VLG+G +G V + + KIL + + E VE + + + L
Sbjct: 26 VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
C + + R+ V EYVN G+L + G + + + A + + L +LH+
Sbjct: 86 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GLFFLHKR 139
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR-VMGTFGYVAPEYANT 319
+++RD+K N+++D + + K++DFG+ K VTTR GT Y+APE
Sbjct: 140 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D +++GVLL E + G+ P D
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFD 221
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/158 (34%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+H N++ L +G H LV E + G L L +R + EA VL K +
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASF-VLHTIGKTV 134
Query: 255 AYLHEAIEPKVVHRDIKSSNIL-IDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFG 310
YLH VVHRD+K SNIL +D+ N ++ DFG AK L A + T T
Sbjct: 135 EYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+VAPE +E D++S G+LL + G P +G
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG 228
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/158 (34%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+H N++ L +G H LV E + G L L +R + EA VL K +
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASF-VLHTIGKTV 134
Query: 255 AYLHEAIEPKVVHRDIKSSNIL-IDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFG 310
YLH VVHRD+K SNIL +D+ N ++ DFG AK L A + T T
Sbjct: 135 EYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+VAPE +E D++S G+LL + G P +G
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG 228
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 16/213 (7%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 39 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 97
Query: 198 NLVRLLGYCIEGIHRMLV-YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
V+L +C + ++ Y NG L +++ R G AL Y
Sbjct: 98 FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 152
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPE 315
LH ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 153 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 242
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 76/320 (23%), Positives = 130/320 (40%), Gaps = 51/320 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVE 189
E N LG G +G V VAVK + + EKE E++
Sbjct: 27 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL------------------HG 230
+ H+ +H+N+V LLG C G +++ EY G+L +L G
Sbjct: 87 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 231 AMRHHGY-LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
+ G L + A+ +A+L +HRD+ + N+L+ + AK+ DFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 290 LAK-LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
LA+ ++ V ++APE + +SDV+S+G+LL E +
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------- 255
Query: 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALK-RSLLTALRCVDPDSEKRPKM 407
+ L + ++V S+ + V D +P+ S++ A ++P RP
Sbjct: 256 -----LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP--THRPTF 308
Query: 408 SQVVRMLESEEYPIVREDRR 427
Q+ L+ + +EDRR
Sbjct: 309 QQICSFLQEQ----AQEDRR 324
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
LG G +GVV+R G+ A K ++ ++ R E++ + +RH LV L
Sbjct: 59 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
+ +++YE+++ G L H ++ + ++ + K L ++HE VH
Sbjct: 119 DDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 172
Query: 268 RDIKSSNILIDDDFN--AKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNE 324
D+K NI+ + K+ DFGL L +S VTT GT + APE A +
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 229
Query: 325 KSDVYSFGVLLLEAITGRDP 344
+D++S GVL ++G P
Sbjct: 230 YTDMWSVGVLSYILLSGLSP 249
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 15/255 (5%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F+K +G+G +G V++G + VA+K I L ++ + E+ + +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G ++ ++ EY+ G+ L G L +L K L YLH
Sbjct: 89 KYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE 143
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
K +HRDIK++N+L+ + K++DFG+A L + T V GT ++APE
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 199
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV--DWLKMMVG--SRRSEEVVDPN 376
+ K+D++S G+ +E G P P + L+ + + G S+ +E V+
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 259
Query: 377 IEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 260 LNKEPSFRPTAKELL 274
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 13/214 (6%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPV----AVKKILNNVGQAEKEFRVEVEAIGH 193
L F V+G G Y V L + VKK L N + + E
Sbjct: 17 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 194 VRHKNLVRLLGYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+ + L C + R+ V EYVN G+L H M+ L E +
Sbjct: 77 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISL 132
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLHE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+
Sbjct: 133 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 188
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
APE D ++ GVL+ E + GR P D
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 13/214 (6%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPV----AVKKILNNVGQAEKEFRVEVEAIGH 193
L F V+G G Y V L + VKK L N + + E
Sbjct: 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 194 VRHKNLVRLLGYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+ + L C + R+ V EYVN G+L H M+ L E +
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISL 164
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLHE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
APE D ++ GVL+ E + GR P D
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
LG G +GVV+R G+ A K ++ ++ R E++ + +RH LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
+ +++YE+++ G L H ++ + ++ + K L ++HE VH
Sbjct: 225 DDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 278
Query: 268 RDIKSSNILIDDDFN--AKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNE 324
D+K NI+ + K+ DFGL L +S VTT GT + APE A +
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 335
Query: 325 KSDVYSFGVLLLEAITGRDP 344
+D++S GVL ++G P
Sbjct: 336 YTDMWSVGVLSYILLSGLSP 355
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 13/214 (6%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPV----AVKKILNNVGQAEKEFRVEVEAIGH 193
L F V+G G Y V L + VKK L N + + E
Sbjct: 2 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 194 VRHKNLVRLLGYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+ + L C + R+ V EYVN G+L H M+ L E +
Sbjct: 62 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISL 117
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLHE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+
Sbjct: 118 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 173
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
APE D ++ GVL+ E + GR P D
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 13/214 (6%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPV----AVKKILNNVGQAEKEFRVEVEAIGH 193
L F V+G G Y V L + VKK L N + + E
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 194 VRHKNLVRLLGYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+ + L C + R+ V EYVN G+L H M+ L E +
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISL 121
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLHE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 177
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
APE D ++ GVL+ E + GR P D
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 35/289 (12%)
Query: 149 LGEGGYGVV-YRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
LGEGG+ V L +G A+K+IL + Q +E + E + H N++RL+ YC+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 208 E---GIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
H L+ + G L + +LT + + +LLG + L EAI
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL----EAIHA 152
Query: 264 K-VVHRDIKSSNILIDDDFNAKVSDFG---LAKLLGAGKSHVTT-----RVMGTFGYVAP 314
K HRD+K +NIL+ D+ + D G A + G T T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 315 EYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
E + +++E++DV+S G +L + G P D D + + V ++ S
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQNQLS-- 265
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
I P + LL ++ VDP +RP + ++ LE+ + P
Sbjct: 266 -----IPQSPRHSSALWQLLNSMMTVDP--HQRPHIPLLLSQLEALQPP 307
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+G+G YG V+RG L +G VAVK I ++ + E+ +RH N+ LG+
Sbjct: 15 CVGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIA 69
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL-------TWEARMKVLLGTAKA--LAYLH 258
+ N + + WL HG L T E + + L + A LA+LH
Sbjct: 70 SDMTS-------RNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLH 122
Query: 259 EAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT----RVMGTF 309
I +P + HRD KS N+L+ + ++D GLA + G ++ RV GT
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTK 181
Query: 310 GYVAPEYANTGLLNEK------SDVYSFGVLLLE 337
Y+APE + + + +D+++FG++L E
Sbjct: 182 RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWE 215
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 137 ELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIG 192
++ N F +LG+G +G V+ G A+K + V A+ E E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT- 250
+ RH L L Y + R+ V EY N G L + H + R + AR G
Sbjct: 61 NTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAE 113
Query: 251 -AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 137 ELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIG 192
++ N F +LG+G +G V+ G A+K + V A+ E E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT- 250
+ RH L L Y + R+ V EY N G L + H + R + AR G
Sbjct: 61 NTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAE 113
Query: 251 -AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 137 ELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIG 192
++ N F +LG+G +G V+ G A+K + V A+ E E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT- 250
+ RH L L Y + R+ V EY N G L + H + R + AR G
Sbjct: 61 NTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAE 113
Query: 251 -AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 37/236 (15%)
Query: 143 FSKEN-----VLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKE-FRVEVEA 190
F +EN VLG G +G V S VAVK + +E+E E++
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 191 IGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG------------- 236
+ + H+N+V LLG C L++EY G+L +L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 237 ------YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290
LT+E + AK + +L VHRD+ + N+L+ K+ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 291 AKLLGAGKSHVT-TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
A+ + + ++V ++APE G+ KSDV+S+G+LL E + G +P
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ DF LA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 137 ELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIG 192
++ N F +LG+G +G V+ G A+K + V A+ E E +
Sbjct: 4 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT- 250
+ RH L L Y + R+ V EY N G L + H + R + AR G
Sbjct: 64 NTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAE 116
Query: 251 -AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 117 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 172
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 215
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 13/217 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVEVE-AIGHVRHKNLVRLLGY 205
LG G YGVV + ++ +G +AVK+I V Q +K ++++ ++ V V G
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+ E ++ +L+++ + + + K+ + KAL +LH + V
Sbjct: 119 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL---- 321
+HRD+K SN+LI+ K+ DFG++ L S T G Y+APE N L
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVDH-GRPAHEVNLV 357
+ KSD++S G+ ++E R P D G P ++ V
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 137 ELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIG 192
++ N F +LG+G +G V+ G A+K + V A+ E E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT- 250
+ RH L L Y + R+ V EY N G L + H + R + AR G
Sbjct: 61 NTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAE 113
Query: 251 -AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 137 ELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIG 192
++ N F +LG+G +G V+ G A+K + V A+ E E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT- 250
+ RH L L Y + R+ V EY N G L + H + R + AR G
Sbjct: 61 NTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAE 113
Query: 251 -AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH VV+RDIK N+++D D + K++DFGL K G GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
Y+APE D + GV++ E + GR P DH R
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKN 198
FS +G G +G VY ++ N VA+KK+ + Q+ ++++ EV + +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ G + LV EY G+ L H L V G + LAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY-- 316
++HRD+K+ NIL+ + K+ DFG A ++ V GT ++APE
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 223
Query: 317 -ANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
+ G + K DV+S G+ +E + P+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPL 253
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+++L LV++ + G L +L + L+ + K++ + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVIC 138
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
LH+ +VHRD+K NIL+DDD N K++DFG + L G+ V GT Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPE 193
Query: 316 YANTGL------LNEKSDVYSFGVLLLEAITGRDPVDH 347
+ ++ D++S GV++ + G P H
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+++L LV++ + G L +L + L+ + K++ + +
Sbjct: 70 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVIC 125
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
LH+ +VHRD+K NIL+DDD N K++DFG + L G+ V GT Y+APE
Sbjct: 126 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPE 180
Query: 316 YANTGL------LNEKSDVYSFGVLLLEAITGRDPVDH 347
+ ++ D++S GV++ + G P H
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 218
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 15/255 (5%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F+K +G+G +G V++G + VA+K I L ++ + E+ + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G ++ ++ EY+ G+ L G L +L K L YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 138
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
K +HRDIK++N+L+ + K++DFG+A L + V GT ++APE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 194
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV--DWLKMMVG--SRRSEEVVDPN 376
+ K+D++S G+ +E G P P + L+ + + G S+ +E V+
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 377 IEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 255 LNKEPSFRPTAKELL 269
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G V+RG G VAVK + + + FR E+ +RH+N+ LG+
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENI---LGF-- 101
Query: 208 EGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYL---------TWEARMKVLLGTAKALAYL 257
+ + +NG Q WL HG L T E +K+ L TA LA+L
Sbjct: 102 ------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 155
Query: 258 HEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTF 309
H I +P + HRD+KS NIL+ + ++D GLA + + +GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 310 GYVAPEYANTGL------LNEKSDVYSFGVLLLE 337
Y+APE + + +++D+Y+ G++ E
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 65.5 bits (158), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 66/277 (23%), Positives = 124/277 (44%), Gaps = 36/277 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--------LNNVGQAEKEFRVEVEAI 191
++ ++V+G G VV R + G AVK + + + + R E +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 192 GHVR-HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
V H +++ L+ LV++ + G L +L + L+ + ++
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSL 209
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+A+++LH +VHRD+K NIL+DD+ ++SDFG + L G+ + GT G
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPG 264
Query: 311 YVAPEYANTGL------LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
Y+APE + ++ D+++ GV+L + G P H R + L+M++
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMIM 318
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDS 401
+ + P + R ST + L++ L VDP++
Sbjct: 319 EGQY--QFSSPEWDDRSST---VKDLISRLLQVDPEA 350
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ FGLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRH 196
++ K +GEG YG V++ N VA+K++ ++ G R E+ + ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
KN+VRL LV+E+ + +L+++ +G L E L K L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGF 116
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
H V+HRD+K N+LI+ + K++DFGLA+ G + V+ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 317 ANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHG 348
L S D++S G + E P+ G
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPG 205
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G V+RG G VAVK + + + FR E+ +RH+N+ LG+
Sbjct: 12 IGKGRFGEVWRGKW-RGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENI---LGF-- 63
Query: 208 EGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYL---------TWEARMKVLLGTAKALAYL 257
+ + +NG Q WL HG L T E +K+ L TA LA+L
Sbjct: 64 ------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 117
Query: 258 HEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTF 309
H I +P + HRD+KS NIL+ + ++D GLA + + +GT
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 310 GYVAPEYANTGL------LNEKSDVYSFGVLLLE 337
Y+APE + + +++D+Y+ G++ E
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 211
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+++L LV++ + G L +L + L+ + K++ + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVIC 138
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
LH+ +VHRD+K NIL+DDD N K++DFG + L G+ V GT Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSVCGTPSYLAPE 193
Query: 316 YANTGL------LNEKSDVYSFGVLLLEAITGRDPVDH 347
+ ++ D++S GV++ + G P H
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKN 198
FS +G G +G VY ++ N VA+KK+ + Q+ ++++ EV + +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ G + LV EY G+ L H L V G + LAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY-- 316
++HRD+K+ NIL+ + K+ DFG A ++ V GT ++APE
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 317 -ANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
+ G + K DV+S G+ +E + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 143 FSKENVLGEGGYG----VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++ EN +G G +G V +G I A KKI + F+ E+E + + H N
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRR---AAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RL + LV E G L + + H +++ A+AY H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 259 EAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+ V HRD+K N L D K+ DFGLA GK T +GT YV+P+
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQ 178
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
GL + D +S GV++ + G P
Sbjct: 179 VLE-GLYGPECDEWSAGVMMYVLLCGYPP 206
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G V+RG G VAVK + + + FR E+ +RH+N+ LG+
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENI---LGF-- 62
Query: 208 EGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYL---------TWEARMKVLLGTAKALAYL 257
+ + +NG Q WL HG L T E +K+ L TA LA+L
Sbjct: 63 ------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 258 HEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTF 309
H I +P + HRD+KS NIL+ + ++D GLA + + +GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 310 GYVAPEYANTGL------LNEKSDVYSFGVLLLE 337
Y+APE + + +++D+Y+ G++ E
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G V+RG G VAVK + + + FR E+ +RH+N+ LG+
Sbjct: 37 IGKGRFGEVWRGKW-RGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENI---LGF-- 88
Query: 208 EGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYL---------TWEARMKVLLGTAKALAYL 257
+ + +NG Q WL HG L T E +K+ L TA LA+L
Sbjct: 89 ------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 142
Query: 258 HEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTF 309
H I +P + HRD+KS NIL+ + ++D GLA + + +GT
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 310 GYVAPEYANTGL------LNEKSDVYSFGVLLLE 337
Y+APE + + +++D+Y+ G++ E
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 236
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
LG G +G V+R + G AVKK+ V +AE E+ A + +V L G
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 155
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-KALAYLHEAIEPKVV 266
EG + E + G+L Q ++ G L E R LG A + L YLH +++
Sbjct: 156 EGPWVNIFMELLEGGSLGQ----LVKEQGCLP-EDRALYYLGQALEGLEYLHSR---RIL 207
Query: 267 HRDIKSSNILIDDD-FNAKVSDFGLAKLL---GAGKSHVT-TRVMGTFGYVAPEYANTGL 321
H D+K+ N+L+ D +A + DFG A L G GKS +T + GT ++APE
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 322 LNEKSDVYSFGVLLLEAITGRDP 344
+ K DV+S ++L + G P
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHP 290
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 15/255 (5%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F+K +G+G +G V++G + VA+K I L ++ + E+ + +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G ++ ++ EY+ G+ L G L +L K L YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 123
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
K +HRDIK++N+L+ + K++DFG+A L + V GT ++APE
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 179
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV--DWLKMMVG--SRRSEEVVDPN 376
+ K+D++S G+ +E G P P + L+ + + G S+ +E V+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 239
Query: 377 IEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 240 LNKEPSFRPTAKELL 254
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G V+RG G VAVK + + + FR E+ +RH+N+ LG+
Sbjct: 17 IGKGRFGEVWRGKW-RGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENI---LGF-- 68
Query: 208 EGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYL---------TWEARMKVLLGTAKALAYL 257
+ + +NG Q WL HG L T E +K+ L TA LA+L
Sbjct: 69 ------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 122
Query: 258 HEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTF 309
H I +P + HRD+KS NIL+ + ++D GLA + + +GT
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 310 GYVAPEYANTGL------LNEKSDVYSFGVLLLE 337
Y+APE + + +++D+Y+ G++ E
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 216
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ D GLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV--RHKNLVRLLGY 205
+G+G YG V+RG+ G VAVK + EK + E E V RH+N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 206 CIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
+ H L+ Y G+L +L L + ++++L A LA+LH I
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 262 -----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT----RVMGTFGYV 312
+P + HRD+KS NIL+ + ++D GLA + + + RV GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 313 APEYANTGLLNE------KSDVYSFGVLLLEA 338
APE + + + + D+++FG++L E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR-VEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G V+RG G VAVK + + + FR E+ +RH+N+ LG+
Sbjct: 14 IGKGRFGEVWRGKW-RGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENI---LGF-- 65
Query: 208 EGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYL---------TWEARMKVLLGTAKALAYL 257
+ + +NG Q WL HG L T E +K+ L TA LA+L
Sbjct: 66 ------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 119
Query: 258 HEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTF 309
H I +P + HRD+KS NIL+ + ++D GLA + + +GT
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 310 GYVAPEYANTGL------LNEKSDVYSFGVLLLE 337
Y+APE + + +++D+Y+ G++ E
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 213
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 33/252 (13%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVE 189
F + +EL R VL EGG+ VY + +G A+K++L+N E++ R ++
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQ 74
Query: 190 AIGHVR----HKNLVRLLGYCI-------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ ++ H N+V+ G L+ + G L ++L M G L
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPL 133
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ + +K+ T +A+ ++H +P ++HRD+K N+L+ + K+ DFG A +
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 299 SH---VTTRVM--------GTFGYVAPE----YANTGLLNEKSDVYSFGVLLLEAITGRD 343
+ R + T Y PE Y+N + EK D+++ G +L +
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQH 251
Query: 344 PVDHGRPAHEVN 355
P + G VN
Sbjct: 252 PFEDGAKLRIVN 263
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV--RHKNLVRLLGY 205
+G+G YG V+RG+ G VAVK + EK + E E V RH+N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 206 CIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
+ H L+ Y G+L +L L + ++++L A LA+LH I
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 262 -----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT----RVMGTFGYV 312
+P + HRD+KS NIL+ + ++D GLA + + + RV GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 313 APEYANTGLLNE------KSDVYSFGVLLLEA 338
APE + + + + D+++FG++L E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSP-VAVKKILNNVGQAEKEFRV--EVEAIGHVR---HKNLVR 201
+GEG YG V++ +L NG VA+K++ G+ EV + H+ H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 202 LLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
L C LV+E+V+ +L +L + G T E ++ + L +
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPT-ETIKDMMFQLLRGLDF 135
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH +VVHRD+K NIL+ K++DFGLA++ + T V+ T Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
D++S G + E R P+ G
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG 221
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 143 FSKENVLGEGGYG----VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++ EN +G G +G V +G I A KKI + F+ E+E + + H N
Sbjct: 28 YTLENTIGRGSWGEVKIAVQKGTRIRR---AAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RL + LV E G L + + H +++ A+AY H
Sbjct: 85 IIRLYETFEDNTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKDVLSAVAYCH 140
Query: 259 EAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+ V HRD+K N L D K+ DFGLA GK T +GT YV+P+
Sbjct: 141 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQ 195
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
GL + D +S GV++ + G P
Sbjct: 196 VLE-GLYGPECDEWSAGVMMYVLLCGYPP 223
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ D GLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
T+ + + +G G Y V R + AVK I + +E + + + +H N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ L +G + +V E + G L L +R + EA VL K + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSEREAS-AVLFTITKTVEYLH 133
Query: 259 EAIEPKVVHRDIKSSNIL-IDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
VVHRD+K SNIL +D+ N ++ DFG AK L A + T T +VAP
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAP 189
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
E + D++S GVLL +TG P +G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV--RHKNLVRLLGY 205
+G+G YG V+RG+ G VAVK + EK + E E V RH+N++ +
Sbjct: 44 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 99
Query: 206 CIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
+ H L+ Y G+L +L L + ++++L A LA+LH I
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 154
Query: 262 -----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT----RVMGTFGYV 312
+P + HRD+KS NIL+ + ++D GLA + + + RV GT Y+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 213
Query: 313 APEYANTGLLNE------KSDVYSFGVLLLEA 338
APE + + + + D+++FG++L E
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
T+ + + +G G Y V R + AVK I + +E + + + +H N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ L +G + +V E G L L +R + EA VL K + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELXKGGEL---LDKILRQKFFSEREASA-VLFTITKTVEYLH 133
Query: 259 EAIEPKVVHRDIKSSNIL-IDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
VVHRD+K SNIL +D+ N ++ DFG AK L A + T T +VAP
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAP 189
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
E + D++S GVLL +TG P +G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTXLTGYTPFANG 223
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSP-VAVKKILNNVGQAEKEFRV--EVEAIGHVR---HKNLVR 201
+GEG YG V++ +L NG VA+K++ G+ EV + H+ H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 202 LLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
L C LV+E+V+ +L +L + G T E ++ + L +
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPT-ETIKDMMFQLLRGLDF 135
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH +VVHRD+K NIL+ K++DFGLA++ + T V+ T Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
D++S G + E R P+ G
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG 221
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 12 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 70
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 71 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 126
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 127 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 215
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N++ LL R L E N+ L L GA + LT + ++ +
Sbjct: 82 NVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L Y+H A ++HRD+K SN+ +++D K+ D GLA+ T + T Y A
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRA 190
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 13/213 (6%)
Query: 138 LATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGH 193
+ N F +LG+G +G V+ G A+K + V A+ E E + +
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 194 VRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH L L Y + R+ V EY N G L + H + R + AR
Sbjct: 208 SRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL--FFHLS-RERVFSEDRARF-YGAEIVS 262
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLH E VV+RD+K N+++D D + K++DFGL K G GT Y+
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 319
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
APE D + GV++ E + GR P
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 39/275 (14%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV---EVEAIGHVRHK 197
R++ +LG+G +G V + + I AVK ++N K+ EVE + + H
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHP 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+++L + +V E G L + R + +V G + Y+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG----ITYM 137
Query: 258 HEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
H+ +VHRD+K NIL++ D + K+ DFGL+ + + R+ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAP 192
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-----------NLVDWLKMM 363
E G +EK DV+S GV+L ++G P +G+ +++ +L W +
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTI- 249
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVD 398
S +++++ + PS R +TA +C++
Sbjct: 250 --SDDAKDLIRKMLTFHPSLR------ITATQCLE 276
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 13/216 (6%)
Query: 135 DLELATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEA 190
D + N F +LG+G +G V+ G A+K + V A+ E E
Sbjct: 4 DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 63
Query: 191 IGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ + RH L L Y + R+ V EY N G L + H + R + AR
Sbjct: 64 LQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL--FFHLS-RERVFSEDRARF-YGAE 118
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL YLH E VV+RD+K N+++D D + K++DFGL K G GT
Sbjct: 119 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTP 175
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
Y+APE D + GV++ E + GR P
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 138 LATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGH 193
+ N F +LG+G +G V+ G A+K + V A+ E E + +
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 194 VRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH L L Y + R+ V EY N G L + H + R + AR
Sbjct: 205 SRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL--FFHLS-RERVFSEDRARF-YGAEIVS 259
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLH E VV+RD+K N+++D D + K++DFGL K G GT Y+
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPV---DH 347
APE D + GV++ E + GR P DH
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSP-VAVKKILNNVGQAEKEFRV--EVEAIGHVR---HKNLVR 201
+GEG YG V++ +L NG VA+K++ G+ EV + H+ H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 202 LLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
L C LV+E+V+ +L +L + G T E ++ + L +
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPT-ETIKDMMFQLLRGLDF 135
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH +VVHRD+K NIL+ K++DFGLA++ + T V+ T Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
D++S G + E R P+ G
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG 221
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 11 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 69
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 70 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 125
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 126 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 214
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 9 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 67
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 68 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 123
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 124 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 212
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRHK 197
++ K +GEG YG V++ N VA+K++ ++ G R E+ + ++HK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+VRL LV+E+ + +L+++ +G L E L K L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFC 117
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H V+HRD+K N+LI+ + K+++FGLA+ G + V+ T Y P+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVD 358
L S D++S G + E GRP N VD
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANA------GRPLFPGNDVD 209
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVE-VEAIGHV 194
+AT+R+ +G G YG VY+ + +G VA+K + + N G + V + +
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 195 R------HKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
R H N+VRL+ C I LV+E+V+ +L +L A L E
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETI 122
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
++ + L +LH +VHRD+K NIL+ K++DFGLA++ + T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LT 177
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
V+ T Y APE D++S G + E
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 211
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 68
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 124
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 67/275 (24%), Positives = 125/275 (45%), Gaps = 39/275 (14%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV---EVEAIGHVRHK 197
R++ +LG+G +G V + + I AVK ++N K+ EVE + + H
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHP 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+++L + +V E G L + R + +++ + Y+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYM 137
Query: 258 HEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
H+ +VHRD+K NIL++ D + K+ DFGL+ + + R+ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAP 192
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-----------NLVDWLKMM 363
E G +EK DV+S GV+L ++G P +G+ +++ +L W +
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTI- 249
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVD 398
S +++++ + PS R +TA +C++
Sbjct: 250 --SDDAKDLIRKMLTFHPSLR------ITATQCLE 276
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
++ SD+++ G ++ + + G P G
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPPFRAG 237
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 67/275 (24%), Positives = 125/275 (45%), Gaps = 39/275 (14%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV---EVEAIGHVRHK 197
R++ +LG+G +G V + + I AVK ++N K+ EVE + + H
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHP 81
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+++L + +V E G L + R + +++ + Y+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYM 137
Query: 258 HEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
H+ +VHRD+K NIL++ D + K+ DFGL+ + + R+ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAP 192
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-----------NLVDWLKMM 363
E G +EK DV+S GV+L ++G P +G+ +++ +L W +
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTI- 249
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVD 398
S +++++ + PS R +TA +C++
Sbjct: 250 --SDDAKDLIRKMLTFHPSLR------ITATQCLE 276
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 13/213 (6%)
Query: 138 LATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGH 193
+ N F +LG+G +G V+ G A+K + V A+ E E + +
Sbjct: 5 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 194 VRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH L L Y + R+ V EY N G L + H + R + AR
Sbjct: 65 SRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL--FFHLS-RERVFSEDRARF-YGAEIVS 119
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLH E VV+RD+K N+++D D + K++DFGL K G GT Y+
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 176
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
APE D + GV++ E + GR P
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFRVEVE--AIGHV 194
+ F VLG+G +G V+ + +G A+K + + R ++E + V
Sbjct: 28 SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 195 RHKNLVRL-LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
H +V+L + EG L+ +++ G+L L + T E L A
Sbjct: 88 NHPFVVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALG 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L +LH +++RD+K NIL+D++ + K++DFGL+K GT Y+A
Sbjct: 143 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMA 198
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE N + +D +S+GVL+ E +TG P
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 13/213 (6%)
Query: 138 LATNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGH 193
+ N F +LG+G +G V+ G A+K + V A+ E E + +
Sbjct: 6 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 194 VRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH L L Y + R+ V EY N G L + H + R + AR
Sbjct: 66 SRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL--FFHLS-RERVFSEDRARF-YGAEIVS 120
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLH E VV+RD+K N+++D D + K++DFGL K G GT Y+
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 177
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
APE D + GV++ E + GR P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVE-VEAIGHVR 195
+AT+R+ +G G YG VY+ + +G VA+K + V E+ + V + +R
Sbjct: 1 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGEEGLPISTVREVALLR 58
Query: 196 ------HKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
H N+VRL+ C I LV+E+V+ +L +L A L E
Sbjct: 59 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIK 115
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
++ + L +LH +VHRD+K NIL+ K++DFGLA++ +
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LAP 170
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
V+ T Y APE D++S G + E
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSP-VAVKKI-LNNVGQAE----KEFRVEV 188
D++ R+ K + LGEG + VY+ N + VA+KKI L + +A+ + E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV-L 247
+ + + H N++ LL + LV+++ +E L ++ + + + +K +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYM 118
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG 307
L T + L YLH+ ++HRD+K +N+L+D++ K++DFGLAK G+ +V+
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV- 174
Query: 308 TFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAI 339
T Y APE + D+++ G +L E +
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 90
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 93
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 94 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 149
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 150 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 238
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
LG G +G V+R + G AVKK+ V +AE E+ A + +V L G
Sbjct: 82 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 136
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-KALAYLHEAIEPKVV 266
EG + E + G+L Q ++ G L E R LG A + L YLH +++
Sbjct: 137 EGPWVNIFMELLEGGSLGQ----LVKEQGCLP-EDRALYYLGQALEGLEYLHSR---RIL 188
Query: 267 HRDIKSSNILIDDD-FNAKVSDFGLAKLL---GAGKSHVT-TRVMGTFGYVAPEYANTGL 321
H D+K+ N+L+ D +A + DFG A L G GK +T + GT ++APE
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 322 LNEKSDVYSFGVLLLEAITGRDP 344
+ K DV+S ++L + G P
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHP 271
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 93
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 94 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 149
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 150 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 238
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 32/277 (11%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
L E G +++G G+ + VK K+ + + ++F E + H N++ +LG C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 207 --IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
H L+ + G+L LH + +K L A+ A+LH +EP
Sbjct: 77 QSPPAPHPTLITHWXPYGSLYNVLHEGTNF--VVDQSQAVKFALDXARGXAFLH-TLEPL 133
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
+ + S ++ ID+D A++S + G+ + V PE N
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTN----R 189
Query: 324 EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE--VRP 381
+D +SF VLL E +T EV D +G + + E + P I + P
Sbjct: 190 RSADXWSFAVLLWELVT-----------REVPFADLSNXEIGXKVALEGLRPTIPPGISP 238
Query: 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418
L + C + D KRPK +V +LE +
Sbjct: 239 HVSKLXKI------CXNEDPAKRPKFDXIVPILEKXQ 269
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 38/222 (17%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR-HKNLVRLL 203
LG+G YG+V++ + G VAVKKI + N A++ FR E+ + + H+N+V LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 204 GYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
R LV++Y +E LH +R + L + V+ K + YLH
Sbjct: 76 NVLRADNDRDVYLVFDY-----METDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG- 128
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL--------------------GAGKSHV 301
++HRD+K SNIL++ + + KV+DFGL++ +
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 302 TTRVMGTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGR 342
T + T Y APE + + D++S G +L E + G+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKN 198
N E +LG G G VV++G+ G PVAVK++L + A E ++ E+ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPN 70
Query: 199 LVRLLGYCIEGIHRMLVYEY-VNNGNLEQWLHGAMRHHGYLTWEAR---MKVLLGTAKAL 254
++R YC E R L + N NL+ + L + + +L A +
Sbjct: 71 VIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 255 AYLHEAIEPKVVHRDIKSSNILID-------------DDFNAKVSDFGLAKLLGAGKSHV 301
A+LH K++HRD+K NIL+ ++ +SDFGL K L +G+S
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 302 TTRV---MGTFGYVAPEYANTG-------LLNEKSDVYSFGVLLLEAIT-GRDP 344
T + GT G+ APE L D++S G + ++ G+ P
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 90
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVE-VEAIGHVR 195
+AT+R+ +G G YG VY+ + +G VA+K + V E+ + V + +R
Sbjct: 1 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGEEGLPISTVREVALLR 58
Query: 196 ------HKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
H N+VRL+ C I LV+E+V+ +L +L A L E
Sbjct: 59 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIK 115
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
++ + L +LH +VHRD+K NIL+ K++DFGLA++ +
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LDP 170
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
V+ T Y APE D++S G + E
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 90
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVE-VEAIGHVRHKNLVRLLGYC 206
LG G +G V+R + G AVKK+ V FRVE + A + +V L G
Sbjct: 80 LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAV 133
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-KALAYLHEAIEPKV 265
EG + E + G+L Q ++ G L E R LG A + L YLH ++
Sbjct: 134 REGPWVNIFMELLEGGSLGQ----LIKQMGCLP-EDRALYYLGQALEGLEYLHTR---RI 185
Query: 266 VHRDIKSSNILIDDDFN-AKVSDFGLAKLL---GAGKSHVT-TRVMGTFGYVAPEYANTG 320
+H D+K+ N+L+ D + A + DFG A L G GKS +T + GT ++APE
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
+ K D++S ++L + G P
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHP 269
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 142 RFSKENV-LGEGGYGVVYRG-NLINGSPVAVKKILN-NVGQAEKE-FRVEVEAIGHVRHK 197
RF K ++ +G G + VY+G + VA ++ + + ++E++ F+ E E + ++H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHP 85
Query: 198 NLVRLLGY---------CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
N+VR CI +LV E +G L+ +L ++KVL
Sbjct: 86 NIVRFYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKV--------XKIKVLR 132
Query: 249 GTA----KALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTT 303
K L +LH P ++HRD+K NI I + K+ D GLA L ++
Sbjct: 133 SWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAK 188
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
V+GT + APE +E DVY+FG LE T P + A ++
Sbjct: 189 AVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQI 238
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVE-VEAIGHVR 195
+AT+R+ +G G YG VY+ + +G VA+K + V E+ + V + +R
Sbjct: 1 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGEEGLPISTVREVALLR 58
Query: 196 ------HKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
H N+VRL+ C I LV+E+V+ +L +L A L E
Sbjct: 59 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIK 115
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
++ + L +LH +VHRD+K NIL+ K++DFGLA++ +
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP-- 170
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
V+ T Y APE D++S G + E
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G YG V + +G VA+KK+ + A++ +R E+ + H++H+N++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 205 YCIEGIHRMLVYE-YVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHEAIE 262
Y+ Y+ ++ L M G E +++ L+ K L Y+H A
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSA-- 145
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGL 321
VVHRD+K N+ +++D K+ DFGLA+ A + +V TR Y APE + +
Sbjct: 146 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 199
Query: 322 -LNEKSDVYSFGVLLLEAITGR 342
N+ D++S G ++ E +TG+
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGK 221
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPPFRAG 237
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 37 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 95
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 96 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 151
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 152 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 240
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 16 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 74
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 75 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 130
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 131 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 219
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 92
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 89
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 90 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 145
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 146 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 234
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G YG V + +G VA+KK+ + A++ +R E+ + H++H+N++ LL
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 205 YCIEGIHRMLVYE-YVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHEAIE 262
Y+ Y+ ++ L M G E +++ L+ K L Y+H A
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSA-- 163
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGL 321
VVHRD+K N+ +++D K+ DFGLA+ A + +V TR Y APE + +
Sbjct: 164 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 217
Query: 322 -LNEKSDVYSFGVLLLEAITGR 342
N+ D++S G ++ E +TG+
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + V + S KIL KE +V E + + + H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 89
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 90 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 145
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 146 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 234
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ K + LGEG Y VY+G + + + VA+K+I L + A EV + ++H N+V
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHE 259
L LV+EY++ +L+Q+L G + +K+ L + LAY H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YAN 318
KV+HRD+K N+LI++ K++DFGLA+ V+ T Y P+
Sbjct: 119 Q---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLG 174
Query: 319 TGLLNEKSDVYSFGVLLLEAITGR 342
+ + + D++ G + E TGR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
R+ + LG+GG+ Y ++ V K +L Q EK E+ +
Sbjct: 42 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+ ++V G+ + +V E +L + LH R EAR + T + +
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHK--RRKAVTEPEARY-FMRQTIQGVQ 156
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAP 314
YLH +V+HRD+K N+ ++DD + K+ DFGLA K+ G+ T + GT Y+AP
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAP 211
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
E + + D++S G +L + G+ P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVE-VEAIGHVRHKNLVRLLGYC 206
+G G +G V+R + G AVKK+ V FRVE + A + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAV 119
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-KALAYLHEAIEPKV 265
EG + E + G+L Q ++ G L E R LG A + L YLH ++
Sbjct: 120 REGPWVNIFMELLEGGSLGQ----LIKQMGCLP-EDRALYYLGQALEGLEYLHTR---RI 171
Query: 266 VHRDIKSSNILIDDDFN-AKVSDFGLAKLL---GAGKSHVT-TRVMGTFGYVAPEYANTG 320
+H D+K+ N+L+ D + A + DFG A L G GKS +T + GT ++APE
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
+ K D++S ++L + G P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 36/262 (13%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R EA K+
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-----EATCKL 257
Query: 247 LL-GTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVT 302
A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 258 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 312
Query: 303 TRVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD- 369
Query: 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419
+ S + + P + S +AL L+ L VDP + R + +R +
Sbjct: 370 ---QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA--RFTTEEALR------H 414
Query: 420 PIVREDRRHRRTQGGTSMEIES 441
P ++++ R+ Q S E ES
Sbjct: 415 PWLQDEDMKRKFQDLLSEENES 436
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVE-VEAIGHVRHKNLVRLLGYC 206
+G G +G V+R + G AVKK+ V FRVE + A + +V L G
Sbjct: 82 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAV 135
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-KALAYLHEAIEPKV 265
EG + E + G+L Q ++ G L E R LG A + L YLH ++
Sbjct: 136 REGPWVNIFMELLEGGSLGQ----LIKQMGCLP-EDRALYYLGQALEGLEYLHTR---RI 187
Query: 266 VHRDIKSSNILIDDDFN-AKVSDFGLAKLL---GAGKSHVT-TRVMGTFGYVAPEYANTG 320
+H D+K+ N+L+ D + A + DFG A L G GKS +T + GT ++APE
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
+ K D++S ++L + G P
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHP 271
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVEVE-AIGHVRHKNLVRLLGY 205
LG G YGVV + ++ +G +AVK+I V Q +K ++++ ++ V V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+ E ++ +L+++ + + + K+ + KAL +LH + V
Sbjct: 75 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV-MGTFGYVAPEYANTGL--- 321
+HRD+K SN+LI+ K+ DFG++ G V + G Y+APE N L
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 322 -LNEKSDVYSFGVLLLEAITGRDPVDH-GRPAHEVNLV 357
+ KSD++S G+ ++E R P D G P ++ V
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E + Q L + G L E +A+ + H
Sbjct: 75 VIRLLDWFERPDSFVLILERMEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVE 187
+++ E +++ +LG GG+G VY G ++ + PVA+K + +++ G+ RV
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 188 VEAIGHVR----HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
+E + + ++RLL + +L+ E Q L + G L E
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELA 117
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVT 302
+A+ + H V+HRDIK NILID + K+ DFG LL K V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
T GT Y PE+ + +S V+S G+LL + + G P +H
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 43/262 (16%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRV----EVEAIGH 193
+++ K +G+G +G V++ + G VA+KK+L + EKE F + E++ +
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQL 73
Query: 194 VRHKNLVRLLGYC---IEGIHRM-----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
++H+N+V L+ C +R LV+++ + +L L + + M+
Sbjct: 74 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+LL L Y+H K++HRD+K++N+LI D K++DFGLA+ K+ R
Sbjct: 133 MLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 306 MG---TFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNL 356
T Y PE LL E+ D++ G ++ E T R P+ G H++ L
Sbjct: 187 XNRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 241
Query: 357 VDWLKMMVGSRRSEEVVDPNIE 378
+ L GS E V PN++
Sbjct: 242 ISQL---CGSITPE--VWPNVD 258
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R ++
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTT 303
LL A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 124 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMR 174
Query: 304 RVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD-- 230
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
+ S + + P + S +AL L+ L VDP + R + +R +P
Sbjct: 231 --QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA--RFTTEEALR------HP 276
Query: 421 IVREDRRHRRTQGGTSMEIES 441
++++ R+ Q S E ES
Sbjct: 277 WLQDEDMKRKFQDLLSEENES 297
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R ++
Sbjct: 64 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTT 303
LL A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 123 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMR 173
Query: 304 RVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD-- 229
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
+ S + + P + S +AL L+ L VDP + R + +R +P
Sbjct: 230 --QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA--RFTTEEALR------HP 275
Query: 421 IVREDRRHRRTQGGTSMEIES 441
++++ R+ Q S E ES
Sbjct: 276 WLQDEDMKRKFQDLLSEENES 296
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHK 197
F +LGEG + + S KIL KE +V E + + + H
Sbjct: 32 FKFGKILGEGSFSTTVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHP 90
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ R G AL YL
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ SD+++ G ++ + + G P G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R ++
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTT 303
LL A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 124 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMR 174
Query: 304 RVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD-- 230
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
+ S + + P + S +AL L+ L VDP + R + +R +P
Sbjct: 231 --QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA--RFTTEEALR------HP 276
Query: 421 IVREDRRHRRTQGGTSMEIES 441
++++ R+ Q S E ES
Sbjct: 277 WLQDEDMKRKFQDLLSEENES 297
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 146 ENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLL 203
E +LG G G VV++G+ G PVAVK++L + A E ++ E+ H N++R
Sbjct: 38 EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 204 GYCIEGIHRMLVYEY-VNNGNLEQWLHGAMRHHGYLTWEAR---MKVLLGTAKALAYLHE 259
YC E R L + N NL+ + L + + +L A +A+LH
Sbjct: 93 -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 260 AIEPKVVHRDIKSSNILID-------------DDFNAKVSDFGLAKLLGAGKSHVTTRV- 305
K++HRD+K NIL+ ++ +SDFGL K L +G+ +
Sbjct: 152 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 306 --MGTFGYVAPEYANTGL---LNEKSDVYSFGVLLLEAIT-GRDP 344
GT G+ APE L D++S G + ++ G+ P
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G YG V + G+ VA+KK+ A++ +R E+ + H+RH+N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 205 -YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHEAIE 262
+ + Y+ + L M+H E R++ L+ K L Y+H A
Sbjct: 92 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAA-- 147
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA-NTGL 321
++HRD+K N+ +++D K+ DFGLA+ S + V+ T Y APE N
Sbjct: 148 -GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV-TRWYRAPEVILNWMR 202
Query: 322 LNEKSDVYSFGVLLLEAITGR 342
+ D++S G ++ E ITG+
Sbjct: 203 YTQTVDIWSVGCIMAEMITGK 223
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R ++
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTT 303
LL A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 124 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMR 174
Query: 304 RVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD-- 230
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
+ S + + P + S +AL L+ L VDP + R + +R +P
Sbjct: 231 --QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA--RFTTEEALR------HP 276
Query: 421 IVREDRRHRRTQGGTSMEIES 441
++++ R+ Q S E ES
Sbjct: 277 WLQDEDMKRKFQDLLSEENES 297
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVE 187
+++ E +++ +LG GG+G VY G ++ + PVA+K + +++ G+ RV
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 188 VEAIGHVR----HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
+E + + ++RLL + +L+ E Q L + G L E
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELA 117
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVT 302
+A+ + H V+HRDIK NILID + K+ DFG LL K V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
T GT Y PE+ + +S V+S G+LL + + G P +H
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 145 KENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRL 202
+E+VLGEG + V NLI AVK I G EVE + + H+N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
+ + E LV+E + G++ +H RH L EA + V+ A AL +LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNEL--EASV-VVQDVASALDFLHNK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFN---AKVSDFGLA---KLLGAGKSHVTTRVM---GTFGYVA 313
+ HRD+K NIL + K+ DFGL KL G T ++ G+ Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 314 PEYA-----NTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE + +++ D++S GV+L ++G P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVE 187
+++ E +++ +LG GG+G VY G ++ + PVA+K + +++ G+ RV
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 188 VEAIGHVR----HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
+E + + ++RLL + +L+ E Q L + G L E
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELA 117
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVT 302
+A+ + H V+HRDIK NILID + K+ DFG LL K V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
T GT Y PE+ + +S V+S G+LL + + G P +H
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 146 ENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLL 203
E +LG G G VV++G+ G PVAVK++L + A E ++ E+ H N++R
Sbjct: 38 EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 204 GYCIEGIHRMLVYEY-VNNGNLEQWLHGAMRHHGYLTWEAR---MKVLLGTAKALAYLHE 259
YC E R L + N NL+ + L + + +L A +A+LH
Sbjct: 93 -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 260 AIEPKVVHRDIKSSNILID-------------DDFNAKVSDFGLAKLLGAGKSHVTTRV- 305
K++HRD+K NIL+ ++ +SDFGL K L +G+ +
Sbjct: 152 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 306 --MGTFGYVAPEYANTGL---LNEKSDVYSFGVLLLEAIT-GRDP 344
GT G+ APE L D++S G + ++ G+ P
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R ++
Sbjct: 71 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTT 303
LL A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 130 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMR 180
Query: 304 RVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD-- 236
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
+ S + + P + S +AL L+ L VDP + R + +R +P
Sbjct: 237 --QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA--RFTTEEALR------HP 282
Query: 421 IVREDRRHRRTQGGTSMEIES 441
++++ R+ Q S E ES
Sbjct: 283 WLQDEDMKRKFQDLLSEENES 303
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 75 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 90 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 90 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 91 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 44/283 (15%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAE----------- 181
+ +L + ++ + + G YG V G G PVA+K++ N V
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 182 KEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRMLVYEYVNNGNLEQWLHG-----AM 232
K E+ + H H N++ L + +H++ + + +L Q +H +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 233 RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292
+H Y + +LLG L LHEA VVHRD+ NIL+ D+ + + DF LA+
Sbjct: 134 QHIQYFMYH----ILLG----LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 293 --LLGAGKSHVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349
A K+H T Y APE + D++S G ++ E + R + G
Sbjct: 183 EDTADANKTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAE-MFNRKALFRGS 237
Query: 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLT 392
+ N ++ + +VG+ + E+VV + PS R R+ L+
Sbjct: 238 TFY--NQLNKIVEVVGTPKIEDVV---MFSSPSARDYLRNSLS 275
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 91 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 103 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 43/262 (16%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRV----EVEAIGH 193
+++ K +G+G +G V++ + G VA+KK+L + EKE F + E++ +
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQL 73
Query: 194 VRHKNLVRLLGYC---IEGIHRM-----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
++H+N+V L+ C +R LV+++ + +L L + + M+
Sbjct: 74 LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+LL L Y+H K++HRD+K++N+LI D K++DFGLA+ K+ R
Sbjct: 133 MLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 306 MG---TFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNL 356
T Y PE LL E+ D++ G ++ E T R P+ G H++ L
Sbjct: 187 XNRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 241
Query: 357 VDWLKMMVGSRRSEEVVDPNIE 378
+ L GS E V PN++
Sbjct: 242 ISQL---CGSITPE--VWPNVD 258
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVE 187
+++ E +++ +LG GG+G VY G ++ + PVA+K + +++ G+ RV
Sbjct: 23 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 188 VEAIGHVR----HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
+E + + ++RLL + +L+ E Q L + G L E
Sbjct: 83 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELA 139
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVT 302
+A+ + H V+HRDIK NILID + K+ DFG LL K V
Sbjct: 140 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 193
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
T GT Y PE+ + +S V+S G+LL + + G P +H
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 239
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 91 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 220
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 43/262 (16%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRV----EVEAIGH 193
+++ K +G+G +G V++ + G VA+KK+L + EKE F + E++ +
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQL 72
Query: 194 VRHKNLVRLLGYC---IEGIHRM-----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
++H+N+V L+ C +R LV+++ + +L L + + M+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+LL L Y+H K++HRD+K++N+LI D K++DFGLA+ K+ R
Sbjct: 132 MLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 306 MG---TFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNL 356
T Y PE LL E+ D++ G ++ E T R P+ G H++ L
Sbjct: 186 XNRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 240
Query: 357 VDWLKMMVGSRRSEEVVDPNIE 378
+ L GS E V PN++
Sbjct: 241 ISQL---CGSITPE--VWPNVD 257
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 43/262 (16%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRV----EVEAIGH 193
+++ K +G+G +G V++ + G VA+KK+L + EKE F + E++ +
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQL 73
Query: 194 VRHKNLVRLLGYC---IEGIHRM-----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
++H+N+V L+ C +R LV+++ + +L L + + M+
Sbjct: 74 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+LL L Y+H K++HRD+K++N+LI D K++DFGLA+ K+ R
Sbjct: 133 MLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 306 MG---TFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNL 356
T Y PE LL E+ D++ G ++ E T R P+ G H++ L
Sbjct: 187 XNRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 241
Query: 357 VDWLKMMVGSRRSEEVVDPNIE 378
+ L GS E V PN++
Sbjct: 242 ISQL---CGSITPE--VWPNVD 258
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 104 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 44/283 (15%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAE----------- 181
+ +L + ++ + + G YG V G G PVA+K++ N V
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 182 KEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRMLVYEYVNNGNLEQWLHG-----AM 232
K E+ + H H N++ L + +H++ + + +L Q +H +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 233 RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292
+H Y + +LLG L LHEA VVHRD+ NIL+ D+ + + DF LA+
Sbjct: 134 QHIQYFMYH----ILLG----LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 293 --LLGAGKSHVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349
A K+H T Y APE + D++S G ++ E + R + G
Sbjct: 183 EDTADANKTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAE-MFNRKALFRGS 237
Query: 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLT 392
+ N ++ + +VG+ + E+VV + PS R R+ L+
Sbjct: 238 TFY--NQLNKIVEVVGTPKIEDVV---MFSSPSARDYLRNSLS 275
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 103 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 104 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 104 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 104 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 103 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 67/296 (22%), Positives = 124/296 (41%), Gaps = 35/296 (11%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
L++ ++ + ++G+G +G VY G + + I + K F+ EV A
Sbjct: 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
RH+N+V +G C+ H ++ L + A L ++ K
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVK 141
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG---AGKSHVTTRVM-GT 308
+ YLH ++H+D+KS N+ D+ ++DFGL + G AG+ R+ G
Sbjct: 142 GMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 309 FGYVAPEYA---------NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359
++APE + ++ SDV++ G + E + R+ +PA + W
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPAEAII---W 253
Query: 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+M G + PN+ + + LL C + E+RP ++++ MLE
Sbjct: 254 -QMGTGMK-------PNLSQIGMGKEISDILLF---CWAFEQEERPTFTKLMDMLE 298
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 103 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 118 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 14 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 74 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 131 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 184
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 215
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
R+ + LG+GG+ Y ++ V K +L Q EK E+ +
Sbjct: 42 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+ ++V G+ + +V E +L + LH R EAR + T + +
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHK--RRKAVTEPEARY-FMRQTIQGVQ 156
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAP 314
YLH +V+HRD+K N+ ++DD + K+ DFGLA K+ G+ + GT Y+AP
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAP 211
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
E + + D++S G +L + G+ P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 118 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 228
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 63 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 123 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 180 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 233
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 264
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 39/253 (15%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLL 203
++LG+G V+RG + K+ NN+ + + R E E + + HKN+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 204 GYCIEGI--HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
E H++L+ E+ G+L L +G L + VL + +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLREN- 131
Query: 262 EPKVVHRDIKSSNIL--IDDDFNA--KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+VHR+IK NI+ I +D + K++DFG A+ L + V+ + GT Y+ P+
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMY 187
Query: 318 NTGLLNEKS--------DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
+L + D++S GV A TG P RP G RR+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF---RPFE------------GPRRN 232
Query: 370 EEVVDPNIEVRPS 382
+EV+ I +PS
Sbjct: 233 KEVMYKIITGKPS 245
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E+E + + H ++++ + + +V E + G L + G R EA K+
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-----EATCKL 243
Query: 247 LL-GTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVT 302
A+ YLHE ++HRD+K N+L+ ++D K++DFG +K+L G++ +
Sbjct: 244 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 298
Query: 303 TRVMGTFGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359
+ GT Y+APE T N D +S GV+L ++G P R +V+L D
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD- 355
Query: 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDS 401
+ S + + P + S +AL L+ L VDP +
Sbjct: 356 ---QITSGKYNFI--PEVWAEVSEKAL--DLVKKLLVVDPKA 390
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
R+ + LG+GG+ Y ++ V K +L Q EK E+ +
Sbjct: 42 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+ ++V G+ + +V E +L + LH R EAR + T + +
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHK--RRKAVTEPEARY-FMRQTIQGVQ 156
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAP 314
YLH +V+HRD+K N+ ++DD + K+ DFGLA K+ G+ + GT Y+AP
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 211
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
E + + D++S G +L + G+ P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 16/224 (7%)
Query: 139 ATNRF---SKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHV 194
A N F SK +LG G +G V++ KI+ G +KE + E+ + +
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
H NL++L +LV EYV+ G L + LT + + + +
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTELDTILFMKQICEGI 200
Query: 255 AYLHEAIEPKVVHRDIKSSNILI--DDDFNAKVSDFGLAKLLGAGKSHVTTRV-MGTFGY 311
++H+ ++H D+K NIL D K+ DFGLA+ K +V GT +
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEF 254
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+APE N ++ +D++S GV+ ++G P A +N
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/271 (23%), Positives = 102/271 (37%), Gaps = 82/271 (30%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
F +G GG+GVV+ N ++ A+K+I L N A ++ EV+A+ + H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 201 RLLGYCIEG-----------------------------------IHRM------------ 213
R +E I RM
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 214 -----LVYEYVN-----NGNLEQWLHGAM----RHHGYLTWEARMKVLLGTAKALAYLHE 259
VY Y+ NL+ W++ R HG + + + A+A+ +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC-----LHIFIQIAEAVEFLHS 182
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV-----------MGT 308
++HRD+K SNI D KV DFGL + + T +GT
Sbjct: 183 K---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGT 239
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339
Y++PE + + K D++S G++L E +
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
R+ + LG+GG+ Y ++ V K +L Q EK E+ +
Sbjct: 26 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 84
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+ ++V G+ + +V E +L + LH R EAR + T + +
Sbjct: 85 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHK--RRKAVTEPEARY-FMRQTIQGVQ 140
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAP 314
YLH +V+HRD+K N+ ++DD + K+ DFGLA K+ G+ + GT Y+AP
Sbjct: 141 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 195
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
E + + D++S G +L + G+ P +
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 15/227 (6%)
Query: 124 QLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE 183
Q+G G F + ++ + + LG+G + VV R KI+N + ++
Sbjct: 12 QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD 71
Query: 184 F-RVEVEA--IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTW 240
F ++E EA ++H N+VRL E LV++ V G L + Y
Sbjct: 72 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEA 128
Query: 241 EARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAG 297
+A + +++AY H +VHR++K N+L+ K++DFGLA +
Sbjct: 129 DAS-HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVN 182
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
S GT GY++PE ++ D+++ GV+L + G P
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 203 LGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR----HHGYLTWEARMKVLLGTAKALAYL 257
L C + + R+ V EYVN G+L + R H + E + + +K
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---- 462
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+++RD+K N+++D + + K++DFG+ K T GT Y+APE
Sbjct: 463 -------IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEII 514
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D ++FGVLL E + G+ P +
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 148 VLGEGGYGVVYRGNLINGS-PVAVKKI----LNNVGQAEKEFRVEVEAIGHVR----HKN 198
+LG GG+G VY G ++ + PVA+K + +++ G+ RV +E + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++RLL + +L+ E Q L + G L E +A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
V+HRDIK NILID + K+ DFG LL K V T GT Y PE+
Sbjct: 128 NX---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDPVDH 347
+ +S V+S G+LL + + G P +H
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 9/115 (7%)
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
K+ + KAL YL E + V+HRD+K SNIL+D+ K+ DFG++ L K+ R
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DR 183
Query: 305 VMGTFGYVAPEYANTGLLNE-----KSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
G Y+APE + + ++DV+S G+ L+E TG+ P + + EV
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 140 TNRFSKENVLGEGGYGV--VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VR 195
++R+ +G G +GV + R L VAVK I E V+ E I H +R
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDEN---VQREIINHRSLR 74
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR + H ++ EY + G L + + A R + EAR ++
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARF-FFQQLLSGVS 130
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAK---LLGAGKSHVTTRVMGTFG 310
Y H ++ HRD+K N L+D K+ DFG +K L KS V GT
Sbjct: 131 YCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPA 182
Query: 311 YVAPEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVD 346
Y+APE + K +DV+S GV L + G P +
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGY 205
+LGEG Y V +L NG AVK I G + EVE + + +KN++ L+ +
Sbjct: 20 LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+ LV+E + G++ L + + EA +V+ A AL +LH +
Sbjct: 80 FEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREAS-RVVRDVAAALDFLHTK---GI 132
Query: 266 VHRDIKSSNILIDDDFN---AKVSDFGLAKLLGAGKSHV------TTRVMGTFGYVAPEY 316
HRD+K NIL + K+ DF L + S T G+ Y+APE
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 317 A-----NTGLLNEKSDVYSFGVLLLEAITGRDP 344
+++ D++S GV+L ++G P
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKN 198
N E +LG G G VV++G+ G PVAVK++L + A E ++ E+ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPN 70
Query: 199 LVRLLGYCIEGIHRMLVYEY-VNNGNLEQWLHGAMRHHGYLTWEAR---MKVLLGTAKAL 254
++R YC E R L + N NL+ + L + + +L A +
Sbjct: 71 VIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 255 AYLHEAIEPKVVHRDIKSSNILID-------------DDFNAKVSDFGLAKLLGAGKSHV 301
A+LH K++HRD+K NIL+ ++ +SDFGL K L +G+
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 302 TTRV---MGTFGYVAPEYANTG-------LLNEKSDVYSFGVLLLEAIT-GRDP 344
+ GT G+ APE L D++S G + ++ G+ P
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 39/253 (15%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLL 203
++LG+G V+RG + K+ NN+ + + R E E + + HKN+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 204 GYCIEGI--HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
E H++L+ E+ G+L L +G L + VL + +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLREN- 131
Query: 262 EPKVVHRDIKSSNIL--IDDDFNA--KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+VHR+IK NI+ I +D + K++DFG A+ L + V + GT Y+ P+
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMY 187
Query: 318 NTGLLNEKS--------DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
+L + D++S GV A TG P RP G RR+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF---RPFE------------GPRRN 232
Query: 370 EEVVDPNIEVRPS 382
+EV+ I +PS
Sbjct: 233 KEVMYKIITGKPS 245
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 149 LGEGGYGVV---YRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
+G G YG V Y L VAVKK+ ++ A + +R E+ + H++H+N++ L
Sbjct: 28 VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 203 L-----GYCIEGIHRMLVYEYVNNGNLEQWLHGAM---RHHGYLTWEARMKVLLGTAKAL 254
L IE + + + +L + H +L ++ + L
Sbjct: 85 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ--------LLRGL 136
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
Y+H A ++HRD+K SN+ +++D ++ DFGLA+ T + T Y AP
Sbjct: 137 KYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRAP 189
Query: 315 EYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
E N N+ D++S G ++ E + G+
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G+G + VV R N G AVK K ++ G + ++ + E ++H ++V
Sbjct: 31 VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 202 LL-GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH-GYLTWEA----RMKVLLGTAKALA 255
LL Y +G+ M V+E+++ +L R G++ EA M+ +L +AL
Sbjct: 91 LLETYSSDGMLYM-VFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQIL---EALR 144
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
Y H+ ++HRD+K N+L+ N+ K+ DFG+A LG RV GT ++
Sbjct: 145 YCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE + DV+ GV+L ++G P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 17/146 (11%)
Query: 206 CIEGIHRM-LVYEYVNNGNLEQWLHGAMR----HHGYLTWEARMKVLLGTAKALAYLHEA 260
C + + R+ V EYVN G+L + R H + E + + +K
Sbjct: 89 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG------- 141
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
+++RD+K N+++D + + K++DFG+ K T GT Y+APE
Sbjct: 142 ----IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQ 196
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D ++FGVLL E + G+ P +
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFE 222
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 68/240 (28%), Positives = 103/240 (42%), Gaps = 35/240 (14%)
Query: 125 LGWGHWFT--LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQ 179
L W FT ++ + L F V+G G +G V L N V KILN + +
Sbjct: 56 LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 180 AEKE-FRVEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGY 237
AE FR E + + + K + L Y + + + LV +Y G+L
Sbjct: 116 AETACFREERDVLVNGDSK-WITTLHYAFQDDNNLYLVMDYYVGGDL------------- 161
Query: 238 LTWEARMKVLLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDDDFNAKVSDFG- 289
LT ++ + L A YL E + + VHRDIK NIL+D + + +++DFG
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221
Query: 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDP 344
KL+ G + V GT Y++PE G + D +S GV + E + G P
Sbjct: 222 CLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 145 KENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRL 202
+E+VLGEG + V NLI AVK I G EVE + + H+N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
+ + E LV+E + G++ +H RH L EA + V+ A AL +LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNEL--EASV-VVQDVASALDFLHNK-- 130
Query: 263 PKVVHRDIKSSNILIDDDFN---AKVSDFGLA---KLLGAGKSHVTTRVM---GTFGYVA 313
+ HRD+K NIL + K+ DF L KL G T ++ G+ Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 314 PEYA-----NTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE + +++ D++S GV+L ++G P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 149 LGEGGYGVV---YRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
+G G YG V Y L VAVKK+ ++ A + +R E+ + H++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 203 L-----GYCIEGIHRMLVYEYVNNGNLEQWLHGAM---RHHGYLTWEARMKVLLGTAKAL 254
L IE + + + +L + H +L ++ + L
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQ--------LLRGL 144
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
Y+H A ++HRD+K SN+ +++D ++ DFGLA+ T + T Y AP
Sbjct: 145 KYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAP 197
Query: 315 EYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
E N N+ D++S G ++ E + G+
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
EL + +F+ + G G Y I ++ + G + +E EV + +RH
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR----RGVSREEIEREVNILREIRH 67
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ L +L+ E V+ G L +L LT + + L + Y
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHY 123
Query: 257 LHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
LH ++ H D+K NI++ D + K+ DFG+A + AG + GT +V
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFV 178
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N L ++D++S GV+ ++G P
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASP 210
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 116/239 (48%), Gaps = 22/239 (9%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCI 207
LG G Y V+ I + V KIL V + + + E++ + ++R N++ L
Sbjct: 45 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPNIITLADIVK 102
Query: 208 EGIHRM--LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
+ + R LV+E+VNN + +Q L+ + ++ R + KAL Y H +
Sbjct: 103 DPVSRTPALVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GI 152
Query: 266 VHRDIKSSNILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLN 323
+HRD+K N++ID + ++ D+GLA+ G+ + RV + + PE + + +
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYD 210
Query: 324 EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
D++S G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
EL + +F+ + G G Y I ++ + G + +E EV + +RH
Sbjct: 19 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR----RGVSREEIEREVNILREIRH 74
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ L +L+ E V+ G L +L LT + + L + Y
Sbjct: 75 PNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHY 130
Query: 257 LHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
LH ++ H D+K NI++ D + K+ DFG+A + AG + GT +V
Sbjct: 131 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFV 185
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N L ++D++S GV+ ++G P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEA--IGHVRHKNLVRLLGY 205
LG+G + VV R ++ G A K I A ++E EA ++H N+VRL
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E H L+++ V G L + + Y + + +A+ + H+ V
Sbjct: 90 ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 142
Query: 266 VHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
VHRD+K N+L+ K++DFGLA + G+ GT GY++PE
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 323 NEKSDVYSFGVLLLEAITGRDP 344
+ D+++ GV+L + G P
Sbjct: 202 GKPVDLWACGVILYILLVGYPP 223
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 149 LGEGGYGVV---YRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
+G G YG V Y L VAVKK+ ++ A + +R E+ + H++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 203 L-----GYCIEGIHRMLVYEYVNNGNLEQWLHGAM---RHHGYLTWEARMKVLLGTAKAL 254
L IE + + + +L + H +L ++ + L
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ--------LLRGL 144
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
Y+H A ++HRD+K SN+ +++D ++ DFGLA+ T + T Y AP
Sbjct: 145 KYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAP 197
Query: 315 EYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
E N N+ D++S G ++ E + G+
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 8/155 (5%)
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ +V+H LV L V +Y+N G L + R +L AR
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAA-EI 148
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A AL YLH +V+RD+K NIL+D + ++DFGL K + T+ GT
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
Y+APE + + D + G +L E + G P
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 149 LGEGGYGVVYR-----GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+ + + + K +L Q EK +E+ + H+++V
Sbjct: 29 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 87
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAKALAYLHEA 260
G+ + +V E +L + LH R EAR +++LG YLH
Sbjct: 88 GFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQ----YLHRN 140
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+ +++D K+ DFGLA K+ G+ T + GT Y+APE +
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 195
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + DV+S G ++ + G+ P +
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFE 222
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 149 LGEGGYGVVYR-----GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+ + + + K +L Q EK +E+ + H+++V
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 83
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAKALAYLHEA 260
G+ + +V E +L + LH R EAR +++LG YLH
Sbjct: 84 GFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQ----YLHRN 136
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+ +++D K+ DFGLA K+ G+ T + GT Y+APE +
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 191
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + DV+S G ++ + G+ P +
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFE 218
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + +E EV + +RH N++ L +L+ E V+ G L +L
Sbjct: 70 GVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKES 125
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT + + L + YLH ++ H D+K NI++ D + K+ DFG+A
Sbjct: 126 LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 182
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ AG + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 183 IEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
+RF E + G+G +G V G G VA+KK++ + +E ++ ++ + + H N+
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNI 81
Query: 200 VRLLGYCI-------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT-- 250
V+L Y I+ +V EYV + LH R++ Y A +L+
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LHRCCRNY-YRRQVAPPPILIKVFL 135
Query: 251 ---AKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+++ LH V HRDIK N+L+++ D K+ DFG AK L + +V +
Sbjct: 136 FQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--YI 192
Query: 307 GTFGYVAPE--YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
+ Y APE + N D++S G + E + G +P+ G
Sbjct: 193 CSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLG-EPIFRG 234
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 149 LGEGGYGVVYR-----GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+ + + + K +L Q EK +E+ + H+++V
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 83
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAKALAYLHEA 260
G+ + +V E +L + LH R EAR +++LG YLH
Sbjct: 84 GFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQ----YLHRN 136
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+ +++D K+ DFGLA K+ G+ T + GT Y+APE +
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 191
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + DV+S G ++ + G+ P +
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFE 218
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 140 TNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVR 195
++R+ + LG G YG V+ + + G+ A+K I + EV + +
Sbjct: 20 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+++L + + + LV E G L + + +VL GT
Sbjct: 80 HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT---- 135
Query: 256 YLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLH+ +VHRD+K N+L++ D K+ DFGL+ G +GT Y+
Sbjct: 136 YLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYI 190
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE +EK DV+S GV+L + G P
Sbjct: 191 APEVLRKK-YDEKCDVWSCGVILYILLCGYPP 221
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/230 (23%), Positives = 110/230 (47%), Gaps = 23/230 (10%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI--NGS--PVAVKKILNNVGQAE--KEFRV 186
L D+ + +F+ +LG+G +G V L +GS VAVK + ++ + +EF
Sbjct: 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHR------MLVYEYVNNGNLEQWLHGAM--RHHGYL 238
E + H ++ +L+G + + M++ ++ +G+L +L + + L
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ ++ ++ A + YL +HRD+ + N ++ +D V+DFGL++ + +G
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 299 SH---VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ +++ ++A E L SDV++FGV + E +T G+ P
Sbjct: 192 YYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 17/219 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVEVE-AIGHVRHKNLVRLLGY 205
LG G YGVV + ++ +G AVK+I V Q +K +++ + V V G
Sbjct: 42 LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 206 CI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
EG + + + + +L+++ + + + K+ + KAL +LH +
Sbjct: 102 LFREG--DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 157
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV-MGTFGYVAPEYANTGL-- 321
V+HRD+K SN+LI+ K DFG++ L V + G Y APE N L
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYL---VDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 322 --LNEKSDVYSFGVLLLEAITGRDPVDH-GRPAHEVNLV 357
+ KSD++S G+ +E R P D G P ++ V
Sbjct: 215 KGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 140 TNRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKI-------LNNVGQAEKEFRVEVEAI 191
++R+ + LG G YG V+ + + G+ A+K I +N G EV +
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA----LLDEVAVL 58
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
+ H N+++L + + + LV E G L + + +VL GT
Sbjct: 59 KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
YLH+ +VHRD+K N+L++ D K+ DFGL+ G +GT
Sbjct: 119 ----YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGT 169
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
Y+APE +EK DV+S GV+L + G P
Sbjct: 170 AYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPP 204
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 140 TNRFSKENVLGEGGYGV--VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VR 195
++R+ +G G +GV + R N VAVK I G+ E V+ E I H +R
Sbjct: 18 SDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYI--ERGEKIDE-NVKREIINHRSLR 73
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR + H +V EY + G L + + A R + EAR ++
Sbjct: 74 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARF-FFQQLISGVS 129
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTR-VMGTFGYV 312
Y H +V HRD+K N L+D K++DFG +K A H + +GT Y+
Sbjct: 130 YAHAM---QVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYI 183
Query: 313 APEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVD 346
APE + K +DV+S GV L + G P +
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEA--IGHVRH 196
T+ + +G+G + VV R L G A K I A ++E EA ++H
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N+VRL E LV++ V G L + + Y + + +A+ +
Sbjct: 63 SNIVRLHDSISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLH 118
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
H+ VVHRD+K N+L+ K++DFGLA + G GT GY++
Sbjct: 119 CHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLS 174
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE + D+++ GV+L + G P
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVGYPP 205
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 149 LGEGGYGVVYR-----GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+ + + + K +L Q EK +E+ + H+++V
Sbjct: 47 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 105
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAKALAYLHEA 260
G+ + +V E +L + LH R EAR +++LG YLH
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQ----YLHRN 158
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+ +++D K+ DFGLA K+ G+ + GT Y+APE +
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSK 213
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + DV+S G ++ + G+ P +
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFE 240
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF-RVEVEA--IGHVRH 196
++ + + LG+G + VV R KI+N + ++F ++E EA ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N+VRL E LV++ V G L + Y +A + +++AY
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADAS-HCIQQILESIAY 120
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
H +VHR++K N+L+ K++DFGLA + S GT GY++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 175
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE ++ D+++ GV+L + G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 138 LATNRFSKE----NVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEA-- 190
+ RF++E LG+G + VV R ++ G A I A ++E EA
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
++H N+VRL E H L+++ V G L + + Y + +
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQI 119
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMG 307
+A+ + H+ VVHR++K N+L+ K++DFGLA + G+ G
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAG 175
Query: 308 TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
T GY++PE + D+++ GV+L + G P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF-RVEVEA--IGHVRH 196
++ + + LG+G + VV R KI+N + ++F ++E EA ++H
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N+VRL E LV++ V G L + Y +A + +++AY
Sbjct: 64 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADAS-HCIQQILESIAY 119
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
H +VHR++K N+L+ K++DFGLA + S GT GY++
Sbjct: 120 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 174
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE ++ D+++ GV+L + G P
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 205
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 149 LGEGGYGVVYR-----GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+ + + + K +L Q EK +E+ + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAKALAYLHEA 260
G+ + +V E +L + LH R EAR +++LG YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQ----YLHRN 160
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+ +++D K+ DFGLA K+ G+ + GT Y+APE +
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSK 215
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + DV+S G ++ + G+ P +
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFE 242
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF-RVEVEA--IGHVRH 196
++ + + LG+G + VV R KI+N + ++F ++E EA ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N+VRL E LV++ V G L + Y +A + +++AY
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADAS-HCIQQILESIAY 120
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
H +VHR++K N+L+ K++DFGLA + S GT GY++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 175
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE ++ D+++ GV+L + G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 83/306 (27%), Positives = 124/306 (40%), Gaps = 71/306 (23%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-------NVGQAEKEFRVEVEAIGHV 194
++ + +G+G YGVV + KI+N N E+ + EV + +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKL 85
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNL------------------------------ 224
H N+ RL + + LV E + G+L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 225 -EQWLHGAMRHHGY---LTWEARMKVLLGTAK----ALAYLHEAIEPKVVHRDIKSSNIL 276
E+ ++G++ HG+ L + R K++ + AL YLH + HRDIK N L
Sbjct: 146 NEEAINGSI--HGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFL 200
Query: 277 I--DDDFNAKVSDFGLAK---LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE----KSD 327
+ F K+ DFGL+K L G+ + T GT +VAPE NT NE K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT--NESYGPKCD 258
Query: 328 VYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV-RPSTRAL 386
+S GVLL + G P P VN D + ++ + E +PN V P R L
Sbjct: 259 AWSAGVLLHLLLMGAVPF----PG--VNDADTISQVLNKKLCFE--NPNYNVLSPLARDL 310
Query: 387 KRSLLT 392
+LL
Sbjct: 311 LSNLLN 316
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 17/212 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
EL + +F+ E G+ Y I + G + ++ EV + ++H
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR----RGVSREDIEREVSILKEIQH 73
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ L +L+ E V G L +L LT E + L + Y
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYY 129
Query: 257 LHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
LH ++ H D+K NI++ D K+ DFGLA + G + GT +V
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAFV 184
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N L ++D++S GV+ ++G P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEG--IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E+ + + H N+V+L+ + H +V+E VN G + + + L+ +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPLSEDQAR 140
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
K + YLH K++HRDIK SN+L+ +D + K++DFG++ G + +
Sbjct: 141 FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSN 196
Query: 305 VMGTFGYVAPEYANTG--LLNEKS-DVYSFGVLLLEAITGRDPVDHGR------------ 349
+GT ++APE + + + K+ DV++ GV L + G+ P R
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 350 ------PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
P +L D + M+ +V P I++ P
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 18/221 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE----FRVEV 188
+R L++ + V+G G +G V V K+L+ ++ F E
Sbjct: 67 IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ + +V+L + + +V EY+ G+L + Y E K
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFY- 179
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMG 307
TA+ + L ++HRD+K N+L+D + K++DFG K+ G H T V G
Sbjct: 180 -TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-G 237
Query: 308 TFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDP 344
T Y++PE + G + D +S GV L E + G P
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 55.1 bits (131), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 140 TNRFSKENVLGEGGYGV--VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VR 195
++R+ +G G +GV + R N VAVK I G+ E V+ E I H +R
Sbjct: 17 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYI--ERGEKIDE-NVKREIINHRSLR 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR + H +V EY + G L + + A R + EAR ++
Sbjct: 73 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARF-FFQQLISGVS 128
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAK---LLGAGKSHVTTRVMGTFG 310
Y H +V HRD+K N L+D K+ DFG +K L KS V GT
Sbjct: 129 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPA 180
Query: 311 YVAPEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVD 346
Y+APE + K +DV+S GV L + G P +
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 79/295 (26%), Positives = 119/295 (40%), Gaps = 53/295 (17%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNN--VGQAEKEFRV---- 186
+D E + +LG+GG+G V+ G+ L + VA+K I N +G + V
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 187 EVEAIGHVR----HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
EV + V H ++RLL + MLV E Q L + G L E
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG-EG 139
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHV 301
+ G + +A + VVHRDIK NILID AK+ DFG LL
Sbjct: 140 PSRCFFG--QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEP 194
Query: 302 TTRVMGTFGYVAPEYANTGLLNE-KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
T GT Y PE+ + + + V+S G+LL + + G P +
Sbjct: 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-------------- 240
Query: 361 KMMVGSRRSEEVVDPNI----EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
R +E+++ + V P AL R RC+ P RP + +++
Sbjct: 241 -------RDQEILEAELHFPAHVSPDCCALIR------RCLAPKPSSRPSLEEIL 282
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 16/218 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYCI 207
LG G +GVV+R V V K +N +K + E+ + + H L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR-MKVLLGTAKALAYLHEAIEPKVV 266
+ +L+ E+++ G L + Y EA + + + L ++HE +V
Sbjct: 119 DKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 171
Query: 267 HRDIKSSNILIDDD--FNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
H DIK NI+ + + K+ DFGLA L + + T + APE + +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF 229
Query: 325 KSDVYSFGVLLLEAITGRDPV---DHGRPAHEVNLVDW 359
+D+++ GVL ++G P D V DW
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 149 LGEGGYGVVYR-----GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+ + + + K +L Q EK +E+ + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAKALAYLHEA 260
G+ + +V E +L + LH R EAR +++LG YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQ----YLHRN 134
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+ +++D K+ DFGLA K+ G+ + GT Y+APE +
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSK 189
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + DV+S G ++ + G+ P +
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFE 216
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEF---RVEVEA 190
+ ++S + LG G +G V+ + V VK K+L + + + +E+
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 191 IGHVRHKNLVRLLG-YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ V H N++++L + +G ++++ ++ + +L + H L +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL----FAFIDRHPRLDEPLASYIFRQ 138
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A+ YL ++HRDIK NI+I +DF K+ DFG A L GK T GT
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTI 193
Query: 310 GYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
Y APE + +++S GV L + +P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 38/159 (23%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 183 EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL----EQWLHGAMRHHGYL 238
+F+ E++ I ++++ + G ++YEY+ N ++ E + + ++
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ ++ + +Y+H E + HRD+K SNIL+D + K+SDFG ++ + K
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 299 SHVTTRVMGTFGYVAPE-YANTGLLN-EKSDVYSFGVLL 335
+ GT+ ++ PE ++N N K D++S G+ L
Sbjct: 207 IKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 140 TNRFSKENVLGEGGYGV--VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VR 195
++R+ +G G +GV + R N VAVK I A V+ E I H +R
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAAN---VKREIINHRSLR 73
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR + H +V EY + G L + + A R + EAR ++
Sbjct: 74 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARF-FFQQLISGVS 129
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAK---LLGAGKSHVTTRVMGTFG 310
Y H +V HRD+K N L+D K+ DFG +K L KS V GT
Sbjct: 130 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPA 181
Query: 311 YVAPEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVD 346
Y+APE + K +DV+S GV L + G P +
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 31/238 (13%)
Query: 125 LGWGHWFT--LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQ 179
L W FT +++++L F V+G G +G V + N + KILN + +
Sbjct: 56 LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 180 AEKE-FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
AE FR E + + + + + L + H LV +Y G+L L
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL-------------L 162
Query: 239 TWEARMKVLLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291
T ++ + L A Y+ E + + VHRDIK N+L+D + + +++DFG
Sbjct: 163 TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC 222
Query: 292 KLLGAGKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDP 344
+ + ++ +GT Y++PE G + D +S GV + E + G P
Sbjct: 223 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 17/212 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
EL + +F+ E G+ Y I + G + ++ EV + ++H
Sbjct: 18 ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSR----RGVSREDIEREVSILKEIQH 73
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ L +L+ E V G L +L LT E + L + Y
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYY 129
Query: 257 LHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
LH ++ H D+K NI++ D K+ DFGLA + G + GT +V
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N L ++D++S GV+ ++G P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 17/212 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
EL + +F+ E G+ Y I + G + ++ EV + ++H
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR----RGVSREDIEREVSILKEIQH 73
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ L +L+ E V G L +L LT E + L + Y
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYY 129
Query: 257 LHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
LH ++ H D+K NI++ D K+ DFGLA + G + GT +V
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N L ++D++S GV+ ++G P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 31/238 (13%)
Query: 125 LGWGHWFT--LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQ 179
L W FT +++++L F V+G G +G V + N + KILN + +
Sbjct: 72 LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 180 AEKE-FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
AE FR E + + + + + L + H LV +Y G+L L
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL-------------L 178
Query: 239 TWEARMKVLLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291
T ++ + L A Y+ E + + VHRDIK N+L+D + + +++DFG
Sbjct: 179 TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC 238
Query: 292 KLLGAGKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDP 344
+ + ++ +GT Y++PE G + D +S GV + E + G P
Sbjct: 239 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 54 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 109
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 167 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 17/212 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
EL + +F+ E G+ Y I + G + ++ EV + ++H
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR----RGVSREDIEREVSILKEIQH 73
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ L +L+ E V G L +L LT E + L + Y
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYY 129
Query: 257 LHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
LH ++ H D+K NI++ D K+ DFGLA + G + GT +V
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N L ++D++S GV+ ++G P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 18/231 (7%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G+ F Q ++ + + EL + +F+ E G+ Y I +
Sbjct: 1 GMETFKQQKVEDFYDIGE-ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----R 55
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G +E EV + V H N++ L +L+ E V+ G L +L
Sbjct: 56 GVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKES 111
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKL 293
L+ E + + YLH K+ H D+K NI++ D + K+ DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 169 IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 54 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 109
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 167 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSP-VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
+R+ LG GG G+V+ + VA+KKI+ Q+ K E++ I + H N+
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 200 VRLL--------------GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
V++ G E +V EY +E L + L AR+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHARL- 124
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTR 304
+ + L Y+H A V+HRD+K +N+ I+ +D K+ DFGLA+++ SH +
Sbjct: 125 FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH---K 178
Query: 305 VMGTFGYVAPEYANTGLL------NEKSDVYSFGVLLLEAITGR 342
+ G V Y + LL + D+++ G + E +TG+
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG-------QAEKEFRVEVEAIGHVRHKNL 199
++LGEG YG V +++ + + + E + E++ + +RHKN+
Sbjct: 11 DLLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 200 VRL---------------LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
++L + YC+ G+ ML ++ + + HGY
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEML-------DSVPEKRFPVCQAHGYFCQ---- 117
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
L YLH +VH+DIK N+L+ K+S G+A+ L + T R
Sbjct: 118 -----LIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 305 V-MGTFGYVAPEYAN--TGLLNEKSDVYSFGVLLLEAITGRDPVD 346
G+ + PE AN K D++S GV L TG P +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 18/161 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRH 196
+R+ +++G G YG V + + VA+KKIL ++ ++ R E+ + + H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNH 111
Query: 197 KNLVRLLGYCI----EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTA 251
++V++L I E + V + + + ++ + YLT E +K LL
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV----YLT-ELHIKTLLYNLL 166
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292
+ Y+H A ++HRD+K +N L++ D + KV DFGLA+
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
EV + + H N+++L + + + LV E G L + M+ + +V
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLLGAGKSHVTT 303
L G + YLH+ +VHRD+K N+L++ D K+ DFGL+ + K
Sbjct: 146 LSG----VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MK 196
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+GT Y+APE +EK DV+S GV+L + G P
Sbjct: 197 ERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPP 236
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + ++ EV + ++H N++ L +L+ E V G L +L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AEKES 110
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFGLAKL 293
LT E + L + YLH ++ H D+K NI++ D K+ DFGLA
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 26/182 (14%)
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
+T E + A+ + +L K +HRD+ + NIL+ ++ K+ DFGLA+ +
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 298 KSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHE 353
+V TR+ ++APE + + KSDV+S+GVLL E + G P P +
Sbjct: 253 PDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPY----PGVQ 306
Query: 354 VNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ ++ G R R+ E P I L C D ++RP+ +++V
Sbjct: 307 MDEDFCSRLREGMRMRAPEYSTPEI------------YQIMLDCWHRDPKERPRFAELVE 354
Query: 413 ML 414
L
Sbjct: 355 KL 356
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFGLAK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 18/231 (7%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G+ F Q ++ + + EL + +F+ E G+ Y I +
Sbjct: 1 GMEPFKQQKVEDFYDIGE-ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----R 55
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + +E EV + V H N++ L +L+ E V+ G L +L
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKES 111
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKL 293
L+ E + + YLH K+ H D+K NI++ D + K+ DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 169 IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 18/231 (7%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G+ F Q ++ + + EL + +F+ E G+ Y I +
Sbjct: 1 GMEPFKQQKVEDFYDIGE-ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----R 55
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + +E EV + V H N++ L +L+ E V+ G L +L
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKES 111
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKL 293
L+ E + + YLH K+ H D+K NI++ D + K+ DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 169 IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 18/231 (7%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G+ F Q ++ + + EL + +F+ E G+ Y I +
Sbjct: 1 GMEPFKQQKVEDFYDIGE-ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----R 55
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + +E EV + V H N++ L +L+ E V+ G L +L
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKES 111
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKL 293
L+ E + + YLH K+ H D+K NI++ D + K+ DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 169 IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 18/231 (7%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G+ F Q ++ + + EL + +F+ E G+ Y I +
Sbjct: 1 GMEPFKQQKVEDFYDIGE-ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----R 55
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + +E EV + V H N++ L +L+ E V+ G L +L
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKES 111
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKL 293
L+ E + + YLH K+ H D+K NI++ D + K+ DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 169 IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 18/231 (7%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G+ F Q ++ + + EL + +F+ E G+ Y I +
Sbjct: 1 GMEPFKQQKVEDFYDIGE-ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----R 55
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
G + +E EV + V H N++ L +L+ E V+ G L +L
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKES 111
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKL 293
L+ E + + YLH K+ H D+K NI++ D + K+ DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + GT +VAPE N L ++D++S GV+ ++G P
Sbjct: 169 IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 140 TNRFSKENVLGEGGYGV--VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VR 195
++R+ +G G +GV + R N VAVK I G+ E V+ E I H +R
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYI--ERGEKIDE-NVKREIINHRSLR 73
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR + H +V EY + G L + + A R + EAR ++
Sbjct: 74 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARF-FFQQLISGVS 129
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAK---LLGAGKSHVTTRVMGTFG 310
Y H +V HRD+K N L+D K+ FG +K L KS V GT
Sbjct: 130 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV-----GTPA 181
Query: 311 YVAPEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVD 346
Y+APE + K +DV+S GV L + G P +
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID KV+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID KV+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKEFRVEVE 189
+RDL + + V+G G +G V + V K+L+ + +++ F E
Sbjct: 66 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
I + V L Y + + +V EY+ G+L M ++ AR
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN----LMSNYDVPEKWARFY--- 178
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMG 307
TA+ + L +HRD+K N+L+D + K++DFG K+ G T V G
Sbjct: 179 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 308 TFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDPV 345
T Y++PE + G + D +S GV L E + G P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKEFRVEVE 189
+RDL + + V+G G +G V + V K+L+ + +++ F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
I + V L Y + + +V EY+ G+L M ++ AR
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN----LMSNYDVPEKWARFY--- 173
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMG 307
TA+ + L +HRD+K N+L+D + K++DFG K+ G T V G
Sbjct: 174 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 308 TFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDPV 345
T Y++PE + G + D +S GV L E + G P
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 18/221 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKEFRVEVE 189
+RDL + + V+G G +G V + V K+L+ + +++ F E
Sbjct: 66 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
I + V L Y + + +V EY+ G+L M ++ AR
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN----LMSNYDVPEKWARFY--- 178
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMG 307
TA+ + L +HRD+K N+L+D + K++DFG K+ G T V G
Sbjct: 179 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 308 TFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDP 344
T Y++PE + G + D +S GV L E + G P
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID KV+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID KV+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G+G + VV R N G AVK K ++ G + ++ + E ++H ++V
Sbjct: 33 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 202 LL-GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH-GYLTWEA----RMKVLLGTAKALA 255
LL Y +G+ M V+E+++ +L R G++ EA M+ +L +AL
Sbjct: 93 LLETYSSDGMLYM-VFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQIL---EALR 146
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
Y H+ ++HRD+K +L+ N+ K+ FG+A LG RV GT ++
Sbjct: 147 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 202
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE + DV+ GV+L ++G P
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 234
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA----TWTLCGTPEYLA 227
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G + +R G +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 149
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 27 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 79
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G + +R G +
Sbjct: 80 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 135
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 136 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTP 188
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G E + H +R G +
Sbjct: 95 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSH--LRRIGRFSEPHARFYAAQ 150
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 151 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTP 203
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
V+G+G + VV R N G AVK K ++ G + ++ + E ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 202 LL-GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH-GYLTWEA----RMKVLLGTAKALA 255
LL Y +G+ M V+E+++ +L R G++ EA M+ +L +AL
Sbjct: 91 LLETYSSDGMLYM-VFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQIL---EALR 144
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
Y H+ ++HRD+K +L+ N+ K+ FG+A LG RV GT ++
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE + DV+ GV+L ++G P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G + +R G +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 149
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G + +R G +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ 149
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G + +R G +
Sbjct: 95 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 150
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 151 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 203
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
pdb|3JUH|B Chain B, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
Length = 335
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N+LID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVLIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
V LV+L + + +V EYV G + +R G +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 149
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLH +++RD+K N+LID+ +V+DFG AK + T + GT Y+
Sbjct: 140 TFEYLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYL 192
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
APE + N+ D ++ GVL+ E G P +P
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMKVLL 248
V LV+L + + +V EYV G + L R + + A VL
Sbjct: 95 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL- 153
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 154 ----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 28/209 (13%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
LG+G + VV R + KI+N + ++ E ++H N+VRL
Sbjct: 39 LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP-- 263
E LV++ V G L + + + A A +H+ +E
Sbjct: 99 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIHQILESVN 144
Query: 264 -----KVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+VHRD+K N+L+ K++DFGLA + G+ GT GY++PE
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPE 203
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ D+++ GV+L + G P
Sbjct: 204 VLRKDPYGKPVDIWACGVILYILLVGYPP 232
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMKVLL 248
V LV+L + + +V EYV G + L R + + A VL
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL- 152
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 153 ----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID +V+DFGLAK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 141 NRFSKENVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH------ 193
++F + LG G +G V+ ++ G+ A+K + +K+ V+++ I H
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 194 ----VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMKVLL 248
V LV+L + + +V EYV G + L R + + A VL
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL- 152
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
YLH +++RD+K N+LID +V+DFG AK + T + GT
Sbjct: 153 ----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y+APE + N+ D ++ GVL+ E G P +P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 234 HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+ +LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 294 LGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ +V ++APE + +SDV+SFGVLL E + G P P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 298
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 346
Query: 411 VRML 414
V L
Sbjct: 347 VEHL 350
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N++ID KV+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 234 HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+ +LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+
Sbjct: 184 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 240
Query: 294 LGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ +V ++APE + +SDV+SFGVLL E + G P P
Sbjct: 241 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 296
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 297 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 344
Query: 411 VRML 414
V L
Sbjct: 345 VEHL 348
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 140 TNRFSKENVLGEGGYGV--VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VR 195
++R+ +G G +GV + R N VAVK I G+ E V+ E I H +R
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYI--ERGEKIDE-NVKREIINHRSLR 73
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR + H +V EY + G L + + A R + EAR ++
Sbjct: 74 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARF-FFQQLISGVS 129
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTR-VMGTFGYV 312
Y H +V HRD+K N L+D K+ FG +K + H + +GT Y+
Sbjct: 130 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYI 183
Query: 313 APEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVD 346
APE + K +DV+S GV L + G P +
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 234 HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+ +LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+
Sbjct: 191 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 247
Query: 294 LGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ +V ++APE + +SDV+SFGVLL E + G P P
Sbjct: 248 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PG 303
Query: 352 HEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+++ ++ G+R R+ + P + T L C + +RP S++
Sbjct: 304 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSEL 351
Query: 411 VRML 414
V L
Sbjct: 352 VEHL 355
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 66/285 (23%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 149 LGEGGYGVVYRG--------NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
LG+G + +++G ++ + V +K + + F + + HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY-LHE 259
G C G +LV E+V G+L+ +L ++ + W+ L AK LA+ +H
Sbjct: 76 LNYGVCFCGDENILVQEFVKFGSLDTYLKKN-KNCINILWK------LEVAKQLAWAMHF 128
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEY 316
E ++H ++ + NIL+ + + K + KL G S + +V PE
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 317 A-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
N LN +D +SFG L E +G D +P ++ S+R + +
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGD-----KPLSALD----------SQRKLQFYED 233
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
++ P+ +A + + L C+D + + RP ++R L S P
Sbjct: 234 RHQL-PAPKAAELANLIN-NCMDYEPDHRPSFRAIIRDLNSLFTP 276
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 234 HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+ +LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+
Sbjct: 193 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 249
Query: 294 LGAGKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGR 349
+ +V R+ ++APE + +SDV+SFGVLL E + G P
Sbjct: 250 IYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 303
Query: 350 PAHEVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408
P +++ ++ G+R R+ + P + T L C + +RP S
Sbjct: 304 PGVKIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFS 351
Query: 409 QVVRML 414
++V L
Sbjct: 352 ELVEHL 357
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 61/298 (20%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV---R 195
T F + +G G +G V++ ++G A+K+ + + E E H +
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKAL 254
H ++VR E H ++ EY N G+L + R Y EA +K +LL + L
Sbjct: 66 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK-EAELKDLLLQVGRGL 124
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM---GTFGY 311
Y+H +VH DIK SNI I ++ S A G + +VM G G+
Sbjct: 125 RYIHSM---SLVHMDIKPSNIFI-----SRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 176
Query: 312 V----APE-------YANTGLLNE------KSDVYSFGVLLLEAITGRDPVD-HGRPAHE 353
V +P+ + +L E K+D+++ + ++ A G +P+ +G HE
Sbjct: 177 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXA-AGAEPLPRNGDQWHE 235
Query: 354 V--------------NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRS--LLTALR 395
+ + LK+M + P+ E RPS AL + LL+A R
Sbjct: 236 IRQGRLPRIPQVLSQEFTELLKVM---------IHPDPERRPSAMALVKHSVLLSASR 284
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+
Sbjct: 148 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYL 200
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
APE + N+ D ++ GVL+ E G P +P
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238
>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3NGA|B Chain B, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3U4U|A Chain A, Casein Kinase 2 In Complex With Az-Inhibitor
Length = 333
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+
Sbjct: 146 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYL 198
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
APE + N+ D ++ GVL+ E G P +P
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236
>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn
Length = 330
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 110 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 159
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 217
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 266
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+
Sbjct: 146 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYL 198
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
APE + N+ D ++ GVL+ E G P +P
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
pdb|3U87|B Chain B, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
Length = 349
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Cpa)
pdb|3MB7|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Amr)
pdb|3OWJ|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Pyridocarbazole Derivative Inhibitor
pdb|3OWK|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
pdb|3OWL|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
Length = 331
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 227
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human
Protein Kinase Ck2 Catalytic Subunit
pdb|2PVR|A Chain A, Crystal Structure Of The Catalytic Subunit Of Protein
Kinase Ck2 (c- Terminal Deletion Mutant 1-335) In
Complex With Two Sulfate Ions
Length = 334
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 110 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 159
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 217
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 266
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|1JWH|B Chain B, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|3PE1|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-4945
pdb|3PE2|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 In Complex
With The Inhibitor Cx-5011
pdb|3R0T|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-5279
Length = 337
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 8.5
pdb|3Q9X|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9X|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9Y|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 8.5
pdb|3Q9Z|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3Q9Z|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3QA0|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
pdb|3QA0|B Chain B, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
Length = 336
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
pdb|3H30|B Chain B, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
Length = 334
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|B Chain B, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|C Chain C, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|D Chain D, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
Length = 335
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
8.5
Length = 328
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 109 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 158
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 216
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 217 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 265
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3C13|A Chain A, Low Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3FWQ|A Chain A, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3FWQ|B Chain B, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3RPS|A Chain A, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3RPS|B Chain B, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3U9C|A Chain A, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|3U9C|B Chain B, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|4FBX|A Chain A, Complex Structure Of Human Protein Kinase Ck2 Catalytic
Subunit Crystallized In The Presence Of A Bisubstrate
Inhibitor
Length = 335
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 111 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 267
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 61/298 (20%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV---R 195
T F + +G G +G V++ ++G A+K+ + + E E H +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKAL 254
H ++VR E H ++ EY N G+L + R Y EA +K +LL + L
Sbjct: 68 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK-EAELKDLLLQVGRGL 126
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM---GTFGY 311
Y+H +VH DIK SNI I ++ S A G + +VM G G+
Sbjct: 127 RYIHSM---SLVHMDIKPSNIFI-----SRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 178
Query: 312 V----APE-------YANTGLLNE------KSDVYSFGVLLLEAITGRDPVD-HGRPAHE 353
V +P+ + +L E K+D+++ + ++ A G +P+ +G HE
Sbjct: 179 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA-AGAEPLPRNGDQWHE 237
Query: 354 V--------------NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRS--LLTALR 395
+ + LK+M + P+ E RPS AL + LL+A R
Sbjct: 238 IRQGRLPRIPQVLSQEFTELLKVM---------IHPDPERRPSAMALVKHSVLLSASR 286
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/284 (22%), Positives = 122/284 (42%), Gaps = 35/284 (12%)
Query: 149 LGEGGYGVVYRG--------NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
LG+G + +++G ++ + V +K + + F + + HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
G C+ G +LV E+V G+L+ +L ++ + +++V A A+ +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEYA 317
++H ++ + NIL+ + + K + KL G S + +V PE
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 318 -NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
N LN +D +SFG L E +G D +P ++ S+R + +
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGD-----KPLSALD----------SQRKLQFYEDR 234
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
++ P+ +A + + L C+D + + RP ++R L S P
Sbjct: 235 HQL-PAPKAAELANLIN-NCMDYEPDHRPSFRAIIRDLNSLFTP 276
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 39/78 (50%)
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS 326
HRD+K NIL+ D A + DFG+A K +GT Y APE + ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 327 DVYSFGVLLLEAITGRDP 344
D+Y+ +L E +TG P
Sbjct: 217 DIYALTCVLYECLTGSPP 234
>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Ellagic Acid
pdb|3AMY|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Apigenin
pdb|3AT2|A Chain A, Crystal Structure Of Ck2alpha
pdb|3AT3|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivative
pdb|3AT4|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivertive
pdb|3AXW|A Chain A, Crystal Structure Of Human Ck2alpha Complexed With A
Potent Inhibitor
Length = 340
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV+E+VNN + +Q L+ + ++ R + KAL Y H ++HRD+K
Sbjct: 116 LVFEHVNNTDFKQ-LYQTL-----TDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 165
Query: 274 NILIDDDF-NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNEKSDVYSF 331
N++ID + ++ D+GLA+ G+ + RV + + PE + + + D++S
Sbjct: 166 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 223
Query: 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-NIEVRP 381
G +L I ++P HG ++ LV K++ G+ + +D NIE+ P
Sbjct: 224 GCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-GTEDLYDYIDKYNIELDP 272
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
YLH +++RD+K N+LID +V+DFG AK + T + GT Y+A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + N+ D ++ GVL+ E G P +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.317 0.134 0.392
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,087,486
Number of Sequences: 62578
Number of extensions: 531540
Number of successful extensions: 3928
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 890
Number of HSP's successfully gapped in prelim test: 208
Number of HSP's that attempted gapping in prelim test: 1319
Number of HSP's gapped (non-prelim): 1152
length of query: 463
length of database: 14,973,337
effective HSP length: 102
effective length of query: 361
effective length of database: 8,590,381
effective search space: 3101127541
effective search space used: 3101127541
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 53 (25.0 bits)